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SUMMARY
A major feature of the biology of herpes simplex 
virus type 1 (HSV-1) is it's capacity to establish a latent 
infection in peripheral nervous system ganglionic neurons 
and to periodically reactivate to produce recrudescent 
disease.
Until recently the extent and the nature of any
expression from latent HSV genomes was unknown. In 1987, 
latency associated transcripts (LATs) were detected in
murine ganglia which were latently infected with HSV-1. 
The LATs map to the long repeat region and are transcribed 
in the opposite direction to and partially overlap with IE- 
1 mRNA. Subsequent work has refined our knowledge of the 
HSV-1 LATs and shown that transcripts associated with 
latency are also encoded by a number of other herpesviruses 
including pseudorabies virus in swine and bovine herpes
virus in rabbits.
It is now known that the HSV-1 LATs comprise at 
least 3 overlapping non-polyadenylated RNAs which share 
common 5' and 3' ends, but differ in size through
differential splicing. These LAT species are thought to be 
stable introns or stable processing products of a less 
stable 8.3 kb (m-LAT) polyadenylated primary transcript.
Since LAT appears to be the only actively 
transcribed gene during latency, the control of LAT gene 
expression must differ considerably from that of any of the 
lytic cycle genes. A great deal of attention has thus been 
focussed on the LAT promoter in order to identify cis- 
acting sequences responsible for this unique pattern of 
transcription.
In this study, in order to determine the location 
of the LAT promoter, various sequences upstream from the 2 
kb LATs were cloned and examined for their ability to drive 
expression of an adjoining reporter gene in transient 
expression assays in a plasmid expression vector. The 
response of these sequences to the presence of HSV-1 trans­
acting factors was also examined by infecting cells 
transfected with the various LAT promoter/CAT fusion 
constructs. Both the promoter and HSV-1 responsive elements 
mapped to a 137 bp region 800 bp upstream from the 5' end 
of the 2kb LATs. Sequence analysis of this region 
demonstrated that it contained several homologies to 
recognised promoter elememts including a TATA box, a CAAT 
box and two putative Spl binding sites. Comparison of this 
region to the corresponding region of the HSV-2 genome 
revealed that while the 2kb LAT transcription unit itself 
is completely unconserved, the putative LAT promoter region 
bears several interesting conserved loci, possibly 
indicative of the presence of enhancer like elements 
responsible for tissue-specific expression of the LAT gene.
Several of the LAT promoter/CAT fusion constructs 
were examined in the context of the virus genome by use of 
a virus vector whereby DNA sequences of interest are 
introduced into the viral genome by direct ligation. To 
facilitate this analysis, the parental vector was modified 
by deletion of the endogenous LAT sequences, thereby 
preventing possible rearrangments of the viral genome by 
homologous recombination between the endogenous and 
introduced LAT promoter sequences. These recombinant 
viruses were subsequently used for analysis of the LAT 
promoter during infection of tissue culture cell lines. The 
most significant result to come from these studies was the 
finding that sequences upstream from the core LAT 
promoter, while not having any effect on LAT promoter 
strength in BHK cells, considerably enhanced LAT promoter 
strength in C1300 neuroblastoma cells, thereby suggesting 
that these sequences harbour neuronal specific enhancer 
elements.
In addition to studying the LAT promoter, it was 
considered interesting to examine the behaviour of an 
endogenous neuronal specific promoter when introduced into 
the virus genome. To this end, the 5' flanking region of 
the human neurofilament-light chain gene was obtained, and
two constructs, extending from -296 to +84 and -896 to +84 
of the HNF-L promoter fused to the CAT reporter gene were 
made. Transient transfection assays showed that these 
constructs performed at least as well as the HSV-1 gD 
promoter, and were similarly strongly trans-activated upon 
infection of transfected cells with HSV-1. Introduction of 
the HNF-L/CAT fusions into the HSV-1 genome, and subsequent 
examination of these constructs during infection of tissue 
culture cell lines revealed that sequences upstream from 
-296, while only moderately enhancing promoter activity in 
BHK cells, had a greater effect in C1300 neuroblastoma 
cells, thereby suggesting that these sequences perhaps also 
containied neuronal specific enhancer elements.
The original aim of these studies was to examine 
promoter/reporter gene activity of the various recombinant 
viruses in animal latency systems. However, due to lack of 
time and the necessity of replacing the CAT with the l a d  
reporter gene for reasons of sensitivity, these studies 
were unable to be carried out. One virus which was 
available, (vFJ12) containing the HSV-2 IE-4/5 promoter 
fused to the l a d  reporter gene was used in animal latency 
studies. In situ analysis showed that the parental virus 
vector expressed LAT in latently infected murine sensory 
ganglia, thereby demonstrating that this virus could 
establish latency in this system. Histochemical analysis of 
dorsal root ganglia infected with vFJ12 showed that during 
acute infection, a large number of densely stained neurons 
were observed, indicative of strong IE-promoter activity in 
those cells. Suprisingly, histochemicaly stained neurons 
were also observed in the spinal ganglia of mice after long 
term latent infection with vFJ12, thereby suggesting that 
the IE-4/5 promoter may be fuctional during latency. 
Genomic analysis of this virus, however showed that some 
rearrangment had taken place in the Us region of this virus 
where the IE-4/5 promoter/JacZ fusion had been inserted. 
While the IE-4/5 promoter was still immediately upstream of 
the l a d  gene, it seemed likely that the deletion resulted
in the l a d  gene also coming under control of the LAT 
transcription unit, and that subsequent long term l a d  
expression during latency is a consequence of read-through 
transcription from the LAT promoter.
Nevertheless, the parental 1802/1804 vector should 
prove to be a useful system for exploring the control of 
HSV gene expression in neurons, and indeed, may have many 
interesting applications in neurobiology.
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Vmw apparent molecular weight of virus-induced protein
vol volume(s)
v/v volume/volume
VZV varicella zoster virus
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CHAPTER 1: INTRODUCTION 
1A. BIOLOGY OF THE HERPESVIRIDAE
1A.1. Structure and Classification
The Herpesviridae are a morphologically homogeneous 
family of large DNA-containing animal viruses. Herpesvirus 
particles characteristically consist of an icosahedral 
nucleocapsid containing a linear double-stranded DNA genome 
of between 0.1 and 0.25 Mb in size.
Electron-microscopic analysis has revealed that the 
herpes virion consists of four distinct morphological 
features:
i) an electron-dense core, tor'oidal in conformation and 
consisting of a DNA/protein complex (Epstein, 1962b, 
Zamberland & Vatter, 1966, Furlong et al. , 1972, Nazerian, 
1974) .
ii) an icosahedral caps id, 125 nm in diameter and 
comprising 12 pentameric capsomeres and 150 hexameric 
capsomeres, each being 12 nm in diameter (Wildy et al., 
1960, Schrag et al., 1989, Baker et al., 1990).
iii) a tegument, consisting of a largely undefined 
amorphous proteinaceous layer between the capsid and 
envelope (Roizman & Furlong, 1974, Epstein, 1962b, Spear,
1980) .
iv) an envelope of typical trilaminar appearance which 
surrounds the caps id and tegument, and is derived by 
budding through the inner nuclear membrane (Epstein 1962a, 
Nii et al., 1968, Asher et al., 1969). The envelope
contains numerous virally encoded glycoprotein spikes,
2approximately 8 nm in length (Wildy & Watson, 1963, Spear & 
Roizman, 1972).
Herpesvirus classification into three main 
subgroups- a, 13, and Y- has been based largely on host 
range and tropism, as well as in vitro growth rate and 
characteristics of viral latency (Roizman, 1982). Each of 
these groups embrace a large number of viruses, (Honess, 
1984), but here, specific reference will only be made to 
the stereotypic human herpesviruses which happen to be the 
best studied of the herpesviridae.
1A.2. Human Herpesviruses and Disease
There are at least 6 known herpesviruses whose 
natural host is man, and these include representatives of 
all 3 subfamilies:
2.1. The g-Herpesviruses: These 'neurotropic' viruses
typically cause mild primary infections of epithelial cells 
of skin giving rise to vesicular lesions. HSV-1 is 
typically associated with lesions of the eyes (herpes 
keratitis) and oral cavity (herpes labialis), while HSV-2 
is predominantly associated with lesions of the genital 
tract (herpes genital is),(Whit ly, 1985). Following primary 
infection, alphaherpesviruses typically persist in a latent 
form and may give rise to periodic recurrences of mild 
disease. The normal sites of latency appear to be the 
ganglionic neurons innervating the primarily infected area 
(Baringer & Swoveland, 1973, Fraser et al. , 1981). HSV has 
also been associated with serious generalized infections of 
neonates, or a rare, but fatal encephalitis in adults 
(Whit'ly, 1985). Spread of the virus is typically by oral 
or genital contact.
Primary infection of varicella zoster virus (VZV) 
results in the childhood disease known as chicken pox
3(varicella). VZV can establish a latent infection in dorsal 
root ganglia during primary infection. Upon reactivation, 
the cutaneous disease herpes zoster (shingles), a 
predominantly adult disease may be produced. In vitro, 
alphaherpesviruses typically have a broad host range and 
relatively rapid growth cycle (<18h).
2.2. The fl-Herpesviruses: Members of this 1 salivary-gland' 
virus group tend to be in vitro species-specific. A 
betaherpesvirus prototype is human cytomegalovirus (HCMV). 
HCMV infection in normal adults is widespread, but results 
in a benign and asymptomatic disease. However, disease can 
be disseminated and severe in unborn children or in 
immunosupressed patients, particularly in transplant 
therapy, and more recently, in patients with acquired 
immune deficiency syndrome (AIDS). The virus can be passed 
from mother to foetus and is a major cause of congenital 
damage in infants. The site(s) and essential features of 
betaherpesvirus latency are unknown, but they can be 
isolated from salivary gland epithelium, lymphoreticular 
cells and kidney cells. The reproduction cycle is slow and 
is characterized by cell enlargement (cytome^Lia) and 
presence of DNA inclusions in the nucleus.
2.3. The V-Herpesviruses: These 'lymphotrophic' viruses are 
typified by the B-cell lymphotrophic Epstein-Barr virus 
(EBV), the causitive agent of infectious mononucleosis 
(glandular fever). In African populations, EBV is 
associated with Burkitts lymphoma (a B-cell malignancy), 
and in Asian populations, with nasopharyngeal carcinoma (an 
epithelial cell malignancy). Gammaherpesvirus in vitro host 
range is usually restricted to the same family or order as 
the natural host. EBV is able to establish latency in 
lymphocytes. It efficiently immortalizes B-lymphocytes in 
vitro which has facilitated the study of a model 
gammaherpesvirus latent state (Dambaugh et al., 1986,
4Epstein & Achong, 1986).
A sixth human herpesvirus was described in 1986. It 
was first termed human B-lymphotrophic virus (Josephs et 
al., 1986, Salahuddin et al., 1986) but is now known as 
human herpesvirus-6 (HHV-6) (Ablashi et al. , 1987). It was 
first isolated from patients with AIDS or 
lymphoproliferative disorders, however, the only disease in 
which HHV-6 has been implicated is exanthem subitim, a 
transient childhood illness (Yamanishi et al., 1988). It is 
now thought that this virus can grow in lymphocytes of both 
B and T lineages (Downing et al. , 1987, Lopez et al. ,
1988) . Classification of this virus has proven to be 
problematic; although originally classified in the gamma 
subfamily on the basis of its ability to infect lymphoid 
cell lines, sequencing studies show that at the molecular
level it is more closely related to HCMV (Lawrence et al. ,
1990) .
The isolation of a seventh human herpesvirus from
CD4 + T cells has recently been reported (Frenkel et al.,
1990). This virus, termed human herpesvirus 7 (HHV-7),
appears to be partially related to HHV-6 as identified by 
restriction enzyme and blot hybridization analysis. No 
such cross-hybridization was observed with probes from HSV, 
EBV or HCMV.
1A.3. and Oncogenesis
HSV and HCMV have long been associated with the 
induction of premalignant or malignant disease; 
particularly HSV-2 in the case of squamous cell carcinoma 
of the cervix. Early links between HSV and neoplastic 
disease were based on seroepidemiological studies (reviewed 
by Rawls, 1983; Vonka et al., 1984). However, any direct
5role for HSV-2 in the development of cervical carcinoma has 
proven difficult to evaluate; the presence of viral DNA 
sequences has only been detected in a small proportion 
(about 10%) of cervical carcinoma tissues, in contrast to 
human papilloma virus (HPV), which is strongly associated 
with human genital neoplasia, being present in over 80% of 
tumours (reviewed by Macnab, 1987).
Morphological studies have failed to demonstrate 
HSV encoded transforming genes (Cameron et al., 1985) 
similar to those of the DNA tumour viruses eg, adeno and 
papova viruses. However, 3 regions of the HSV genome and 
one region from the HCMV genome (termed morphological 
transforming regions; MTRs) have been demonstrated to 
induce transformation of cultured cells. These regions are: 
MTR I, Xbal f, (0.29 to 045 m.u.) and Bglll i, (0.311 to 
0.415 mu) of HSV-1, (Reyes et al. , 1979); MTR II, mapping 
in HSV-2 Bglll n, (0.58 to 0.62 mu), (Reyes et al. , 1979; 
Macnab & McDougall, 1980; Galloway & McDougall, 1981; 
Cameron et al. , 1985); MTR III, mapping in HSV-2 Bglll c, 
(0.54 to 0.58 mu), (Jariwalla et al., 1983) and HCMV MTR 
Hindlll E (0.123 to 0.140), (Galloway et al., 1984; Nelson 
et al. , 1984). These transforming regions share no
homologies with each other. Moreover, surprisingly small 
subfragments of these regions, unable to encode any intact 
proteins, have been shown to induce morphological 
transformation (Galloway et al. , 1984). Also, the DNA used 
to induce morphological transformation is not necessarily 
maintained within the transformed cell (Galloway & 
McDougall, 1983; Galloway et al., 1984; Cameron et al., 
1985; Jariwalla et al., 1986), which possibly suggests some 
kind of "hit and run" mechanism (Skinner, 1976; Minson et 
al., 1976), where the DNA is involved in the initiation of 
transformation, yet its presence is not required for 
maintenance of the transformed state.
One model has been suggested where the specific 
arrangement of DNA in these sequences may initiate
6transformation; Galloway et al., (1984) proposed that small 
stem/loop structures of 737 bp in MTR II and 490 bp in the 
HCMV MTR may induce morphological transformation, acting 
either as a mutagen or transcriptional activator. However, 
there is no evidence that these structures have any 
significance, indeed, it is possible to generate similar 
structures with randomly shuffled DNA sequences (Macnab,
1987).
There are many possible mechanisms whereby HSV may 
disrupt normal cellular gene regulation or perhaps even 
cause rearrangements or gene amplification. HSV has been 
shown to act as a mutagen on a cellular reporter gene 
(Pilon et al., 1985; 1986) and also induce chromosome
damage (Peat & Stanley, 1986) and gene amplification (Lavi,
1981). HSV has the potential to elevate the expression of 
various cellular genes upon infection, (LaThangue et al., 
1984; Kennedy et al., 1985; Macnab et al., 1985; Patel et 
al., 1986; Latchman et al., 1987), occurring directly 
through the HSV transcriptional activators or as a result 
of the mutagenic activity of HSV gene products involved in 
DNA metabolism and rearrangement. Indeed, some HSV-1 
transformed cell lines have been shown to transcribe 
certain cellular genes at elevated levels (Filion et al.,
1988) and some cellular polypeptides expressed at increased 
levels in infected cells also accumulate to higher levels 
in transformed cells (Macnab, 1985).
1A.4. Genome Structures of the Human Herpeaviruaea
The structure and organisation of herpesvirus 
genomes has aroused great interest since it was
demonstrated that HSV-1 DNA could be isolated from virions 
as a linear duplex molecule containing single-stranded 
nicks (Kieff et al., 1971; Wilkie, 1973).
7The HSV-1 DNA is regarded as consisting of two 
covalently linked segments termed the Long (L) and short 
(S) regions. Each of these contains a unique sequence, (Ul 
and Us) which is flanked by a pair of oppositely oriented 
repeat sequences (Rl and Rs) . The terminal and internal 
copies of Rl are termed TRl and IRl respectively; for Rs, 
these are termed TRs and IRs. (see Figure 1; Sheldrick and 
Berthelot, 1974). The molecules also possess a terminal 
redundancy of some 400 bp, termed the a sequence; one or 
more additional copies of this sequence are located 
internally at the joint region between the L and S segments 
in opposite orientation to the terminal a sequences 
(Sheldrick & Berthelot, 1974; Wadsworth et al.f 1975, 
Wagner & Summers, 1978; McGeoch et al., 1986). Each 
terminus possesses one overhanging 3' residue, with the 3 1 
hydroxyl group free (Mocarski & Roizman, 1982a). In a 
productively infected cell, an inversion process occurs at 
the internal a sequence so that the progeny virion DNA 
consists of a mixture of four sequence-oriented isomers 
which differ in the relative orientations of their L and S 
segments, (Hayward et al., 1975; Delius & Clements, 1976; 
Wilkie, 1976). One isomer is designated the prototype for
mapping purposes (Roizman, 1979).
The full genomic sequence of HSV-1 strain 17+ 
became available in 1988 and was shown to comprise 152,260 
residues in each strand (McGeoch et al., 1985; McGeoch et 
al, 1986; McGeoch et al., 1988a; Perry & McGeoch, 1988), 
however this value will probably vary somewhat due to the
natural variability of different HSV-1 strains and
different copy numbers of reiterations. HSV-1 DNA has a 
base composition of 68.3% G+C (McGeoch et al. , 1988a)
although the actual composition of specific regions of the 
genome may deviate from this value, eg, the 6.6 kbp Rs with 
a G+C content of 79.5%. The genome of HSV-1 is predicted as 
possessing 74 genes, densely arranged, and encoding 71 
distinct proteins. There are 12 genes in Us and 56 in Ul ,
Figure 1. Gross structures of the human herpesviruses. Each 
linear genomic DNA is shown with unique sequences as heavy 
lines and repeat elements as boxes with relative 
orientations indicated by arrows.
Nomenclature:
Ul Unique-long
Us Unique-short
I/TRl Internal/terminal long repeat.
I/TRs Internal/terminal short repeat
MIR Major internal repeat.
Dp Direct repeat (right).
D l Direct repeat (left).
This Figure is based on one published in McGeoch (1989), 
reproduced with permission.
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Figure 2. Layout of genes in the genome of HSV-1. The HSV-1 
genome is shown on four successive lines, with unique 
regions represented by solid lines an major repeat elements 
as open boxes. The lower scale represents kilobases, 
numbered from the left terminus, and the upper scale 
represents fractional map units. The sizes and orientations 
of proposed functional ORFs are shown by arrows. Overlaps 
of adjacent, similarly oriented ORFs are not shown 
explicitly. Locations of proposed transcription 
polyadenylation sites are shown as short vertical bars. 
Locations of origins of DNA replicaton are indicated as X. 
In the U l region, on the first three lines, genes UL1 to 
UL56 are labelled. In the Us region, on the bottom line, 
genes US1 to US12 are labelled. The locations of introns in 
the coding regions of gene UL15 and the two copies of the 
IE110 gene are indicated. Three additional genes are not 
shown. These are ICP34.5 (see Figure 5), UL26.5, and
UL49.5.
This Figure is taken directly from McGeoch et al. (1988a) 
with permission.
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Table 1. Summary of functions and phenotypes for genes of 
HSV-1.
HSV-1 gene Protein and/or function
ICP34.5 Neurovirulence
IE110 IE transcriptional regulatory protein
UL1 Unknown
UL2 Uracil-DNA glycosylase
UL3 Unknown
UL4 Unknown
UL5 Required for DNA replication; probable DNA
helicase component 
UL6 Presumed virion protein; possible role in
DNA packaging 
UL7 Unknown
UL8 Required for DNA replication; function
unknown
UL9 Required for DNA replication; ori-binding
protein
UL10 Function unknown; possible membrane
inserted protein 
UL11 Unknown
UL12 Deoxyribonuclease
UL13 Predicted protein kinase
UL14 Unknown
UL15
exon 1 Unknown (related to T4 packaging protein)
exon 2 
UL16 Unknown
UL17 Unknown
UL18 Capsid protein
UL19 Major capsid protein
UL20 Unknown
UL21 Unknown
UL22 Glycoprotein H
UL23 Thymidine kinase
UL24 Unknown
UL25 Virion protein
UL26 Protease
UL26.5 Capsid assembly protein
UL27 Glycoprotein B
UL28 Probable structural protein
UL29 ssDNA binding protein required for DNA
replication 
UL30 Replicative DNA polymerase
UL31 Unknown
UL32 Probable structural protein
UL33 Structural; involved in DNA packaging
UL34 Possible virion protein
UL35 Capsid protein
UL36 Very large tegument protein
UL37 Unknown
UL38 Capsid protein
UL39 Ribonucleotide reductase large subunit
UL40 Ribonucleotide reductase small subunit
UL41 Presumed virion protein; virion host
shutoff
UL42 DNA binding protein, required for DNA
replication
UL43 Unknown
UL44 Glycoprotein C
UL45 Virion protein
UL46 Unknown
UL47 Unknown. May modulate activity of UL48
protein
UL48 Major tegument protein, transactivates IE
genes
UL49 Tegument protein
UL49.5 Possible membrane protein
UL50 Deoxyuridine triphosphatase
UL51 Unknown
UL52 Required for DNA replication, function
unknown
UL53 Possible membrane protein
UL54 IE transcriptional regulatory protein
UL55 Unknown
UL56 Unknown
IE175 IE transcriptional regulatory protein
US1 IE protein
US2 Unknown function
US3 Protein Kinase
US4 Glycoprotein G
US5 Glycoprotein J
US6 Glycoprotein D
US7 Glycoprotein I
US8 Glycoprotein E
US9 Virion protein
US10 Virion protein
US11 Function unknown; localizes in nucleolus
US12 IE protein
This table is adapted from an original table published in 
McGeoch, (1989), with permission.
8while R l contains 2 genes encoding VmwllO and ICP34.5, and 
Rs contains 1 gene encoding Vmwl75. The genomic location of 
the HSV-1 genes are shown on Figure 2, and a summary of 
their functions are given on Table 1.
The genomic structure of HSV-2, though not
completely sequenced yet, is essentially similar to that of 
HSV-1, but with a slightly higher G+C content. DNA
hybridization studies have demonstrated that the HSV-1 and 
HSV-2 genome sequences are highly related and closely 
colinear (Kieff et al., 1972; Davison & Wilkie, 1983). This 
has been borne out by the demonstration that intertypic 
recombinants between HSV-1 and HSV-2 are viable (Wilkie et 
al., 1977). It therefore seems very likely that the genetic 
organization of HSV-2 will be found to be nearly 
indistinguishable from HSV-1. Coding sequences of 
corresponding genes show 70%-80% identities (McGeoch et 
al. , 1987) with homology being less pronounced in non­
coding regions, and most divergence occurring in parts of 
the major repeats (Davison & Wilkie, 1981; Whitton & 
Clements, 1984).
The genome of VZV, also a double-stranded DNA 
molecule, has been demonstrated by DNA sequencing to 
consist of 124,884 bp with a base composition of 46.0% G+C 
(Davison, 1983; Davison & Scott, 1983). The genome consists 
of two covalently-linked regions, L and S, thus resembling 
that of HSV-1, except that where Us is flanked by large
inverted repeats (TRs , IRs; 7320 bp), Ul is flanked by
inverted repeats of only 88 bp. VZV does not possess a 
terminal redundancy, and as with HSV—1, each terminus has 
an unpaired residue (Davison, 1984). VZV DNA also occurs in 
four sequence—oriented isomers, however, two of the isomers 
(representing one orientation of U l )/ axe about 20—fold 
more abundant than the other two (Davison, 1984).
The EBV genome, the first herpesvirus genome to be 
sequenced, is a linear double—stranded molecule of 
prototype sequence 172,282 bp with 59.9% G+C content (Baer
9et al., 1984). However, further analysis indicated that the 
prototype strain, B95-8, was an unusual deletion derivative 
(an artifact common in laboratory strains maintained in 
cell lines), (Raab-Traub et al., 1980; Laux et al., 1985), 
indicating that the true length of the EBV genome is 
probably closer to 186 kbp. The EBV genome termini consist 
of tandem repeats of 538 bp (termed terminal repeats; TR;) 
(Given et al. 1979; Kintner et al., 1979). A variable 
number of large internal repeats of 3072 bp, termed major 
internal repeats (MIRs), join a short and long unique 
region (Given & Kieff, 1979; Rymo & Forsblom, 1978; Hayward 
et al. 1980). Another set of two lOOObp repeat regions of 
nearly identical sequence, termed D l  and D r ,  are located 
near the extremities of Ul (Laux et al. , 1985; Raab-Traub 
et al., 1980). These elements lie in the same orientation, 
and each is adjacent to a family of tandemly reiterated 
sequences.
The HCMV genome is structurally similar to HSV with 
respect to the layout of unique and repeat sequences, 
(Geelen et al. , 1978; Kilpatrick & Huang, 1977; Stinski et 
al., 1979; Weststrate et al. , 1983). It possesses the
equivelant of an a sequence (Spaete & Mocarski, 1985) and
also occurs in four sequence-oriented isomers. HCMV, at 230 
kbp with a base composition of 56% G+C, is the largest of 
the human herpesvirus genomes (due.
Information concerning the structure of the HHV-6 
genome is scarce, however, it is thought to contain around 
160 kbp (42% G+C) in a structure consisting of a single 
unique sequence flanked by a pair of large direct repeats 
(Lawrence et al. , 1990). As yet, no information at all
exists concerning the genomic structure/content of the 
putative HHV-7.
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1A.5. THE HSV-1 LYTIC CYCLE
5.1. Adsorption and Penetration
Virus entry into a cell requires virus attachment 
and penetration of the cell surface (Morgan et al. , 1968). 
Adsorption and penetration are distinct processes involving 
different components of the virion envelope. Most work 
concerning the virion components has centred upon the viral 
glycoproteins gB, gD and gH which have been shown to be 
indispensible for virion infectivity (Sarmiento et al, 1979 
Cai et al. , 1987; Desai et al. , 1988; Ligas & Johnson,
1988; Little et al., 1981). HSV virions contain at least 
five other membrane glycoproteins, (gC, gG, gl, gE and gJ), 
however, these seem to be dispensible for infection of 
cultured cells, (Heine et al., 1974; Homa et al. , 1986a;
Longnecker & Roizman, 1987; Neidhardt et al., 1987).
The initial attachment of HSV to cells involves the 
binding of the virion to heparan sulphate moieties of cell 
surface proteoglycans (WuDunn & Spear 1989). Neither gB nor 
gD are involved in this initial attachment as virions 
devoid of either glycoprotein can adsorb to cells normally 
(Cai et al., 1988; Ligas & Johnson, 1988). Although not 
tested yet, it seems likely that gH-negative mutants will 
also prove to be adsorption competent and penetration 
negative. The finding that monoclonal antibodies specific 
for gB (Highlander et al. , 1988), gD (Fuller et al. , 1987; 
Highlander et al. , 1987) and gH (Fuller et al. , 1989), and 
ts mutants of these proteins; gB (Sarmiento et al. , 1979; 
Little et al. , 1981; Cai et al., 1988) and gD (Ligas &
Johnson, 1988, Johnson & Ligas, 1988), can block 
penetration without blocking adsorption are consistent with 
the role for these proteins in steps subsequent to initial 
adsorption. In addition there is evidence that the UL25 
gene product, a probable tegument protein, is required at a
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late stage of viral entry since the mutant £sl204 which has 
a lesion in this polypeptide has a penetration defect at 
the NPT (Addison et al., 1984).
Although the initial binding of HSV to cells 
requires the presence of heparan sulphate on the cell 
surface, stable attachment may require subsequent 
interactions of the virion glycoproteins with other cell 
surface receptors. Indeed, there is evidence that gD 
interacts with its own distinct cell surface receptor 
(Fuller & Spear, 1985; Campadelli-Fiume et al., 1988; 
Johnson & Ligas, 1988; Ligas & Johnson et al. , 1988;
Johnson & Spear, 1989). It is still not clear whether gB 
and gH interact with specific cell surface receptors.
Once fusion of the viral envelope and cell membrane 
has taken place, the viral nucleocapsid and tegument 
proteins are released into the cytoplasm (Morgan et al. , 
1968). Once inside the cell, nucleocapsids accumulate at 
nuclear pores where the viral DNA is released; a ts mutant 
mapping to UL36, a very large tegument protein of unknown 
function is deficient in releasing virion DNA from capsids 
at the nuclear pores (Batterson et al., 1983; Knipe et al.,
1981) .
5.2. The Effect of HSV on Host Cell Macromolecular 
Synthesis
Infection of tissue culture cells by HSV causes a 
well characterized decline in host cell macromolecular 
synthesis that typically occurs within 2-4 hours post­
infection in a strain dependent manner (reviewed by 
Fenwick, 1984). Early studies indicated that upon HSV 
infection, synthesis of cellular DNA is blocked (Roizman & 
Roane, 1964), and that cell mitosis is arrested (Wildy et 
al., 1961). HSV-1 infection has also been shown to induce
specific chromosome damage at early times of infection,
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which becomes more extensive at late times (Peat & Stanley,
1986) .
Inhibition of host protein synthesis has been 
clearly shown to be brought about by the action of a 
component of the HSV virus particle; the product of gene 
UL41, termed the virion host shutoff (vhs) function 
(Nishioka & Silverstein, 1978; Fenwick & Walker, 1978; 
Kwong et al., 1988; Fenwick & Everett, 1990; Smibert et 
al. , 1992). The consequence of UL41 gene function is the
shut-off of cellular protein synthesis which is mediated at 
a number of levels including disaggregation of 
polyribosomes synthesising cellular proteins (Sydiskis & 
Roizman, 1966, 1967; Nishioka & Silverstein, 1978) and the 
degradation of cellular mRNAs Nishioka & Silverstein, 
1977,1978; Schek & Bachenheimer, 1985). Inactivation of the 
vhs gene has also been associated with increased stability 
of viral mRNAs (Read & Frenkel, 1983; Oroskar & Read, 
1987,1989; Kwong & Frenkel, 1987; Kwong et al., 1988), 
indicating that RNA degradation probably occurs by an 
indiscriminate mechanism. Mitochondrial RNAs have also been 
shown to be degraded upon HSV infection (Latchman, 1988). 
In addition to vhs, it also appears that a 'late' shutoff 
function requiring expression of early and late 
polypeptides is required for full and efficient shutoff of 
host polypeptide synthesis (Nishioka & Silverstein, 1978; 
Read & Frenkel, 1983).
The efficiency of vhs differs between different 
strains of HSV; HSV-2 strain G displays a strong shutoff 
phenotype, whereas HSV-1 strain 17 syn+ is weak and HSV-2 
strain HG52 is completely deficient (Pereira et al. , 1977; 
Schek & Bachenheimer; 1985 Fenwick & Owen, 1988). The 
latter can be explained by a frameshift mutation within the 
HSV-2 UL41 coding sequence and thus sunthesizes a truncated 
UL41 gene product (Everett & Fenwick, 1990). Surprisingly, 
in mixed infection experiments using weak and strong 
shutoff viruses, the weak UL41 allele generally inhibits
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the shutoff induced by the stronger one. (Hill et al., 
1985; Fenwick & Everett, 1990). Host shutoff therefore 
probably results in preferential synthesis of viral 
proteins due to the more rapid synthesis of their messages; 
vhs RNA degradation probably facilitates the rapid 
transitions in expression of the temporally regulated 
groups of viral genes that are transcriptionally active at 
different times post-infection (Kwong et al., 1988). The 
UL41 gene product has recently been identified by the use 
of rabbit antipeptide antiserum as a 58K phosphoprotein in 
infected cells (Smibert et al., 1992).
Another effect of HSV on host macromolecular 
synthesis is that, despite vhs, a small number of cellular 
proteins are observed to increase in abundance following 
infection. Activation of cellular stress protein gene 
expression occurs after infection with HSV-1 ts mutants 
which overproduce IE polypeptides at NPT (Notarianni & 
Preston, 1982; Russell et al., 1987a). Other studies have 
indicated that infection with HSV-2 induces synthesis of 
minor cellular stress proteins (LaThangue, et al., 1984; 
Patel et al., 1986; Kennedy et al., 1986), and that their 
synthesis is stably increased in cells transformed by HSV 
(Macnab et al., 1985). In some cases, cellular gene 
induction has been shown to be dependent on the expression 
of the viral immediate-early transactivating protein Vmwl75 
(Latchman et al. , 1987; Kemp & Latchman, 1988). In other
cases it is independent of viral protein synthesis (Kemp et 
al. , 1986). Cellular promoters introduced into cell lines
by biochemical transformation can also be activated by HSV- 
1 infection, and this involves the action of IE 
transactivating proteins, VmwllO and Vmwl75 (Everett,
1985). In addition, a recent report has also demonstrated 
that binding of the HSV virion to the cell surface directly 
induces a, so far uncharacterized, 56,000 molecular weight 
protein (Preston, 1990).
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5.3. HSV DNA REPLICATION
Studies of DNA replication have been hampered by
the large size of the HSV genome. However, analysis of
replication intermediates using pulsed labelling and 
electron microscopy have shown that DNA pulse-labelled in 
vivo sediments more rapidly than unit length DNA (Jacob & 
Roizman, 1977), and that it is "endless" ie, the molecular 
termini are fused together (Jacob et al. , 1979; Jongeneel
& Bachenheimer, 1981). On this basis it is proposed that 
parental viral DNA is circularized shortly after entry into 
the host cell, and that replication takes place by a
rolling circle mechanism generating linear concatamers of 
tandemly repeated viral genomes (Jacob & Roizman, 1979). 
This hypothesis is largely untested and other mechanisms eg 
the 'Cairns' type mechanism (which may also account for
higher sedimentation) cannot be discounted (Jongeneel & 
Bachenheimer, 1981).
3a. The Replication Origins
HSV contains two distinct origin sequences (Vlazny 
& Frenkel, 1981). Both have been cloned from the wild-type 
viral genome (Stow, 1982; Stow & McMonagle, 1983; Weller et 
al., 1985) and plasmids containing either of these 
sequences have been shown to be amplified when cells 
transfected with them are infected with HSV. Oris is 
located within the inverted repeat of Us and thus is 
present in two copies (Mocarski & Roizman, 1982b; Stow, 
1982; Stow & McMonagle, 1983). OriL is located in the 
middle of Ul (Locker et al., 1982). Oris appears to consist 
of less than 100 bp, including a 45-bp dyad symmetry with a 
central region of 18-bp containing only A and T residues; 
oriL is very similar, but the dyad symmetrical region is 
longer (Murchie & McGeoch, 1982; Knopf et al. , 1986). The
functional significance of three separate origins of
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replication is not clear. Mutants lacking oriL or one oris 
appear to be viable (Longnecker & Roizman, 1986; Polvino- 
Bodnar et al., 1987). However, it has proven impossible to 
construct a virus lacking both oris sequences hence 
implying that virus replication requires at least two 
origin sequences whether they be on*L or oris. It has been 
demonstrated that two arms of the oris palindrome serve as 
UL9 binding sites (see below) and the central AT-rich
region has been proposed as a potential site of protein-
induced unwinding. However, many questions remain regarding 
the HSV origins. It seems likely that DNA replication 
begins at one or more of the origin sequences however, as 
yet, no information exists on the molecular events by which 
HSV DNA replication is initiated.
3b. Viral Genes Required for DNA Replication
The complete set of viral genes required for DNA
replication were identified by means of a transient 
complementation assay in which cloned HSV-1 DNA fragments 
were tested for the ability to support replication of a 
cotransfected plasmid containing oris or oriL (Challberg,
1986). Seven genes were found to be both necessary and
sufficient for origin-dependent DNA sythesis (Wu et al. ,
1988) . The functions of the products of most of the genes 
are either unknown or only recently identified. These are 
listed below:
DNA P o l y  erase (UL30) . Most highly purified preparations 
consist predominantly of a monomer of single polypeptide 
chain about 140 kd in size (O'Donnell et al., 1987; Powell 
& Purifoy, 1977) in good agreement with the size of product 
as predicted from the DNA sequence (Wu et al., 1988). The 
polypeptide is in itself a catalytically active polymerase, 
however it is not clear whether accessory factors may be 
required to increase efficiency or modify activity in some
U L42  i s  p r o p o s e d  t o  s e r v e  a s  a p r o c e s s i v i t y  f a c t o r  f o r  v i r a l  
DNA p o l y m e r a s e ,  a n d  t h a t  a  h e t e r o d i m e r  o f  U L 3 0  an d  UL42  
r e p r e s e n t s  t h e  f u n c t i o n a l  DNA p o l y m e r a s e  h o l o e n z y m e
( G o t t l e i b  et al ., 1 9 9 0 ) .
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way. As with many other polymerases, it has an intrinsic 
3 1”5 1 exonuclease activity that probably serves as a 
proofreading function to increase fidelity of DNA synthesis 
(Haffey et al., 1988).
UL42. A DNA binding protein of as yet unknown function 
(Parris et al. , 1988). In HSV-2, it can be co-purified with 
DNA polymerase as a 55 kd protein (Powell & Purifoy, 1977). 
It s effect, if any, on the DNA polymerase has yet to be 
determined.
Single—Stranded DNA Binding Protein (UL29). Recognized as 
an abundant HSV-1 induced protein of 130 kd present in 
infected cells (Honess & Roizman, 1973; Powell & Courtney, 
1975) and has been shown to bind tightly to single-stranded 
DNA cellulose columns (Ruyechan, 1983). It s function is 
presumably to bind single-stranded DNA present at the 
replication fork formed by unwinding of the parental
duplex, and to facilitate the use of these strands as 
templates for DNA polymerase.
Origin-Binding Protein (UL9). Originally identified in HSV 
infected cell extracts (Elias et al., 1986). Consists of a 
single major polypeptide of about 83 kd (McGeoch et al., 
1988b). UL9 protein has been expressed using a baculovirus 
expression system and demonstrated to interact with two
nearly identical sites located on each arm of the oris
palindrome (Olivo et al. , 1988; Weir et al. , 1989; Weir &
Stow, 1990). The role of UL9 binding in HSV DNA replication 
is not clear, however by analogy with other prokaryotic and 
eukaryotic origin recognition proteins, the binding of UL9 
to oris or orih may initiate assembly of a multiprotein 
replication complex. It has recently been shown, however, 
that the ability of the UL9 protein to bind to the viral 
origins of replication is not sufficient for it to 
facilitate DNA synthesis (Stow, 1992). It is also possible
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that it is involved in unwinding the two parental strands 
at the origin before DNA synthesis.
Helicaae/Primase. Infection of cells with HSV induces novel 
helicase and primase activities (Crute et al., 1988; Holmes 
et al., 1988). Both activities are components of a 3- 
subunit enzyme composed of the products of the UL5, UL8 and 
UL52 genes (Crute et al., 1989). The helicase can utilize 
either ATP or GTP as a co-factor for unwinding and moves in 
a 3 1 —5 1 direction on the strand to which it is bound 
(Hodgman, 1988; Zhu & Weller, 1988). This suggests that the 
enzyme may prime lagging strand synthesis as it unwinds DNA 
at the replication fork. The activities of the component 
polypeptides at the complex have yet to be determined, 
although UL5 contains several sequence motifs that are 
shared by helicases (McGeoch et al., 1988b).
Although HSV-1 contains only seven genes that are 
required for viral DNA replication in cultured cells, the 
virus encodes several other proteins likely to be involved 
in nucleoside/nucleotide metabolism, and DNA repair. These 
include a thymidine kinase (UL23)(Kit & Dubbs, 1963), a
ribonucleotide reductase (UL39 and UL40)(Frame et al., 
1985; Preston et al., 1984), a dUTPase (UL50)(Fisher & 
Preston. 1986), a uracil-DNA glycosylase (UL2)(Worrad & 
Carradona, 1988; Mullaney et al, 1989) and an alkaline
exonuclease (UL12)(Preston & Cordingly, 1982) , although a 
convincing role has not been identified for the latter. 
Genetic studies have demonstrated that while mutations in 
these genes have only minor or no effects on viral DNA 
synthesis in infected tissue culture cells, they may cause 
profound defects in the ability of the virus to replicate 
following experimental infection of animals (Cameron et 
al., 1988; Goldstein & Weller, 1988a). It is likely that 
rapidly dividing cultured cells may provide functions that 
are lacking in non-mitotic cells encountered by the virus
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in a natural infection. Whether host cells provide 
functions necessary for viral DNA replication that are not 
virus-encoded remains to be determined.
Despite the large body of information now 
accumulating concerning HSV DNA replication, any further 
in-depth analysis of this process requires the development 
of a soluble origin-dependent in vitro system.
5.4. Virus Maturation.
Following replication, the large concatameric HSV 
genomes are cleaved within the a sequences situated at the 
junctions between adjacent viral genomes. Studies with 
temperature-sensitive mutants have suggested that the 
cleavage process may be linked to packaging (Ladin et al., 
1982; Preston et al., 1983), with the a sequences probably 
serving as the recognition sequence for the machinery that 
processes concatamers to unit length during the 
encapsidation process (Stow et al, 1983; Varmuza & Smiley, 
1985; Diess et al., 1986). The product of gene UL26, termed 
p40, has been shown to be present in empty capsids, but not 
present as a component of full capsids or mature virions 
indicating that it is transiently associated with capsids, 
and that its removal from capsids is linked with the 
process of DNA packaging (Rixon et al., 1988; Sherman &
Bachenheimer, 1988). Any pair of a sequences along the 
concatameric molecule can be cleaved resulting in the 
packaging of monomers, dimers and higher multimeric forms 
into nuclear capsids. However, the multimeric forms do not 
contain any intact genomes, and only nucleocapsids 
containing unit length DNA are enveloped (Vlazny et al. , 
1982).
The classical theory of final virion maturation is 
that intranuclear capsids become enveloped by budding 
through the inner lamella of the nuclear membrane (which
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has been modified by viral glycoproteins) into the 
perinuclear space (Roizman & Furlong, 1974). Virions are 
then transported to the cytoplasmic membrane, possibly via 
the golgi apparatus, where virus egress typically initiates 
at around 8 hrs post-infection (Johnson & Spear, 1982). 
Recent studies, however, using the 8-herpesvirus HHV-6 
(Roffman et al., 1990) and the a-herpesviruses PRV (Whealy 
et al. , 1991) and HSV-1 (Cheung et al., 1991) support the 
belief that envelopment of nascent capsids takes place in 
the cytoplasm. In their model, Roffman et al. (1990) 
suggest that the envelope gained by the intranuclear 
capsids by budding through the inner nuclear membrane is 
lost by subsequent fusion with the outer nuclear membrane, 
culminating in release of the capsid into the cytoplasm. 
They also suggest that prior to this, tegumentation of the 
HHV-6 capsid occurs in a cytoplasmic inclusion in the 
nucleus termed the tegusome. Evidence for tegusome-1ike 
compartments has not been found in HSV-1 infected cells 
(personal communication, F.J. Rixon), and tegumentation of 
HSV-1 therefore probably occurs in the cytoplasm prior to 
envelopment by budding into the Golgi apparatus.
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IB. HSV-1 GENE REGULATION 
1B.1. An Overview
The expression of HSV-1 genes during infection of 
tissue culture cells can be divided into at least 3 
temporally regulated classes termed immediate-early (IE or 
alpha) , early (E or beta) and late (L or gamma) (Honess & 
Roizman, 1974; Clements et al., 1977). Regulation of HSV 
gene expression generally occurs at the transcriptional 
level (as opposed to translational) as demonstrated by the 
close correlation between the detection of mRNA 
transcripts and the kinetics of the expression of proteins 
encoded by them (Zhang & Wagner, 1987; Smith & Sandri- 
Goldin, 1988). Viral genes of all three kinetic classes are 
transcribed by the cellular RNA polymerase II (Costanzo et 
al., 1977) and are expressed in a coordinate and sequential 
fashion during the course of productive infection (Honess & 
Roizman, 1975).
Immediate-early genes are the first to be expressed 
during the replicative cycle, being detected within 1 hr. 
pi (Honess & Roizman, 1975). The synthesis of early gene 
products is detectable shortly after the appearance of the 
IE proteins, but peaks later at around 4-6 hrs pa; early 
gene expression requires functional immediate-early 
proteins (Preston, 1979a; Dixon & Schaffer, 1980). Finally, 
the late genes are expressed, appearing at about 2 hrs 
after the onset of viral DNA replication; maximal 
expression of late genes requires the activities of both IE 
and E gene products as well as viral DNA synthesis (Holland 
et al., 1980; O'Hare & Hayward, 1985). Late genes can 
actually be sub-divided into two further groups termed 
early-lates (or delayed-early) and true lates. The primary 
difference is that early-late gene expression does not 
require viral DNA synthesis (although viral DNA synthesis 
is required for maximal expression), whereas expression of
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true-late genes is j dependent upon viral DNA
synthesis (Wagner, 1985, Roizman & Batterson, 1985).
In terms of general function, IE genes encode the
major HSV regulatory proteins, early genes code for
proteins involved in viral DNA synthesis, and the late 
genes specify virion structural proteins.
IB.2. The Immediate-Early Genes of HSV-1
Immediate-early genes are the only HSV-1 genes 
expressed in the absence of de novo protein synthesis, with 
their mRNAs accumulating to high levels under these 
conditions (Kozak & Roizman, 1974; Clements et al. , 1977;
Jones & Roizman, 1979). 32P-labelled IE-RNA transcripts 
were used to identify the positions of the IE genes on the 
virus genome, with in vitro translation being used to 
define their protein products (Watson et al. , 1979). HSV-1 
encodes five IE mRNA species from five IE genes (IE175, 
IE110, US1, UL54 and US12); their genomic locations and 
orientations (Clements et al., 1979), are shown in Figure 
3.
Analysis of the IE genes by RNA mapping and DNA 
sequencing has revealed many interesting features
concerning the structures of these genes (Clements et al. , 
1979; Rixon et al., 1982; Murchie & McGeoch, 1982; McGeoch 
et al., 1985, 1986, 1988a; Perry et al. , 1986). Three of
the five primary IE transcripts (IE genes 1,4 and 5) are 
spliced; a phenomenon that is particularly rare in HSV 
(Wagner, 1985). The IE-4 and IE-5 RNAs are derived from 
identical promoters located in the repeat sequences which 
bound Us. The mRNA leader sequences and splice sites of 
these transcripts are located in the repeat sequences while 
their coding sequences are different, being located at 
either end of Us (Watson et al. , 1979a; Rixon & Clements,
1982). The transcript of the IE-1 gene is also spliced and 
maps wholly within the Rl repeat sequences thereby making
Figure 3. A simplified map of the HSV-1 genome showing the 
positions and orientations of the IE genes. The internal 
and terminal repeat sequences are labelled IR and TR with 
the subscript denoting the unique segment with which they 
are associated. The IE genes are labelled 1 to 5. (Not to 
scale).
Table 2. Nomenclature and properties of the HSV-1 IE genes 
and their products. The Glasgow system of nomenclature for 
the HSV-1 IE genes and their products is shown with the 
sizes of the primary unmodified amino acid sequence deduced 
from the DNA sequence and the sizes of the polypeptides as 
determined from SDS-polyacrylamide gel electrophoresis.
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it diploid (Perry et al., 1986). The IE-3 RNA is unspliced, 
and again diploid as it is transcribed entirely from within 
the Rs repeat sequences (Rixon et al., 1982). The only IE 
gene that is not in any way associated with the repeat 
sequences is that of the IE-2 gene whose unspliced RNA maps 
in U l (Whitton et al., 1983).
It seems that there is a discrepancy between 
the rate of IE gene transcription and IE mRNA and protein 
accumulation (Weinheimer & McKnight, 1987). Nuclear run-on 
assays have demonstrated that while IE-3 gene transcription 
is turned off after 1 hr, the IE-1 and 4/5 genes are still 
transcribed with increasing rates up to 5 hrs pa This 
observation is in contrast to the pattern of mRNA 
accumulation in the presence of metabolic inhibitors of 
mRNA and protein synthesis, which is similar for IE-1, 3
and 4/5 genes, thus suggesting that a post-transcriptional 
level of control must be regulating mRNA accumulation 
(Weinheimer & McKnight, 1987).
IB.3. Regulation of IE Gene Expression.
The control of transcription of the IE genes is an 
important area of research and a wealth of knowledge is 
accumulating concerning this subject. Expression from the 
HSV-1 IE promoters is regulated by the complex interactions 
of cellular factors and viral gene products which combine 
to interact at cis-acting elements upstream of the 5' ends 
of the IE-mRNAs. Indeed, the mechanism of IE gene trans­
induction by virion/cellular factor interactions is among 
the best understood and has become a fine example of 
combinatorial control of eukaryotic transcription.
3.1. The IE-Promoters.
Comparison of the 5' flanking regions of IE genes
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in HSV-1 and their counterparts in HSV-2 has revealed
several discrete blocks of conserved DNA sequences (Whitton
et al., 1983; Whitton & Clements, 1984). The promoter
regions of the IE genes, like many cellular genes, can be
dissected into two components. The proximal component
consists of TATA box homologies and IE-mRNA cap sites which
are necessary for basal and induced levels of
transcription. The distal component comprise multiple cis-
acting elements which confer enhancer function and
responsivity to IE regulation (Mackem fit Roizman, 1982a,b;
Cordingley et al., 1983; Preston et al., 1984; Kristie fit
Roizman, 1984; Bzik fit Preston, 1986). These distal elements
include 5 1-CCCGCCC motifs that bind the purified cellular
factor Spl in vitro, and these have been shown to be
associated with basal expression properties of the IE-3 and
4/5 promoters (Jones fit Tijan, 1985). Another conserved
block is the consensus 5'-TAATGARAT motif (R=purine) which
is present in several copies upstream from IE genes,
usually beyond -110 bp from the mRNA cap site. Functional
analysis has demonstrated that this element is essential
for the responses to trans-induction by the virion
associated polypeptide Vmw65 (Mackem & Roizman, 1982b;
Preston et al. , 1984; Kristie fit Roizman, 1985; Gaffney et
al., 1985; Bzik fit Preston, 1986; O'Hare fit Hayward, 1987).
In contrast to the previously mentioned motifs, the
TAATGARAT has not been found upstream from any of the HSV
avc«A 'M.i'v
early or late genes ^ '(Wagner, 1985). DNA fragments which
contain the TAATGARAT consensus can confer an IE pattern 
of regulation on the thymidine kinase gene (TK; an HSV 
early function) (Post et al. , 1981; Cordingley et al. ,
1983) and plasmids with HSV IE upstream sequences from 
which the TAATGARAT motif has been deleted are unable to 
activate transcription from a linked promoter on 
superinfection (Preston et al., 1984). A second IE promoter 
element which may contribute to the response to Vmw65, 5'- 
GCGGAAC, has also been described (Bzik & Preston, 1984;
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Treizenberg et al., 1988b) and possibly acts cooperatively 
with TAATGARAT.
The IE TAATGARAT motif overlaps with the 5'- 
ATGCAAAT octamer motifs which serve as binding sites for 
the ubiquitous cellular factor NF-III, also termed the
octamer-binding transcription factor (OTF-1) (Pruijn et
al., 1986; Fletcher et al., 1987) and indeed, NFIII has 
been demonstrated to bind TAATGARAT (O'Hare & Goding, 1988; 
Gerster & Roeder, 1988). This interaction is discussed more 
thoroughly in the next section.
Three of the five IE promoters have copies of the 
Vmwl75 binding site ATCGTC which has been implicated in 
repression of the IE-3 promoter (Gelman & Silverstein, 
1987, DeLuca & Schaffer, 1988). The IE-1 and 4/5 promoters 
harbour exact copies of the ATCGTC motif and bind Vmwl75 
(Faber & Wilcox, 1986b, 1988; Kristie & Roizman, 1986a,b; 
Muller, 1987). The IE-2 promoter contains a partial ATCGTC 
homology and is possibly bound by Vmwl75 with weaker 
affinity (Kristie & Roizman, 1986a; Faber & Wilcox, 1988). 
However, Vmwl75-mediated repression has only ever been
convincingly shown for the IE-3 promoter (DeLuca &
Schaffer, 1985; O'Hare & Hayward, 1985b, 1987; Gelman &
Silverstein, 1986, 1987; Roberts et al., 1988).
3.2. Trans-Activation of IE Genes by the Virion-Asaociated 
Trans-Inducing Factor, Vmw65.
Transcription from IE promoters is stimulated upon 
HSV infection by a virion tegument component identified as 
the major late phosphorylated protein Vmw65, known also as 
VP16 and a-TIF (Post et al., 1981; Batterson & Roizman,
1983; Campbell et al., 1984) and is present in the virion 
at approximately 400-600 molecules per particle (Heine et 
al., 1974; Roizman et al., 1975). The virion assembly and 
IE transactivation properties are separable and distinct
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functions of Vmw65 (Ace et al., 1988). This is demonstrated 
by the HSV mutant inl814 containing a 12 bp insertion in 
the Vmw65 gene which assembles apparently normal virus 
particles, but is deficient for trans-induct ion (Ace et 
al., 1989). The Vmw65 defect, like that in VmwllO mutant 
d!1403 (Stow & Stow, 1986; see also section IB.4.4), is 
overcome by infection at high multiplicities. Under these 
conditions, expression of VmwllO and Vmw63 is significantly 
reduced, Vmw68 is slightly affected, and Vmwl75 expression 
is unaffected. At low moi of inl814, the expression of HSV- 
1 TK, an indicator early gene, is profoundly reduced, 
suggesting that IE gene expression is insufficient to 
activate the viral replication cycle. An HSV-2 mutant 
£s2203 with a lesion near the 5' end of the corresponding 
gene causes a block in virion assembly at NPT, but does not 
affect IE transcriptional induction (Ace et al., 1988).
The precise mechanism of trans-activation by Vmw65 
has been a matter of intense investigation in recent years. 
Initial studies indicated that Vmw65 does not posses any 
intrinsic DNA binding properties, and that no other viral 
gene products were required for trans-induction of HSV IE 
gene expression. It therefore seemed likely that the 
TAATGARAT elements were the target for host-cell DNA- 
binding factors through which Vmw65 exerted its influence. 
(McKnight et al., 1987; Preston et al., 1988; O'Hare et 
al. , 1988). Indeed, it was subsequently demonstrated that
the TAATGARAT element was recognised by a host cell factor 
termed variously a-Hl (Kristie & Roizman, 1987), H3 
(Preston et al., 1988) and TRF (O'Hare & Goding, 1988). The 
identification of a good octamer consensus motif 
overlapping many TAATGARAT elements, the identical gel 
mobility of a complexes formed using octamer domain and 
TAATGARAT probes, and the ability of octamer probes to 
compete for the TAATGARAT-binding factor indicated that the 
host cell factor was the ubiquitous octamer-binding factor 
(O'Hare et al., 1988). This transcription factor, known
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variously as oct-1, OTF-1 and OBPIOO (Singh et al., 1986; 
Sive & Roeder, 1986; Bohmann et al., 1987; Sturm et al.,
1987) is indistinguishable from the cellular factor NFIII 
which is involved in adenovirus replication (O'Niell et 
al., 1988). It has now been verified that oct-l-NFIII is 
indeed the factor that binds the TAATGARAT elements 
(Baumrucker et al., 1988; ApRhys et al., 1989). The 
presence of Vmw65 in the infected cell complex formed at 
the TAATGARAT motif (the immediate-early complex; IEC) has 
been demonstrated by the recognition of IEC by a monoclonal 
antibody directed against Vmw65 (Preston et al., 1988; 
O'Hare et al., 1988). Also, the addition of purified or in 
vitro translated Vmw65 to uninfected cell extracts induces 
the formation of a complex identical to IEC (McKnight et 
al. , 1987; Preston et al., 1988; O'Hare et al., 1988; 
Gerster & Roeder, 1988). In the presence of Vmw65, the 
addition of purified oct-1 protein to oct-1 depleted 
extracts stimulates the formation of IEC (Gerster & Roeder,
1988), thereby demonstrating that both Vmw65 and oct-1 are 
part of the IEC.
The oct-1 and closely related lymphoid-specific 
oct-2 proteins are POU homoeodomain-containing proteins, 
characterized by an extensive region of homology called the 
POU domain which is responsible for their ability to bind 
DNA, and includes an N-terminal POU-specific region of 75 
amino acids. Stern et al.,(1989) demonstrated that the oct- 
1 homoeodomain directs formation of the complex with Vmw65. 
Sequence comparisons (Laughon & Scott, 1984) and a 
structural analysis (Otting et al., 1988) indicate that POU 
homoeodomains contain a tri-a-helical structure similar to 
the DNA binding domains of A- and 0434 repressors (Jordon 
et al., 1988; Aggarwal et al., 1988). Changing three of the 
amino acid residues on the surface of the homoeodomain that 
face away from the DNA disrupt complex assembly with Vmw65 
without affecting DNA-binding activity (Stern et al.,
1989). Although affinity-purified oct-1 and oct-2 have been
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demonstrated to bind the TAATGARAT element, only oct-1, is 
capable of forming a DNA-protein complex with Vmw65. 
Corresponding experiments with Vmw65 have demonstrated that 
deletions and single point mutations of residues in the 
region between 380 and 388 aa's abolish IEC formation; this 
region is now proposed to be intimately involved in
protein-protein/ protein-DNA contacts within the IEC 
(Greaves & O'Hare, 1990).
Further investigation has revealed that more 
protein factors are involved in the IEC. In contrast to
mutations in the TAAT bases of TAATGARAT (which abolish
oct-1 DNA-binding), mutations in the GARAT motif still bind 
oct-1 but no longer support formation of a Vmw65/oct-l 
complex (Gerster & Roeder, 1988; O'Hare et al., 1988).
Another intriguing observation is that highly purified oct- 
1 is inefficient at IEC formation (Gerster & Roeder, 1988) 
thus suggesting that other cellular factors are involved. 
Subsequent work with purified Vmw65 expressed from
baculovirus has demonstrated that multiple cellular factors 
interact with Vmw65 to generate protein-DNA complexes more 
complex than Vmw65/oct-l alone. At least an additional two 
as yet unidentified cellular factors are involved; one of 
the components, found in mammalian and insect cells and 
therefore probably a highly conserved and ubiquitous 
factor(s), is necessary for the formation of the Vmw65/oct- 
1 complex by highly purified Vmw65 and oct-1 (Kristie et
al., 1989). Mutations in GARAT preclude formation of this 
complex, thus implicating GARAT as a recognition site for 
this factor. Another component of the IEC has been 
identified in Hela cells, but not insect cells. Since the
footprints of these complexes are similar, this additional
factor probably represents a protein which binds the IEC 
purely through protein-protein interactions (Kristie et 
al., 1989).
The trans-activation domain of Vmw65 is contained 
within the carboxy-terminal 79 amino acids. Deletions in
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this region allow formation of the IEC, but fail to 
transactivate transcription (Triezenberg et al. , 1988a;
Greaves & O'Hare, 1989). This domain can function 
independently of the remainder of the Vmw65 molecule as 
demonstrated by its ability to activate gene expression 
when fused to the DNA-binding domain of the yeast trans­
activator GAL4 (Sadowski et al., 1988; Chasman et al., 
1989; Cousens et al. , 1989). Examination of the predicted
secondary structure likely to be adopted by the carboxy- 
terminal amino acids indicates that they probably form a 
highly negatively charged amphipathic a-helix (Cousens et 
al., 1989). Similar structures have been identified in the 
transcription activation domains of the yeast proteins GAL4 
(Gill & Ptashne, 1987) and GCN4 (Hope & Struhl, 1986), and 
are likely to be present in many although not all 
eukaryotic transcription factors. This acidic amphipathic 
a-helix probably provides a surface for intimate protein- 
protein interactions with other components of the 
transcription machinery such as TFIID, the TATA box binding 
factor or RNA polymerase subunits. Indeed, when used as a 
column ligand for affinity chromatography, the 
transactivation domain of Vmw65 binds strongly and highly 
selectively to the human and yeast TATA box-binding factors 
thus implying that the principal target of acidic 
activation domains in general is the TATA-box factor TFIID 
(Stringer et a l . , 1990; see section 1C.7).
IB.4. HSV IE GENE PRODUCTS
Five IE gene products have been identified in HSV- 
infected cells (see section IB.2), and information 
regarding the IE proteins is displayed in Table 2. The IE 
proteins, with the exeption of Vmwl2, are all 
phosphorylated, found predominantly in the nucleus of 
infected cells, and bind DNA in crude extracts (Pereira et 
al., 1977; Marsden et al., 1978; Hay & Hay, 1980; Ackermann
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et al. , 1984). Their physical properties and kinetics of
expression make them strong candidates as regulators of the 
virus life cycle, and indeed, four of the five HSV IE gene 
products are implicated in viral gene regulation. However, 
only two are absolutely essential for viral multiplication 
(reviewed by Everett, 1987a). The investigation of the role 
of IE gene products during viral replication, particularly 
Vmwl75, has been greatly facilitated by the isolation of 
mutant viruses with temperature-sensitive (ts) lesions or 
deletions in the IE polypeptides. The following sections 
review the properties of each IE gene product.
4.1. Vmwl2
Vmwl2 is the least understood IE protein. Unlike 
the other IE gene products, it is non-phosphorylated and 
cytoplasimally localized (Preston, 1979b; Marsden et al. ,
1982). The isolation of viable deletion mutants which lack 
the whole of this gene demonstrates that it does not play
an essential role during infection of tissue culture cells
(Longnecker & Roizman, 1986; Umene, 1986; Brown & Harland,
1987) .
4.2. Vmw68
A deletion mutant which produces only the carboxy- 
terminal third of Vmw68 (the product of IE-gene 4) has been
constructed (Post & Roizman, 1981). Although this virus is
viable in tissue culture, it is impared for late gene 
expression and grows poorly in some cell types (Sears, 
1985). The mutant virus was not neurovirulent, but could 
establish latency in mice. Vmw68 may therefore play a role 
in late gene regulation and possibly replaces a cell type 
restricted host factor in some cell types. These studies 
have as yet failed to provide an answer to the role of 
Vmw68, and a more complete study is required to determine 
it s true function.
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4.3. Vmw63
The product of IE-gene 2, Vmw63 is an essential 
regulatory protein. HSV-1 mutants with ts lesions in the 
Vmw63 gene exhibit reduced expression of many early-late 
genes and are unable to induce expression of many true-late 
genes at NPT (Sacks et al., 1985). Studies of other mutants 
have indicated that Vmw63 is required to repress expression 
of certain IE and early genes and is absolutely required 
for the transcriptional activation of late genes; a 
function that is independent of early protein and viral DNA 
synthesis (Sacks et al. , 1985; McCarthy et al., 1989; Rice 
et al., 1989).
In contrast to the activities of VmwllO and Vmwl75 
(see below), Vmw63 alone exhibits little regulatory 
activity for HSV promoters in transient expression assays 
(DeLuca et al., 1985; Everett, 1984b; Sekulovich et al.,
1988). An exception though is that Vmw63 by itself can 
trans-activate the early-late glycoprotein B (gB) promoter 
(Rice & Knipe, 1988). It has also been shown to be able to 
up-regulate expression of a retroviral vector containing 
Moloney murine leukemia virus regulatory sequences (Chapman 
et al., 1992). Despite its limited regulatory activity 
alone, Vmw63 can both repress and enhance expresson from a 
variety of HSV-1 promoters whose expression is induced by 
VmwllO or Vmwl75 or both (Everett, 1986; Rice & Knipe, 
1988; Sekulovich et al., 1988; Su & Knipe, 1989). This 
indicates that Vmw63 may act as a modulator of the 
regulatory functions of VmwllO and Vmwl75, although how 
this is achieved is, as yet, unknown.
Mutational analysis and transient expression assays 
have been employed to assign the functional activities of 
repression and enhancement to the Vmw63 molecule. These 
studies have indicated that two functional domains 
responsible for Vmw63-mediated repression lie within the 
hydrophobic carboxy-terminal one-third of the molecule, and 
that the carboxy-terminal half of Vmw63 is required for
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enhancing activity (McMahon & Schaffer, 1990). Studies
utilising mutant viruses with in-frame deletion and ts 
lesions in Vmw63 have indicated that Vmw63 is responsible 
for a distinct shift in mobility of Vmwl75 in SDS gels, 
implicating Vmw63 in post-translational modification of 
Vmwl75 (Sacks et al. , 1985; Rice & Knipe, 1989; McMahan & 
Schaffer, 1990). Vmw63 also performs its repressing and
enhancing functions at different times during infection; it 
functions as an enhancer of viral gene expression at early 
times of infection and as a repressor of early gene
expression and enhancer of late gene expression at later 
stages of the HSV-replication cycle (McMahan & Schaffer,
1990) .
4.4. VmwllO
As yet, no ts mutants in IE-gene 1 have been 
isolated, and evidence suggests that this gene is not 
absolutely essential for virus growth in tissue culture. 
Reduction of IE-1 mRNA to less than 10% of normal levels 
has no effect on virus gene expression or virus yield 
(Sandri-Goldin et al., 1987). Also, virus mutants with 
large deletions within both copies of the IE-1 coding 
sequence are viable in tissue culture. They grow very 
poorly at low multiplicities of infection (moi), although
this defect is overcome at high moi. (Stow & Stow, 1986; 
Sacks & Schaffer, 1987).
Transfection experiments have demonstrated VmwllO 
to be a promiscuous transactivator of both HSV and 
heterologous promoters, acting independently and in synergy 
with Vmwl75 (Everett, 1984b, 1986; Gelman & Silverstein,
1985; O'Hare & Hayward, 1985a, b; Quinlan & Knipe, 1985). 
Although VmwllO can be shown to have a substantial effect 
in such assays, its role during normal virus infection is 
an unresolved question. It has been demonstrated to confer 
strong growth advantage to the virus, however, despite 
being a potent activator of gene expression, it cannot
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complement the activities of Vmwl75 in viruses carrying 
defects in the IE-3 gene (Deluca & Schaffer, 1985, 1988;
Russel et al., 1987b).
The predicted VmwllO polypeptide contains 775 amino 
acids, and two introns are spliced out of the coding region 
of the primary transcript to form the mature mRNA (Perry et 
al. , 1986). One particular region of the protein has been
predicted to have an interesting predicted secondary 
structure motif; a region from residues 99-156 containing 9 
cysteine residues, including 3 C-n-n-C pairs which are 
proposed to form a zinc-finger binding domain (Berg, 1986). 
Such regions are predominantly involved in nucleic acid 
binding, although their involvement in protein-protein 
interactions has also been noted (Frankel & Pabo, 1988). 
VmwllO also contains a serine-rich domain from residues 
554-594 which could potentially form a site of 
phosphorylation of the protein.
Mutagenesis and transient transfection studies have 
revealed that the VmwllO polypeptide can be divided into at 
least 5 regions important for transcriptional activation of 
the gD promoter in synergy with Vmwl75 (Everett, 1987b,
1988). The regions important for VmwllO activation in the 
absence of Vmwl75 however are somewhat different, implying 
that these two activities are distinct functions of the 
VmwllO polypeptide. The predicted zinc finger domain is 
important for VmwllO activity alone, but not in the 
presence of Vmwl75> whereas the carboxy-terminal region is 
important for synergistic, but not independent activity.
The nuclear localization signal of VmwllO has been 
shown to lie between residues 475-638 and contains a highly 
basic sequence similar to other similarly identified 
signals (Kalderon et al. , 1984; Krippl et al. , 1985;
Everett, 1988) .
The growth properties of recombinant HSV-1 viruses 
encoding insertion and deletion mutants have been examined 
(Everett, 1989). Deletions in the cysteine-rich region
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severely impaired virus growth, while lesions in the C- 
terminal region proved to be less important, thus 
indicating that the putative zinc-finger is important for 
the biological role of VmwllO in the HSV-1 lytic cycle.
Despite the detailed functional analysis of VmwllO, 
the exact mechanism of VmwllO action and its precise 
function remain poorly understood although, as with Vmw63, 
it clearly has a function in committing virus infection to 
the lytic cycle. In this respect, the role of VmwllO in the 
establishment and reactivation of latency is now coming 
under intense scrutiny.
4.5. Vawl75
The product of IE-gene 3 has an apparent molecular 
weight of 175 kd although the size of the unmodified 
protein is 132,835 (McGeoch et al., 1986). Mutational 
analysis of Vmwl75 has demonstrated the central role of 
this polypeptide in the virus growth cycle. Viruses with ts 
lesions in Vmwl75 are generally inefficient or completely 
unable to activate transcription of later classes of genes, 
while overexpressing IE functions (Preston, 1979a; Dixon & 
Schaffer, 1980; DeLuca et al., 1984; Preston, 1981). From 
this, it was concluded that functional Vmwl75 is required 
for transcription of later classes of viral genes and is 
also directly or indirectly ivolved in the autoregulation 
of IE gene transcription (Preston, 1979b; Dixon & Schaffer, 
1980; Watson & Clements, 1980). The mapping of these 
mutations has revealed that many lie towards the carboxy- 
terminal of the protein while others (including tsK) are in 
the central region of the gene (Dixon & Schaffer, 1980; 
Preston, 1981). The IE-gene 3 fcsK lesion has been 
identified as a C-T transition causing an alanine to valine 
change in a region which exhibits a high level of homology 
with the corresponding VZV 140K protein (Davison et al. , 
1984; McGeoch et al., 1986). Other ts lesions of IE-3 which 
overproduce Vmwl75 and Vmw63 and synthesise many early but
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no late polypeptides map to the carboxy-terminal end of the 
protein (DeLuca et al., 1984).
Vmwl75 is post-translationally modified both by 
phosphorylation and poly(ADP)ribosylation and migrates as 
multiple species on SDS polyacrylamide gels (Pereira et 
al., 1977; Preston & Notarianni, 1983). Partially purified 
Vmwl75 has been obtained and appears to exist in the form 
of a homodimeric complex (Metzler & Wilcox, 1985). The 
predicted primary sequence of Vmwl75 can be divided into 
five regions on the basis of similarity to the 
corresponding proteins expressed by other
alphaherpesviruses (McGeoch et al., 1986; Grundy et al., 
1989; Vlcek et al., 1989). Regions 2 and 4, composed of 
residues 315-484 and 797-1224 respectively, are the most 
highly conserved and include the locations of several ts 
lesions (Davison et al., 1984; DeLuca et al., 1984; 
Paterson et al., 1990). In addition, the construction of 
insertion mutants in a plasmid-encoded copy of IE-3 has 
demonstrated that mutations in regions 2 and 4 affect the 
ability of Vmwl75 to regulate gene expression in 
transfection assays (Paterson & Everett, 1988).
A major step in understanding the mechanism of 
Vmwl75 action has been the demonstration that it can bind 
to DNA sequences containing a consensus ATCGTC motif (Beard 
et al., 1986; Faber & Wilcox, 1986b; Muller, 1987; Kattar- 
Cooley &. Wilcox, 1989; Tedder et al. , 1989) and also,
although probably less strongly, to other less well 
characterized sequences (Michael et al., 1988). The ATCGTC 
motifs, however, are not located in promoter regions of 
early or late promoters, although an exception is an ATCGTC 
motif found 100 bp upstream of the 5' end of the gD mRNA 
which has been implicated in optimal stimulation of the gD 
promoter by Vmwl75 in vitro (Tedder et al, 1989). How this 
Vmwl75 DNA-binding activity is related to the 
transcriptional activation mechanism of early and late 
promoters is unknown. Strong Vmwl75 DNA-binding activity at
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the IE-gene 3 cap site has however been implicated in the 
mechanism of autoregulation, both in transfection assays 
(Roberts et al., 1988) and in the viral genome (DeLuca and 
Schaffer, 1988). It has been postulated that such binding 
to the IE-3 promoter may impede either the passage of RNA 
polymerase or the formation of transcriptional pre­
initiation complexes, thus preventing expression of the IE- 
3 gene.
Mutational analysis of Vmwl75 has demonstrated that 
the principal part of the polypeptide required for DNA- 
binding lies within region 2 (DeLuca & Schaffer, 1988; 
Paterson & Everett, 1988; Shepard et al., 1989). The Vmwl75 
polypeptide encoded by HSV-1 tsl225 is able to bind DNA in 
vitro at temperatures at which it fails to autoregulate in 
vivo thus demonstrating that DNA-binding and autoregulation 
are distinguishable activities of the Vmwl75 polypeptide, 
and DNA-binding per se is insufficient for autoregulation 
in vivo (Paterson et al. , 1990). It has also been noted
that HSV-1 IE-3 mutants unable to bind DNA are partially 
permissive for early gene transcription (DeLuca et al., 
1984; Paterson et al., 1990), which suggests that the 
ability of Vmwl75 to bind to at least one class of 
recognition sequences in vitro does not correlate with the 
activation of early genes during infection.
Like the other IE-genes of HSV, the actual 
mechanism of transcriptional regulation by Vmwl75 remains 
an enigma. Further insight into this phenomenon awaits 
further analysis of Vmwl75 DNA-binding, and a study of the 
interactions between Vmwl75 and the host transcriptional 
machinery. In this later respect, TFIID remains the obvious 
target for such an interaction(c£. LV. VE ^  57),
IB.5. Regulation of Early Gene Expression
The study of early gene expression has centred 
predominantly upon the analysis of promoter DNA sequence 
requirements for the activation of transcription in trans
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by viral gene products. The best studied examples in this 
respect are the promoters of the tk gene (UL23) and gD gene 
(US6) which have both been dissected using a variety of 
techniques. These experiments generally involved 
mutagenesis of the E promoter region and quantitation of 
their activity by their ability to drive expression of a 
linked reporter gene when injected into Xenopus oocytes 
(McKnight et al., 1981, 1982; Jones et al., 1985) or
transfected into eukaryotic cells (Everett, 1983, 1984b).
Additionally, mutagenized E (tk gene) promoter sequences
have been introduced back into the HSV-1 genome and assayed 
for their ability to drive gene expression during virus 
infection (Coen et al., 1986).
These approaches demonstrated that the tk promoter 
consists of 110 bp (McKnight & Kingsbury, 1982) and the gD 
promoter of 83 bp (Everett, 1983) immediately upstream from 
the RNA capsite. The functional regions of these promoters 
consist of a consensus CAAT box and GC- (Spl binding) or 
GA-rich motifs in their distal promoter regions and a
proximal TATA box. These sequence elements have been shown 
to be required for their trans-activation by both Vmwl75
and VmwllO (Everett, 1984a; Eisenberg et al., 1985; Coen et
al., 1986; Jones et al., 1985). In addition, mutations in
the capsite region result in a moderate reduction in
promoter activity (Everett, 1984b). Studies of the tk and 
gD promoters did not identify sequences required for viral 
trans-activation which were not needed for cis-activation 
(Everett, 1984b; Eisenberg et al., 1985; Coen et al., 1986) 
suggesting that IE products activate E gene transcription 
either by binding sequences recognized by cellular
transcription factors or by altering the activity of 
cellular transcription factors.
Analysis of linker scanning mutations of the tk 
gene locus in the HSV-1 genome (Coen et al., 1986)
demonstrated that the same promoter elements were important 
for activity in the virus genome as in the short term
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transfection assays. However, the upstream distal promoter 
elements were shown to be quantitatively less crucial than 
the TATA box and cap site. Interestingly, mutations 
downstream of the RNA capsites have also shown to cause a 
reduction in tk promoter activity during virus infection 
(Coen et al., 1986; Zipser et al., 1981). However, since 
deletion mutants in this region still express appreciable 
amounts of tk RNA (Halpern & Smiley, 1984), it was 
suggested that this region affected the binding of cellular 
factors to the TATA box rather than being a previously 
unidentified promoter domain per se (Coen et al., 1986).
IB.6. Regulation of Late Gene Expression
The late genes of HSV-1 require DNA replication for 
their maximal expression with L gene products reaching a 
maximum by 10h-16h post adsorption (Honess & Roizman, 
1973). The requirement of Vmwl75 and VmwllO for activation 
of L gene transcription is not yet clear although 
activation of the UL44* (gC) promoter by cotransfection with 
IE genes has been detected in a transient assay system 
(DeLuca & Schaffer, 1985; Mavromara-Nazos et al., 1986).
The regulation of the true late gene US11 promoter 
(Johnson et al., 1986) has been studied in some detail and 
has been shown to require DNA replication for its maximal 
expression, even when present on a plasmid (Johnson & 
Everett, 1986a). The promoter sequence elements of the US11 
promoter were delineated using a plasmid containing an HSV 
origin of replication (oris) and the US11 promoter linked 
to the rabbit beta globin gene (Johnson & Everett, 1986a). 
This plasmid was transfected into Hela cells and then all 
the viral gene products required for DNA replication were 
provided by infection of the transfected cells. 
Surprisingly, it was discovered that the only sequences 
required for fully efficient regulated expression of the 
US11 gene consisted of a 31 bp region containing the 
proximal TATA box and RNA capsite. A study of the promoter
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region of the gC gene gave similar results (Homa et al., 
1986b). These findings were confirmed by the demonstration 
that an early HSV-1 gene (gD) could be converted to a late 
gene by the removal of sequences 5' of its TATA box 
(Johnson & Everett, 1986b).
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1C. EUKARYOTIC RNA POLYMERASE II TRANSCRIPTION 
1C.1. RNA Polymerase II Promoters
In eukaryotes, the promoters of protein coding 
genes are composed of several distinct elements usually 
located upstream of the start point of transcription. These 
include proximal promoter elements, distal promoter 
elements and enhancers (reviewed by Breathnach & Chambon, 
1981; Nakajima et al. , 1988). The most common promoter
element is the TATA box motif located around -30 from the 
mRNA cap site. Results in vitro and in vivo indicate that 
this is a critical motif for both promoter activity and 
determining the exact point of initiation. Moreover, for 
some promoters, the TATA element (sometimes with sequences 
near the initiation site) is the only DNA sequence required 
for a low level of accurate transcription in vitro (Corden 
et al., 1980; Grosveld et al. , 1981) and for mediating
transcription responses to HSV immediate-early proteins 
both in vivo (Green et al., 1983; Coen et al., 1986), and 
in vitro (Abmayr et al., 1985, 1988). The TATA box
represents a core element and cellular factors exist which 
functionally interact with this. The activities of core 
promoters can be greatly enhanced by the action of distal 
elements; upstream promoter elements act at a short 
distance while enhancer elements can be located up to
several thousand base pairs from the transcription
initiation site (Dynan & Tijan, 1985).
The various components of the human RNA polymerase 
II transcription machinery are being elucidated by the 
biochemical dissection of crude cell-free systems (Matsui 
et al., 1980; Samuels et al. , 1982; Dignam et al. , 1983;
Sawadogo & Roeder, 1985b). This approach has revealed that 
specific transcription initiation by RNA polymerase II
requires the coordinated interaction of multiple protein 
factors. These can be divided into two categories: general 
transcription factors and upstream element binding proteins
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(Dynan & Tijan, 1985). Our most detailed understanding has 
centred around the factors which interact directly with the 
core promoter elements. Crude extracts of mammalian cells 
have been broken down into at least five fractions 
(originally TFIIA through TFIIE) that are required by RNA 
polymerase II for the accurate transcription of a DNA 
template. As TFIIC has been found to be an artifact and 
TFIIE has been split into TFIIE and TFIIF, we are left with 
TFIIA, IIB, IID, H E  and IIF. An enormous amount of effort 
is now being put into identifying the function of these 
factors, the cloning of their genes and how they interact 
with each other and RNA polymerase II.
Due to the vast body of literature accumulating 
concerning RNA polymerase II transcriptional control, it is 
outwith the scope of this thesis to enter into all aspects 
of this rapidly advancing field in great detail. However, 
the following sections will deal with the more interesting 
aspects of RNA polymerase II, the general transcription 
factors, how they interact with each other, and how 
upstream factors interact with the core promoter complex.
1C.2. RNA Polymerase II
Eukaryotic cells contain three distinct forms of 
nuclear DNA-dependent RNA polymerases that transcribe 
different sets of genes. Transcription studies with 
reconstituted RNA polymerase dependent systems has provided 
firm in vitro evidence that RNA polymerase I synthesises 
ribosomal RNA precursors, while RNA polymerase II 
transcribes protein-coding genes and RNA polymerase III 
transcribes 5S and tRNA genes. In view of its pivotal role 
in gene expression, most studies have concentrated on RNA 
polymerase II.
RNA polymerase II has now been purified to near 
homogeneity from more than 20 different organisms; from 
animal and plant tissues, cultured cells and lower 
eukaryotes (Sawadogo & Sentenac, 1990). Such studies have
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demonstrated that RNA polymerase II is a multi-subunit 
enzyme of molecular mass 500,000-600,000 consisting of two 
large polypeptides (Mr > 140,000) and a number of smaller 
polypeptides ranging in size from lOkd to 40kd (Sawadogo & 
Sentenac, 1990). Three different forms of RNA polymerase 
have been described that differ only in the apparent Mr of 
their largest subunit. These enzymes, termed 110, IIA and 
IIB which contain large subunits of Mr 240,000, (IIo), 190- 
220,000 (Ila) and 170-180,000 (lib) respectively have been 
shown to be the products of a single gene in yeast (Ingles 
et al. , 1984), drosophila (Ingles et al., 1983) and mouse 
and human (Cho et al., 1985).
An important discovery in the analysis of the class 
II transcription system was the discovery of an unusual 
carboxy-terminal extension of the Ila and IIo subunits in 
the yeast and mouse enzymes (Corden et al. , 1985). The
sequence of this gene revealed that the C-terminal domain 
(CTD or tailpiece) consists of tandem repeats of the
consensus heptapeptide sequence (Tyr-Ser-Pro-Thr-Ser-Pro- 
Ser) occurring 26 times in the yeast and 52 times in the 
mammalian enzyme. The importance of this novel domain has 
been demonstrated by genetic experiments whereby CTD
deletions in the yeast and drosophila enzymes were shown to 
be lethal (Allison et al., 1988; Zehring et al., 1988) and 
a mouse enzyme with such a deletion was non-functional in 
rodent cells (Bartolomei et al., 1988). A series of
indirect experiments have implicated a role for the CTD in 
the initiation of RNA polymerase II transcription. Early 
experiments demonstrated that a monoclonal antibody 
recognising the IIA enzyme, but not the IIB form (which 
lacks the CTD) prevented accurate initiation of
transcription of a variety of promoters in vitro (Dahmus & 
Kedinger, 1983). Another such monoclonal antibody also 
inhibited the formation of stable initiation-competent 
complexes at the adenovirus major late promoter (MLP) in 
vitro (Allison & Ingles, 1989). A role for the repeats in
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initiation is, however, ambiguous since the drosophila RNA 
pol II with a deleted CTD can still initiate accurate 
transcription in vitro (Zehring et al. , 1988)
It has been proposed that the acid activation 
domains of eukaryotic DNA-binding transcription factors may 
regulate RNA pol II through direct or indirect interactions 
with the CTD (Allison et al. , 1988; Nonet et al., 1987). 
Indeed, it has been demonstrated that mutant RNA pol II 
with a shorter or extended tailpiece can accentuate or 
suppress respectively, the deficiency of mutant GAL4 
proteins or GAL4-GCN4 chimeric proteins to activate 
transcription in vivo (Allison & Ingles, 1989). However, 
there remain some conflicting observations. For example, 
substitution mutations and construction of chimeric 
tailpieces have indicated that all repeats are not 
functionally equivalent, suggesting some sequence 
specificity (Allison et al., 1988). Moreover, while GAL4 is 
functional in drosophila and mammalian cells (Fischer et 
al., 1988; Kakidani & Ptashne, 1988), the hamster CTD can 
replace the yeast CTD in vivo, whereas the drosophila 
domain will not (Allison et al. , 1988). Interestingly,
Brandi & Struhl (1989) demonstrated that GCN4 can interact 
directly and specifically with yeast RNA pol II, but the 
basic carboxy-terminal DNA-binding domain of GCN4 (not the 
acidic activating domain) is sufficient for this 
interaction.
While the actual role of the CTD remains highly 
conjectural, it seems that it may be engaged in sequence- 
specific types of interaction with other enzyme subunits or 
a general transcription factor.
1C.3. The General Transcription Factors
The development of soluble extracts capable of 
reproducing in vitro the accurate transcription of class II 
promoters has been a major breakthrough for investigating 
both the general and regulatory mechanisms of transcription
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initiation by RNA pol II. Crude extracts have currently 
been broken into at least five fractions, TFIIA, IIB, IID, 
H E  and IIF. The following subsections summarize the 
current knowledge concerning each factor.
TFIID. TFIID is the pivotal factor in the basal 
transcription apparatus, and independently binds to an 
approximately 10 bp sequence centered around the TATA 
motif. In vitro, the binding of TFIID to the TATA box is a 
prerequisite for the binding of other factors and RNA pol 
II to form an active transcription complex (Buratowski et 
al., 1989; Davison et al., 1983; Sawadogo & Roeder, 1985b; 
Van Dyke et al. , 1988) and for the in vitro transcription 
of several different genes (Nakajima et al., 1988). Workman 
& Roeder, (1987), demonstrated that the binding of TFIID 
can be inhibited by the presence of nucleosomes over the 
TATA region, suggesting that the state of chromatin in the 
promoter region can influence transcriptional initiation by 
its effect on TFIID binding.
TFIID is functionally conserved among eukaryotes 
(Buratowski et al., 1988; Cavallini et al., 1988) as 
demonstrated by the interchangeabi1ity of the yeast and 
mammalian TFIID in an in vitro transcription system. 
However, as the mammalian factor is highly labile and 
difficult to purify (Nakajima et al., 1988) most 
investigation has centred around the yeast protein. The 
gene encoding TFIID has now been cloned from yeast (Schmidt 
et al. , 1989; Hahn et al., 1989; Eisenmann et al., 1989;
Horikoshi et al., 1989; Cavallini et al., 1989), drosophila 
(Hoey et al., 1990) and humans (Cheng Kao et al., 1990; 
Peterson et al., 1990). These genes encode proteins of 240 
aa (27 kd), 353 aa (38 kd) and 339 aa (37 kd) respectively. 
The TFIID gene products of yeast and drosophila were 
demonstrated to be the products of single unspliced genes, 
a finding which dispelled speculation that different 
TFIID's may have existed for interaction with functionally
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distinct TATA elements.
Sequence analysis of these genes has failed to 
demonstrate any degree of homology to any other previously 
identified protein. Comparison of their sequences has 
revealed that the TFIID protein consists of a bi-partite 
structure, comprising a highly conserved 181 amino acid 
carboxy-terminal domain and a non-conserved amino-terminal 
domain, varying in size in a species-dependent manner. A 
truncated TFIID protein consisting of only 191 of the 
carboxy-terminal amino acids was able to bind DNA as 
effectively as the full length protein, and could activate 
basal-level transcription (Hoey et al., 1990), thus 
demonstrating that the carboxy-terminal domain is a 'core' 
conserved sequence required for basal level activity. While 
the carboxy-terminal region is rich in basic amino acids, 
no sequence similarity with any other previously identified 
DNA-binding motifs has been detected (Johnson & McKnight, 
1989). Interestingly however, there are two copies of a 34 
aa motif present in both yeast and drosophila (Cavallini et 
al. , 1989; Hoejimakers, 1990; Nagai, 1990) which occur in a 
region which shares weak homology with prokaryotic sigma 
factors (Hahn et al., 1989; Horikoshi et al., 1989). Sigma, 
a loosely associated component of the bacterial RNA 
polymerase, is required for accurate initiation of 
transcription, and contains diverse activities such as RNA 
polymerase binding, promoter recognition and DNA melting 
(Helmann & Chamberlin, 1988).
The lack of similarity between the amino-terminal 
domains suggests that they may have evolved to satisfy 
functions specific to each species. The role of this domain 
and its interaction with the regulatory transcription 
apparatus is discussed in section 1C.7.
TFIIA. The extent, or the involvement of TFIIA in RNA pol 
II initiation is highly controversial. The requirement for 
this factor is dependent on it s source and degree of
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purification. The in vitro requirement for TFIIA on the 
synthesis of specific transcripts ranges from no 
requirement (Sawadogo & Roeder, 1985b; Van Dyke et al.r
1988) to a stimulatory effect (Egly et al.r 1984; 
Buratowski et al., 1989) or even an absolute requirement 
(Samuels & Sharp, 1986; Reinberg et al., 1987). Kinetic
experiments seem to indicate a function for TFIIA before 
(Reinberg et al., 1987) or simultaneously with (Egly et 
al., 1984; Samuels & Sharp, 1986) the interaction of TFIID 
with the TATA box, and probably acts to enhance the 
TFIID/TATA box interaction. Interestingly, there is no 
TFIIA requirement for the footprinting of yeast and human 
TFIID (Nakajima et al., 1988) while it is absolutely 
required for gel shift analysis (Buratowski et al. , 1989). 
TFIIA has been purified either as a 43 kd protein (Egly et 
al. , 1984) or as a series of polypeptides ranging in
molecular weight from 12,000 to 19,000 from calf thymus 
(Samuels & Sharp, 1986).
TFIIB. The TFIIB protein is essential for transcription of 
a number of RNA pol II genes (Conaway et al. , 1987; Zheng 
et al., 1987). TFIIB has been purified to near homogeneity 
from human and rat cells as single polypeptides of 35 kd 
and 27 kd respectively (Conaway et al., 1987; Zheng et al., 
1987). Interestingly, TFIIB and TFIIE have been shown to 
interact directly with each other as determined by their 
co-sedimentation on a glycerol gradient (Zheng et al.,
1987) . Neither of these factors recognizes promoters 
directly, nor do they facilitate preinitiation complex 
formation (Conaway & Conaway, 1989). Rather, it seems that 
the interaction of TFIIB and E with transcription 
initiation complexes may be driven by their intrinsic 
affinity for RNA polymerase and/or other transcription 
factors.
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TFIIE/F. TFIIE is a heterotetramer containing two subunits 
of relative molecular mass 57,000 and two of 31,000 
(Conaway & Conaway, 1989; Peterson et al., 1991). The 
genes encoding both subunits have now been cloned (Ohkuma 
et al, . 1991; Peterson et al., 1991; Sumimioto et al.,
1991) and appear to be related to bacterial sigma factors. 
They also contain several interesting structural motifs 
including helix-loop-helix, leucine repeat and zinc finger 
motifs. Flores et al., (1989) also reported the separation 
of TFIIE into two fractions termed TFIIE and TFIIF which 
are both required in their reconstituted system for 
specific transcriptional initiation of a number of cellular 
genes. In addition, they demonstrated that these two 
activities could individually interact with RNA polymerase 
during glycerol gradient centrifugation (Flores et al.,
1988) . TFIIF is thought to be related to the RAP30/74 
complex demonstrated by Sopta et al., (1985) to have very 
strong affinity for RNA polymerase. RAP30/74 is required 
for the formation of the first phosphodiester bond in 
nascent RNA (Burton et al., 1988) and is absolutely 
required for initiation. RAP30/74 also has an ATP dependent 
DNA helicase activity (Sopta et al., 1989).
RAP30 has now been cloned and shown to be a 234 aa 
protein of apparent molecular weight 26,312 (Sopta et al.,
1989). It was demonstrated that RAP30 was not the helicase, 
leaving RAP74 as the most likely candidate for this 
function. It has also been shown that RAP30 binds to RNA 
polymerase II and prevents it from binding nonspecifically 
to DNA (Killeen & Greenblatt, 1992). Sequence analysis of 
RAP30 has indicated homology with bacterial sigma factor. 
It seems likely that TFIID and RAP30 each represent one 
portion of sigma, thus implying that the diverse activities 
of sigma may be distributed among several eukaryotic 
factors. It would therefore seem reasonable to suppose that 
TFIID bears homology to the sigma region thought to contact 
the TATA-1 ike sequences of prokaryotic promoters (Horikoshi
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et al., 1989) and that RAP30 is similar to the sigma region 
which binds bacterial RNA polymerase (Sopta et al., 1989).
1C.4. Mechanism of Transcription Initiation by RNA Pol II
Various approaches have been used to identify and 
characterize intermediate steps in the complex reaction 
pathway leading to specific transcription initiation by RNA 
pol II. The most informative studies so far are those using 
direct physical methods such as footprinting analysis (Van 
Dyke et al., 1988) and native gel electrophoresis 
(Buratowski et al., 1989) which have allowed the 
characterization of various RNA pol II transcription 
complexes and their polypeptide compositions. Buratowski et 
al., (1989) resolved a series of complexes by native gel 
electrophoresis that suggested an ordered assembly of the 
general transcription factors and RNA pol II on an 
Adenovirus-2 MLP template. The proposed complexes 
representing intermediates in the initiation reaction are 
represented in Figure 4 and are described in the following 
subsections.
Complex 1. The first step in initiation is the recognition 
of the TATA box by TFIID. Footprinting analysis 
demonstrated a protected region spanning -37 to -17 with 
yeast TFIID and -38 to -4 with Hela TFIID. This complex is 
undetectable in gel shift assays, and may therefore be 
unstable.
Complex 2. The addition of TFIIA enhances the binding of 
TFIID to the TATA element and modifies the upstream region 
of the footprint (-42 to -17) . This complex is detectable 
in gel shift assays. It is possible that TFIIA may bind 
TFIID before interaction with the TATA box. (Reinberg et 
al., 1987).
Complex 3. TFIIB is probably the next factor in the
Figure 4. A model for preinitiation complex assembly. RNA
polymerase II (polll) and the general transcription factors 
TFIID (D), TFIIA (A), TFIIB (B), TFIIE (E), and TFIIF (F), 
are assembled into a preinitiation complex on the DNA 
template. Buratowski et al. (1989) identified a minimum of 
five intermediate complexes leading to a functional 
preinitiation complex in vitro. The order in which the 
components are recruited onto the template and their 
relative positions within each complex are shown as 
determined; this is discussed more thoroughly in section
1C.4. The transcription start site ( + 1) is marked by the 
arrow, and the numbering at the top of this Figure refers 
to nucleotide positions relative to this.
This Figure is adapted from an original Figure presented in 
Buratowski et al. (1989).
-50 -40 -30 -20 -10 +10 +20 +30
TATA
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48
initiation complex and is absolutely required for the 
formation of all other complexes. Addition of TFIIB to 
TFIID confers additional protection of the coding strand 
from -10 to +10, suggesting that it may be associated with 
one strand and extends beyond the transcription initiation 
site. TFIIB is also required for the subsequent binding of 
RNA polymerase; it has also been noted that TFIIB can be 
associated with RNA polymerase in solution (Zheng et al. , 
1987). It therefore seems likely that TFIIB acts as a 
’binding1 molecule between the TFIIA-TFIID-TATA complex and 
pol II. It has also been proposed to be involved in 
measuring the distance from the complex to the initiation 
site. In this respect it would be interesting to observe 
what happens when mammalian TFIIB is replaced by its yeast 
homologue, since in S. cerevisiae, the initiation site is 
generally at a greater distance (60-120 bp) from the TATA 
motif than in higher eukaryotes (Guarente, 1987).
Complex 4. This complex is generated by the addition of RNA 
pol II to complex 3, and exhibits extensive DNase 
protection (-47 to +20). If the proximal protection is due 
to the polymerase, then this would allow direct interaction 
with USF (the MLP transcription factor) with binding site - 
50 to -66 (Van Dyke et al. , 1988). All pol II complexes
occur in the form of pairs of bands on gel shift assays, 
but have identical footprints. This may be due to the 
binding of different forms of pol II, the binding of 
another protein to the complex (a candidate being the 
transcription elongation factor S-ll (Sopta et al. , 1985), 
or it may be that the mobility change may reflect a change 
in pol-DNA interaction such as observed with E.coli RNA 
polymerase (Straney & Crothers, 1985).
Complex 5. Generated by the addition of TFIIE/F; these 
factors bind downstream of polymerase, protecting form +20 
to +30. As described in section 1C.3, this fraction
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contains a DNA-dependent ATPase activity. Transcription has 
an energy requirement that can be satisfied by the 
hydrolysis of either ATP or dATP, generating what is termed 
an 'activated' transcription complex (Sawadogo & Roeder,
1984). Indeed, addition of dATP causes a dissociation of 
the complex to give one of the same ability as 4 and loss 
of TFIIE/F protection. This is explained by the helicase 
activity of TFIIE/F unwinding the template strand, making 
it accessible to RNA polymerase. The helicase activity 
would run off the template, thus explaining the loss of 
this fraction.
Complex 6. Generated by the addition of NTP's allowing 
transcriptional elongation, this complex migrates near 
complex 4 consistent with the model of loss of TFIIE/F. 
This step is blocked by the addition of a-amanitin (an 
inhibitor of elongation but not pol II binding), whereas 
the dATP/ATP step discussed above is not.
The exact roles played by the various transcription 
factors during the initiation process are as yet unknown, 
as is the reason why any of the factors remain associated 
with the RNA polymerase once it enters elongation mode 
(Flores et al. , 1989). However, it appears that at least
some of the components of the preinitiation complex remain 
bound near the initiation site once RNA polymerase has 
cleared the promoter; minimally USF and TFIID in the case 
of the AdMLP (Van Dyke et al. , 1988). This implies that
after the first round of productive initiation, the 
mechanisms leading to subsequent rounds of transcriptional 
initiation may be facilitated. However, very little 
information is available concerning this important process.
1C.5. Upstream Regulatory Sequences
It is clear that the effect of upstream promoter
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and enhancer elements is to potentiate the events occurring 
at the core element, thus facilitating reaction steps that 
would otherwise be rate limiting.
Upstream activating sequences (UASs) are typically 
short (8-12 bp) gene-specific motifs that act as binding 
sites for transcriptional activators (Guarente, 1987; 
Johnson & McKnight, 1989; Struhl, 1989). These motifs act 
to stimulate transcription either constitutively, as in the 
case of CCAAT box elements (Myres et al., 1986) and Spl 
binding sites (Jones & Tijan, 1985), or in response to 
specific stimuli such as serum stimulation (Triesman,
1985), heat shock (Bienz & Pelham, 1986), viral infection 
(Goodburn et al., 1985, 1986), exposure to heavy metals
(Serfling et al. , 1985) and steroids (Renkawitz et al.,
1984). UASs can operate in either orientation, but show a 
decrease in activity with increasing distance from the TATA 
box (McKnight et al., 1982).
Enhancers are defined by their ability to act over 
considerable distances both upstream and downstream of the 
transcriptional start site, and by their independence of 
orientation in relation to the gene. They are longer than 
UASs, sometimes comprising hundreds of bases (Edlund et 
al., 1985), and contain binding sites for many different 
proteins (Serfling et al., 1985).
Gene specific, and indeed cell specific regulation 
of transcription occurs largely because different 
transcriptional activators respond to different sets of 
regulatory signals.
1C.6. Transcriptional Activators
Transcriptional activators contain distinct domains 
dedicated to DNA binding at the UAS/enhancer and to the 
activation of the transcriptional machinery (Brent & 
Ptashne, 1985; Hope & Struhl, 1986). The DNA-binding
domains of activators described so far are of varying 
classes, termed helix-loop-helix, helix-turn-helix, leucine
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zipper and zinc finger (Johnson & McKnight, 1989). There 
are also several types of activator domains. A majority 
class, including many yeast activators and HSV Vmw65, has a 
highly acidic domain enriched in glutamate and aspartate 
residues (Hope & Struhl, 1986; Ma & Ptashne, 1987;
Triezenberg et al. , 1988a). Alteration of the sequence of
the acidic residues, without changing the overall negative 
charge, strongly affects activation potential (Giniger & 
Ptashne, 1987; Hope et al., 1988) thus demonstrating that 
the physical structure of the acid domain is also critical 
for function.
Other factors (so far found only in mammals) have 
nonacidic domains, including the glutamine-rich activation 
domain of Spl (Courey et al. , 1989) and the proline-rich
CTF/NF-1 (Mermod et al., 1989). It has also been shown that 
in certain cases, residues around the zinc finger of the 
DNA-binding domain may play a direct role in the activation 
of transcription (Kim & Guarente, 1989; Schena et al.,
1989). In other cases, the activator is a heteromeric 
complex containing several protein subunits e.g. AP-1, 
(Olesen et al., 1987; Gentz et al., 1989; Landschulz et 
al., 1989; Turner & Tijan, 1989). In some heteromeric 
complexes, the acidic activation domain is supplied on a 
discrete polypeptide chain eg Vmw65 (section IB.3.2), which 
associate with DNA binding proteins in the nucleus and are 
thereby directed to particular promoters.
1C.7. Mechanism of Action of Gene-Specific Transcription 
Factors
The major question which remains essentially 
unanswered concerns the identity of the primary target(s) 
of and the exact mechanism of action of the various trans­
activator proteins. The favoured model for the mechanism of 
transcriptional activators proposes that activation domains 
contact a target factor in the basic machinery, thereby 
looping out the intervening DNA (Ptashne, 1986, 1988). This
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contact would activate transcription by stabilizing the 
binding of the target factor, or by converting the 
conformation of the bound factor to an active form.
The obvious target in the basal apparatus for such 
an interaction is TFIID (Horikoshi et al., 1988a, b; 
Sawadogo & Roeder, 1985b). Consistent with this notion, 
there is evidence that some transcription
factors including ATF and pseudorabies virus IE, assist 
TFIID binding to DNA (Horikoshi et al., 1988b; Workman et 
al., 1988). In addition, both GAL4 and ATF factors have 
been shown to alter qualitatively the interaction of TFIID 
with the TATA motif, thereby facilitating subsequent 
interactions with other transcription factors (Horikoshi et 
al., 1988a, b ) . However, upstream factors like Spl (Schmidt 
et al., 1989) or CTF/NF-1 (Garcia et al., 1987) do not seem 
to alter the binding of TFIID. Thus, it is not altogether 
clear whether gene activators function directly through 
TFIID or via intermediary fractions that are present in 
partially purified TFIID fractions.
This latter point was addressed by an intricate 
line of reasoning by Pugh & Tijan (1990) to define the 
nature of Spl interaction with the basal apparatus. They 
demonstrated that Spl could only stimulate basal level 
transcription with semi-purified drosophila TFIID 
fractions, and not with cloned TFIID from drosophila or 
yeast. This implied that the interaction between Spl and 
the basal apparatus requires some other component contained 
only in crude TFIID fractions. This component has been 
called a coactivator. Further experiments showed that with 
N-terminal deleted TFIID preparations, induction of basal 
level transcription was also abolished thus demonstrating 
that Spl-induced activation must be mediated via the N- 
terminal tail TFIID. Such an effect has also been 
demonstrated for Spl-induced activation with human TFIID 
(Peterson et al., 1990).
Another line of evidence has been provided by the
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comparison of the effect of the chimeric activator GAL4- 
Vmw65 on templates that contained only a basal promoter 
(TATA box), or that had in addition an upstream sequence, 
either GAL4-UAS or dA:dT-UkS (Berger et al., 1990). It was 
shown that when added to a cellular extract, GAL4-Vmw65 
induced transcription of the GAL4-UAS promoter 100-fold, 
while it's addition to dA:dr-UAS promoters, which have no 
GAL4-Vmw65 binding site almost entirely abolishes 
transcription. Addition of an oligonucleotide containing a 
GAL4 binding site restored basal transcription from the 
dA:dT UAS promoter, but cannot restore the induced level. 
The oligo prevented non-specific binding of GAL4-Vmw65 to 
DNA, thereby preventing cis-inhibition of basal 
transcription. By contrast, the inhibition of activated 
transcription from the dA:dT-UAS is not determined by 
GAL41s ability to bind DNA, and is called trans-inhibition. 
It was proposed that GAL4-Vmw65 titrated an ’adaptor1 that 
bridges between the upstream activator and basic 
transcription machinery. Other experiments suggesting that 
GAL4-Vmw65 requires a factor that is part of the basal
apparatus were reported by Kelleher et al., (1990). Also 
employing a system in which GAL4-Vmw65 inhibits
transcription from the dA;dr-promoter, they found that the 
inhibition could be relieved in vitro by a crude yeast 
nuclear preparation, but not by any known (purified) basal 
transcription factors including TFIID. Yet the ability of 
Vmw65 to interact directly with TFIID is suggested by 
Stringer et al., (1990; see also section IB.3), however 
this remains to be proven with purified proteins whether 
this is the case.
The analysis of the Spl and GAL4-Vmw65 systems 
could be unified if GAL4-Vmw65 is shown to act via an
adaptor that recognises the N-terminal region of TFIID. 
Recent evidence from Lin and Green, (1991) has
demonstrtated that the the yeast acidic transcriptional 
activator GAL4 stimulates transcription by increasing the
54
number of functional preinitiation complexes, and that this 
increase is effected by recruiting the general 
transcription factor TFIIB to the promoter. They also 
demonstrated a specific interaction between the acidic 
activating region and TFIIB, and proposed that TFIIB, or 
perhaps a very closely associated factor is the direct 
target of acidic activators in general.
The fact that TFIID can support basal level 
transcription independently of its ability to interact with 
the regulatory apparatus is itself a significant advance, 
yet begs the question of how the factors that bind to the 
N-terminal domain actually change the transcription complex 
so as to increase the rate of initiation. This could be 
purely an internal matter concerning interactions between 
components of the transcription apparatus, or perhaps it is 
connected to other changes, for example in the surrounding 
chromatin.
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ID. HSV LATENCY
A major feature of the biology of the herpesviridae 
is their capacity to establish latent infections, following 
which they can reactivate to cause episodes of significant, 
sometimes serious disease. Latency per se can be defined as 
a type of inapparent infection where the viral genome is 
present, but infectious virus is not produced except during 
intermittent episodes of reactivation. Despite the enormous 
advances made recently in understanding the molecular 
biology of HSV, particularly with respect to the structure 
and organisation of the virus genome, the molecular events 
surrounding the establishment and maintenance of and 
reactivation from latency remain poorly understood.
1D.1. Latency: A Historical Perspective
The phenomenon of recurrent herpes simplex has been 
recognised for centuries. The concept of a connection 
between herpetic lesions and the nervous system arose from 
various clinical observations at the beginning of this 
century (Cushing, 1905). Involvement of the sensory ganglia 
emerged from the classical observations of neuropathology 
of HSV in rabbits by Goodpasture & Teague, (1925) and 
Goodpasture, (1925) and engendered the view that the 
nervous system might also be involved in the pathogenesis 
of herpetic disease in man. These studies lead Goodpasture, 
(1929), to make what subsequently proved to be a farsighted 
prediction that HSV can establish a latent infection in the 
neurons of the trigeminal ganglion. This ganglion supplies 
sensory nerves to the opthalmic and facial areas where 
recurrent herpetic lesions are often observed. This early 
work was supported by more careful documentation of 
cutaneous herpetic lesions in man following surgery of the 
trigeminal tract (Carton & Kilbourne, 1952; Carton, 1953).
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Goodpasture’s hypothesis was eventually
substantiated through direct evidence from experimentation 
with animal systems, in particular the guinea pig, rabbit 
and mouse (Stevens & Cook, 1971; Stevens et al., 1972; 
Knotts et al. , 1973; Baringer & Swoveland, 1974; Walz et
al., 1974; Scriba, 1975, 1976) and most significantly, from 
human tissues (Bastian et al., 1972; Baringer & Swoveland, 
1973; Plummer, 1973; Warren et al., 1978). Historically, 
however, incisive studies have proven difficult to design 
using animal systems, since even under the best 
experimental conditions, latently infected neurons 
represent a minority (approximately 1%) of cells in a 
latently infected sensory ganglion. In addition, neurons 
are difficult to purify from such tissues. These problems 
have limited the number of biochemical and molecular 
biological techniques that can be applied to the systems 
studied.
ID.2. Animal Models of Latency
HSV can establish latent infections in man, and 
when inoculated into experimental animals. In all cases, 
the basic pattern of infection is essentially similar. 
After initial infection and many rounds of replication at 
the skin, the following series of events ensues: The virus 
caps id ascends the nerve axons by retrograde axonal 
transport to associated somas in sensory ganglia. There, 
either viral replication with neuronal destruction, or 
establishment of a latent infection and neuronal survival 
occurs. In later episodes, the viral genome may reactivate 
and pass (possibly as a virion in a vacuole) anterograde in 
axons, crossing from axon to epithelium where a productive 
infection, and lesions develop.
The first animal latency system to be developed was 
the mouse footpad model (Stevens & Cook, 1971; 1973a, b;
Walz et al., 1974). Following inoculation into the rear 
footpad, the virus spreads through to the peripheral and
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central nervous system, eventually reaching the brain. This 
develops into an acute infection which peaks at around 5 
days post-inoculation (pi) and may eventually lead to 
temporary posterior paralysis and possibly death. 
Throughout this period (lasting up to 10 days pi), 
infectious virus can be recovered from the sciatic nerve, 
the dorsal root ganglia, the spinal cord and medulla 
oblongata. After this period, virus can be recovered
from the animal by explantation and cocultivation of the 
lumbrosacral dorsal root ganglia with cell monolayers 
(Stevens & Cook, 1971); if are homogenised
prior to plating on monolayers, virus cannot be recovered. 
This series of experiments provided conclusive proof that 
HSV resides in a latent state in peripheral nervous system 
ganglia in a non-infectious form. Similar systems of 
latency in lumbrosacral dorsal root ganglia have been 
developed for guinea pigs through footpad and vaginal 
inoculation (Scriba, 1975; 1976).
The other most commonly used systems involve 
inoculations of the eye of the mouse (Knotts et al., 1974; 
Walz et al., 1974) and rabbit (Stevens et al, 1972). 
Following infection of the cornea via scarification or 
inoculation, HSV establishes a latent infection in the 
trigeminal ganglion which can also be reactivated by 
explantation and cocultivation. In addition, latent 
infections of the trigeminal ganglion and cervical dorsal 
root ganglion can be achieved through inoculation of the 
lip and ear respectively (Walz et al. , 1975; Hill et al. , 
1975) .
Spontaneous reactivation with recurrence or 
recrudescence of HSV has been observed with animal systems. 
Latent virus is not readily reactivated from the mouse; 
spontaneous recrudescence has only been observed in a small 
proportion of animals using the ear model developed by Hill 
et al, (1975). This reactivation was characterised by 
occurrences of redness and vesicles from which infectious
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virus could sometimes be recovered (Hill et al.r 1975; 
Harbour et al., 1981). By contrast however, spontaneous 
recurrences are common in the guinea pig inoculated 
vaginally with HSV-2 (Scriba, 1976). Reactivation can be 
induced in some systems by neurectomy to produce an acute 
infection in associated ganglia (Walz et a l . , 1974; Price & 
Schmitz, 1978). Reactivation can also be induced by 
exposure to a variety of physical, chemical or systemic 
stimuli (see section ID.5.1).
Animal model systems such as the mouse where 
spontaneous reactivation is rare are suitable for 
investigation of the requirements for establishment and 
maintenance of the latent state, whereas other systems 
where reactivation occurs spontaneously or can be induced 
are useful for identifying the factors responsible for 
recurrent herpetic disease.
ID.3. ESTABLISHMENT OF LATENCY
3.1. Sites of Latency
Following initial infection at the periphery, HSV 
can pass from dermatome to ganglion intra-axonally by 
retrograde axonal transport (Kristenssen et al., 1971; Hill 
et al., 1972; Cook & Stevens, 1973; Baringer & Swoveland, 
1974; Para et al., 1980). Although the form in which the 
virus travels has not been firmly established, there is 
some ultrastructural evidence that it passes as a 
nucleocapsid (Lycke et al. , 1984). This interpretation
makes good sense as infection of tissue culture cells 
involves fusion of the cell membrane and viral envelope 
followed by entry of the nucleocapsid into the cytoplasm 
(section 1A.5.1). In the in vivo situation, it is likely 
that the viral envelope is left at the site of entry into 
the cell, most probably at the intraepithelial nerve
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endings. Depending on the site of inoculation, HSV has been 
shown to establish latency in any sensory or sympathetic 
nerve ganglion, including autonomic nerve ganglia in mice 
(Price et al., 1975) and humans (Warren et al., 1978).
During acute HSV-1 infection in trigeminal ganglia, 
infectious virus is present from 2-8 days pi with a peak on 
day 4 (Knotts et al., 1974; Rock & Fraser, 1983; Steiner et 
al., 1988). Infectious virus is not detectable after day 9. 
Viral RNAs in acutely infected ganglia are detectable from 
2-6 days post-infection, with a maximum at 4 days (Spivak & 
Fraser, 1988a). The presence of viral proteins in 
trigeminal ganglia during acute infection has been 
demonstrated by immunostaining and radioimmunoprecipitation 
at 3 days pi with a peak at approximately 4-5 days pi 
(Wroblewska et al., 1989). Viral proteins were not 
detectable from day 6 pi. The reason for this abrupt
disappearance was unclear, however, it was proposed that 
this may have been due to a decrease of viral protein 
synthesis to below the level of detection, or
alternatively, that the antibody response to the infected 
cells masked antigenic sites (Wroblewska et al., 1988) or 
the possible removal of infected cells by macrophages.
Subsequent to the period of acute infection, HSV 
DNA has been demonstrated in tissues of the peripheral 
nervous system (PNS)(Walz et al., 1976; Puga et al., 1978; 
Cabrera et al., 1980; Kennedy et al., 1983; Puga et al., 
1984) and central nervous system (CNS)(Cabrera et al., 
1980; Rock & Fraser, 1983; Stroop et al., 1984) of 
animals. Latent HSV DNA has also been detected in human 
brain tissue (Fraser et al., 1981). Although HSV has been 
demonstrated by explantation and cocultivation to establish 
latency in the CNS in a small fraction of infected mice and
rabbits (Knotts et al., 1973; Plummer et al., 1973; Cook &
Stevens, 1976; Cabrera et al., 1980), there appears to be a 
difference in the efficiency of reactivation from these 
tissues and those of the PNS. In the study carried out by
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Cabrera et al. (1980), latent HSV could be recovered by 
explantation from 95% of trigeminal ganglia, but only 5% of 
brain tissue explants of the same mice. HSV DNA sequences 
were, however, detected in the brains of 30% of mice which 
harboured latent HSV in their trigeminal ganglia, thus 
suggesting that virus which progresses from the PNS to the 
CNS is capable of establishing a latent infection in the 
CNS that cannot be reactivated by the explantation 
technique.
3.2. Nervous Tissue Cells Harbouring Latent HSV
It is now universally accepted that sensory neurons 
harbour the latent virus, the evidence for which comes from 
a number of sources: Cook et al., (1974) using their in
vitro reactivation system showed that the neuron was the 
cell type in which virus products were initially detected 
after excision and culture of latently infected ganglia. 
These results were confirmed and extended by Mclennan & 
Darby (1980) who used ts mutants to establish latent 
infections in mice (which have a core temperature of 
38.5°C, the restrictive temperature for mutant growth). 
They reactivated the virus by peripheral nerve section in 
vivo or by explantation at the restrictive temperature in 
vitro. Since spread of the virus from the site of 
activation was not possible, and detection of viral 
antigens was limited to neuronal cells, it was concluded 
that latent HSV must reside only in the neuron. Kennedy et 
al., (1983) also detected HSV antigens initially in neurons 
identified by neuronal-specific antiserum in dissociated 
cultures from latently infected mouse ganglia. More recent 
evidence has demonstrated that the latency-associated 
transcript (LAT; see section ID.7.2) is detectable only in 
PNS and CNS neurons (Stevens et al., 1987; Deatly et al., 
1988a) ; their presence has not been detected in any other 
cell type in latently infected animals.
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Although the sensory neurons have been of greatest 
interest, the fact that many neural tissues have been shown 
to harbour latent virus (Cook & Stevens, 1976; Warren et 
al., 1978) suggests that a variety of neuronal cell types 
can become latently infected.
3.3. Non-Neuronal Sites of Latency
There has been a lot of interest expressed in the 
possibility of latent infections in non-neuronal sites, 
particularly of cells at the body surface, and there is 
evidence from experimental animal systems for establishment 
of latent infection in both footpads and corneas.
HSV-1 and HSV-2 could be reactivated 12 weeks pi by 
in vitro cultivation of the skin and subcutaneous tissues 
of the inoculated footpad (Al-Saadi et al., 1983; Clements 
& Subak-Sharpe, 1983; Subak-Sharpe et al., 1984a, b; Al-
Saadi et al., 1988; Clements & Subak-Sharpe, 1988). Virus 
was not detectable in these tissues immediately at the time 
of explant. This evidence was strengthened by the 
demonstration of reactivation of virus from feet which had 
been denervated 1 week prior to explantation (Clements & 
Subak-Sharpe, 1988). To decrease the possibility that these 
animals harboured replicating virus, acycloguanosine was 
administered in their drinking water beginning 6 weeks 
after infection. In addition, Al-Saadi et al., (1988) 
demonstrated that virus could be reactivated from feet of 
mice which were denervated prior to initial infection, but 
not from the associated sensory ganglia. In situ 
hybridisation analysis of explanted footpad tissue using 
HSV-specific probes revealed that the footpad cell types in 
which HSV RNA first appeared were basal cells of hair 
follicles, cells of the hair root sheath, in epithelial 
cells of the sebacious gland and in cells within the 
epidermis (Clements & Jamieson, 1989).
Virus has also been reactivated from cultured cells 
of explanted corneal tissue from rabbits (Cook et al.,
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1987) and mice (Openshaw, 1983), in cases where infectious 
virus could not be detected in homogenised tissue 
fragments. HSV has also been recovered from human corneas 
removed during corneal transplantation as a result of 
chronic stromal keratitis (Shimeld et al., 1982; Tullo et 
al., 1985). However, cultures of skin explants from sites
in humans at which HSV recurrences had been observed 
failed to yield any virus (Rustigian et al., 1966), but
recurrent HSV lesions have been observed in patients in 
areas of skin where the nerve supply had previously been 
severed (Hoyt & Billson, 1976).
Although it is clear that the PNS ganglionic 
neurons are the predominant site of latency in human and 
experimental animals, these results indicate that HSV may 
reside in a latent state in non-neuronal tissues in mice 
and rabbits. Any relation of these observations to HSV 
latency in humans has yet to be established.
ID.4. FACTORS AFFECTING ESTABLISHMENT OF LATENCY
4.1. Viral Factors
The most obvious factor affecting establishment of 
latency is the ability of the virus to replicate at the 
periphery or in the sensory ganglia as measured by viral 
titres in tissue homogenates. Such replication would 
increase the amount of virus that has the potential to 
establish a latent infection. Any virus that is unable to 
replicate at the site of inoculation is less likely to gain 
access to nerve endings than a virus that is replication 
competent. A replication-defective virus may be able to 
enter neurons directly through nerve endings, though such a 
virus would be unable to leave neurons during reactivation 
in a cocultivation assay.
Initial studies on the role of HSV-1 replication at 
the site of inoculation, and in sensory ganglia were based 
on studies using ts mutants (Watson et al. , 1980), immune
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serum (Klein, 1980), or antiviral drugs (Klein et al., 
1979). These studies are, however, treated with caution due 
to the possibilities that ts mutants may leak, and that 
antiviral drugs and immune serum may not completely block 
viral replication.
More recent studies using viruses with deletion, 
insertion and nonsense mutations in essential genes have 
ensured that viral replication could not occur at any stage 
of the infection process. Lieb et al., (1989) demonstrated 
that null mutants with lesions in the essential genes 
encoding Vmwl75 and Vmw63 did not replicate in the eye (the 
site of inoculation) or ganglion. They also failed to 
detect any latent virus, either by DNA-blot hybridization 
or by attempts to rescue the virus from explanted ganglion 
cultures in the presence of complementing feeder cells or 
by superinfection with a complementing virus.
Viruses carrying lesions in the IE-1 gene encoding 
VmwllO were able to replicate in the eye and establish a 
latent infection (Lieb et al., 1989; Gordon et al., 1990). 
These mutants, however, exhibited reduced levels of viral 
DNA in ganglia relative to wild-type; it is possible that 
this effect was multiplicity-dependent since defects in the 
IE-1 gene are only apparent at low multiplicities (see 
section IB.4.4). It is likely that low multiplicities of 
infection are encountered during acute infection and 
establishment of latency at the ganglion which could 
therefore explain the low efficiency of VmwllO mutants in 
establishing latency.
Steiner et al., (1990) examined the role of Vmw65 
during acute and latent infection in vivo using the mutant 
virus inl814 which contains a 12 bp insertion in the Vmw65 
gene and lacks the Vmw65 trans-activating function (Ace et 
al. , 1989; see section IB.3.2). Productive infection of
this virus was not detectable in the eyes or trigeminal 
ganglia of mice, although a low level of replication could 
not be excluded. Despite it s apparent lack of replication,
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inl814 was able to establish a latent infection which could 
reactivate from ganglia with kinetics similar to that of 
wild-type, thereby demonstrating that Vmw65 is not 
essential for the establishment of latency. \ v, .
Various groups have reported that although^ tk- 
negative HSV mutants do not replicate in murine sensory 
ganglia, they do establish latency in these ganglia (Coen 
et al., 1989; Efsthatiou et al., 1989; Leist et al., 1989; 
Tenser et al., 1989; Kosz-Vnenchak et al., 1990). Kosz- 
Vnenchak et al., (1990) used a tk" mutant to examine the 
initial events leading to latent infection without 
simultaneous lytic infection in the ganglionic tissue. They 
demonstrated that in the first few days following their 
inoculation into mouse corneas, tk" mutant strains of HSV 
express nuclear LAT RNA in ganglionic neurons without 
expression of any of a series of viral lytic genes (IE-gene 
3; UL30, the DNA polymerase, and the late gene encoding
gC). Only a very limited level of expression of IE-genes 1 
and 2 were detectable using in situ hybridization. The 
observation that a defect in tk, an early gene product, led 
to decreased levels of IE gene products was surprising. The 
use of reduced levels of wt virus inoculation resulting in 
reduced ganglionic virus levels did not mimic the situation 
observed with the tk" viruses, thus demonstrating that the 
tk" phenotype was due to some kind of novel behaviour of 
the mutant virus, and not a result of less virus reaching 
the ganglion. This demonstrated that expression of 
immediate-early and other lytic genes is actually reduced 
in neurons during establishment of latent infection.
Another HSV-mutant that has been investigated is a 
virus with a deletion in the gene encoding the large 
subunit of ribonucleotide reductase. Although it can 
replicate in many cell types in culture (Goldstein & 
Weller, 1988a), it is highly defective for replication in 
mouse cells at 38.5° (Jacobsen et al., 1989). Following 
corneal inoculation, this mutant replicated very poorly in
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the eye, achieving barely detectable titres. It also failed 
to achieve detectable titres in trigeminal ganglia during 
the four days post-inoculation, or to reactivate from these 
ganglia upon explant 30 days post-inoculation (Jacobsen et 
al. , 1989).
Recently, Katz et al., (1990) using polymerase 
chain reaction assays to detect viral DNA have shown that 
viral genomes can associate with ganglia despite lack of 
any replication at the site of inoculation. The amount of 
HSV DNA detectable in the ganglion showed a rough, but not 
absolute correlation with the ability of the virus to 
undergo productive replication. While wt (KOS) virus DNA 
was found at 0.5 copies per cell (5x10s per ganglion), tk~ 
and ribonucleotide reductase- mutants were detected at 0.01 
copies per cell (104 per ganglion). The finding that HSV 
DNA levels in mice infected with tk- and rr- viruses were 
similar was surprising since, unlike rr- mutants, tk- 
mutants replicate to wild-type levels in the mouse eye. 
Interestingly, viral DNA could also be detected in ganglia 
of mice infected with non-replicating HSV mutants with 
lesions in IE-genes 2 and 3, and in UL30, (encoding the DNA 
polymerase), at 0.0001 copies per cell (102 per ganglion). 
These mutants must have gained access to ganglia by budding 
directly into the corresponding nerve-endings upon 
inoculation and demonstrated that mutants which are 
severely restricted for productive virus replication and 
gene expression can establish latency.
Despite a large number of studies there is no 
evidence for any HSV mutants which fail to establish 
latency. These include mutants in IE-gene 5, glycoproteins 
G and E, the HSV protein kinase and the genes US n (21K DNA 
binding protein) and USTv. (Meignier et al. , 1988). It
therefore appears that establishment of latency does not 
require any virus gene expression.
Several hypotheses have now been advanced to 
explain the non-permissive infection of neurons by HSV
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which leads to latent infection:
i) lack of necessary cellular transcription factors for 
viral IE-gene expression in certain neurons (Roizman & 
Sears, 1987).
ii) lack of transport of the virion trans-inducing factor 
to the neuron nucleus, leading to reduced level of viral 
IE-gene products (Roizman & Sears, 1987).
iii) presence of an inhibitor of IE-gene expression in 
neuronal cells (Kemp et al., 1990).
iv) dominance of viral negative regulatory gene products in 
neurons leading to reduced level of early or late gene 
products (O'Hare & Hayward, 1985b; Su & Knipe, 1989).
All studies carried out so far suggest that the 
establishment of HSV latency does not require the lytic 
pathways of gene expression, and that viral replication 
itself merely permits an increase in the number of viral 
genomes that can gain access to neuronal nuclei. It is 
possible that as yet unidentified viral regulatory proteins 
promote the latency pathway, however, all available results 
suggest that establishment of latency is a passive process 
that is governed by neuronal factors rather than by any de 
novo synthesised viral gene product.
4.2. Neuronal Factors Affecting Latency
The neuronal cell is long-lived and non-mitotic and 
cellular DNA synthesis occurs only as a consequence of DNA 
repair mechanisms. The relatively quiescent state of the 
neuronal genome may therefore have a role in permitting HSV 
to reside in a similarly inactive state. Most work 
examining the interaction of HSV with cells of neuronal 
origin has been through the use of neuronal cell lines, 
since the amount of material available from primary 
cultures of sensory neurons have proven insufficient for 
any informative studies.
Vahlne & Lycke (1977, 1978) demonstrated that the
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neuronal cell line C1300 is non-permissive for lytic 
infection with HSV. This effect was shown by nuclear run-on 
assays (Kemp & Latchman, 1989) to be mediated by a failure 
to transcribe the viral IE genes following infection, and 
that this block could be relieved by by pretreating the 
cells with sodium butyrate which is known to increase their 
permissivity to HSV infection (Ash, 1986). Kemp et al., 
(1990) subsequently demonstrated that this transcriptional 
repression is mediated by the binding of a repressor factor 
to the octamer-related TAATGARAT motif (see section 
IB.3.1). This repressor activity was specific to cells of 
neuronal origin (being absent in a range of permissive non­
neuronal cells) and is also able to repress a range of 
cellular octamer-containing promoters introduced into C1300 
cells; the repression could be relieved by mutagenesis or 
deletion of the octamer element.
Although the specific nature of this octamer- 
binding protein has not been identified, it is interesting 
to note that several octamer-binding proteins other than 
the ubiquitous oct-1 and B-cell specific oct-2 have been 
identified in other cell types, most notably in embryonal 
carcinoma cells (Lenardo et al., 1989; Scholer et al.,
1989) which like C1300 cells are non-permissive for HSV 
(Bell et al., 1987). He et al., (1990), when examining 
expression of a series of POU-homoeodomain genes (including 
oct-1 and oct-2) in embryos and adults by in situ 
hybridisation found that oct-1 gene expression in the adult 
rat nervous system was highly restricted, being detectable 
only in certain regions of the brain; oct-1 expression 
could not be detected in any of the sensory or trigeminal 
ganglia. Instead, they found low levels of a novel POU- 
domain gene (termed Tst-1) expressed in sensory ganglia and 
low levels of two other novel POU-domain proteins (termed 
Brn-1 and Brn-2) in the trigeminal ganglia.
During the establishment of latency, the lack of
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transport of Vmw65 to the neuron nucleus, coupled to the 
lack of oct-1 in neuronal cells probably leads to the 
suppression of IE gene expression and therefore the 
suppression of lytic infection. It would be intruiging to 
propose that the novel POU-domain proteins found in 
neuronal cells, like oct-2, are unable to support Vmw65- 
mediated trans-induction of immediate-early gene 
expression, and may indeed repress IE gene expression by 
binding the TAATGARAT motif as proposed by Kemp et al. 
(1990).
4.3. Immunological Factors Affecting Latency
Initial infection by HSV-1 is usually followed by 
the appearance of a protective specific immune response 
which includes neutralizing antibodies directed against 
glycoproteins present in the viral envelope (Carter et al., 
1982) and cytotoxic T-cells which, at least in the murine 
model, are directed against structural glycoproteins in the 
virion envelope and in the infected cell (Carter et al., 
1982; Glorioso et al., 1985; Martin et al., 1988) and non- 
structural proteins, predominantly the products of the 
immediate-early genes (Martin et al., 1988).
The role of the immune response in protection 
against the establishment of a latent infection is not very 
clearly understood. It has been demonstrated though that it 
is difficult to establish latent HSV infection in animals 
which have been either previously infected or immunized 
against HSV infection (Walz et al., 1976; Cremer et al.,
1985; Rooney et al., 1988). Neutralizing antibody (Walz et 
al., 1976; Cremer et al., 1985; Rooney et al., 1988), 
infiltrating B-lymphocytes (Cook & Stevens, 1983) and T- 
lymphocytes (Nash et al., 1987) have all been implicated as 
being important in preventing infection of neurons or in 
restricting HSV multiplication once the virus is in the 
ganglia. It has been demonstrated that the adoptive 
transfer of HSV-specific cytotoxic T-lymphocytes (CTL's) to
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recipient animals immediately before infection in the 
footpad significantly decreases the levels of infectious 
virus able to be recovered from the footpad (Larsen et al., 
1984; Rouse et al., 1985; Bonneau & Jennings, 1989). This 
treatment also reduced the levels of HSV able to be 
reactivated from latency, thus suggesting that CTL's may 
play a role in the control of HSV infection and restriction 
of HSV multiplication in ganglia.
Although there is clear evidence that prevention of 
HSV replication by the immune response can greatly reduce 
reactivatable latent infections, it has been suggested that 
this is due to decreasing the number of virus genomes that 
are capable of establishing latent infections (Katz et al., 
1990). These observations have lead to speculation that 
vaccine strategies targeted against lytic functions of the 
virus may be unable to prevent HSV latency completely.
ID.5. MAINTENANCE AND REACTIVATION FROM LATENCY
5.1. General Considerations
Reactivation of latent HSV in humans can be induced 
by a number of stimuli including exposure to ultraviolet 
light, fever, stress and hormonal changes (Hill, 1985). 
Reactivation can also be induced in a number of animal 
model latency systems by exposure of their periphery to a 
variety of physical and chemical stimuli, including
exposure to uv light (Blyth et al., 1976), repeated
applications of cellophane tape (Hill et al. , 1983) or
chemicals such as dimethylsulphoxide (DMSO) and xylene 
(Harbour et al., 1983).
Such evidence has led to a number of theories 
pertaining to the nature of reactivation, the most favoured 
being the 'ganglion and skin trigger' theory (Hill, 1985). 
This proposes that following a peripheral stimulus, 
reactivation of the latent infection in the ganglion 
results in the production of infectious virus which
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proceeds along the associated nerves to the periphery where 
a recurrent lesion may occur. It has also been suggested 
that whenever a recurrent lesion occurs, any infectious 
virus produced may travel up the peripheral nerve again, 
and latently infect more neurons; the so-called 'round- 
trip' theory (Klein, 1976). The nature of the message that 
is stimulated by the various reactivation-inducing 
treatments is not clear. UV light is known to produce many 
changes in the skin including damage to epithelial cells 
and their replication (Epstein et al., 1971), the release 
of prostaglandins (Harbour et al., 1983) and the reduction 
of ATPase staining of Langerhans cells (Bergstresser et 
al. , 1980). In rabbits, it causes epithelial loss and
swelling in the cornea (Riley et al., 1987) and killing of 
keratinocytes (Ringvold & Davanger, 1985). It is not clear, 
though, how these observations relate to the reactivation 
of HSV. It is possible that reactivation may arise from the 
direct effect of uv light on the peripheral nerve endings. 
A common factor between the different reactivation stimuli 
appears to be their ability to induce inflammation of the 
skin (Harbour et al., 1983); the physiological changes 
which mediate this response could also affect the neuronal 
cell body.
Reactivation may also be related to the metabolic 
changes in neurons associated with repair of damage to 
nerves or nerve endings (Price & Schmitz, 1979). In this 
respect, it is likely that the physical and chemical 
stimuli to the skin all produce alterations or damage in 
the membranes of the nerve endings and thereby cause such 
metabolic changes in the ganglion.
HSV reactivation can also be induced by peripheral 
nerve section (neurectomy) as occurs, for instance, during 
explantation of nervous tissues. This process causes a 
profound alteration in the metabolism of neurons, possibly 
induced by the loss of a trophic factor (eg nerve growth 
factor) from the periphery. These changes include an
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increase in the general level of transcription, protein 
synthesis and DNA synthesis. Reactivation of HSV from 
latently infected ganglia can be enhanced by co-cultivation 
of intact or dissociated ganglia on permissive cell 
monolayers (Knotts et al., 1973; Wohlenberg et al., 1979; 
Harbour et al., 1981), by heterotypic superinfection of 
ganglia (Thomas et al., 1985) or by exposure of ganglia to 
demethylating agents (Bernstein & Kappes, 1988;
Stephanopoulos et al., 1988).
DNA methylation at the dinucleotide 5'-CG-3' has 
been correlated with transcriptional inactivity and appears 
to be an important factor concerning regulation of 
eukaryotic gene expression. In general, hypomethylation is 
a necessary, but not sufficient precondition of gene 
transcription. In several in vitro viral systems, including 
adenoviruses, herpesviruses and retroviruses,
transcriptionally active or replicating viral genomes are 
consistently hypomethylated, or specific inactive regions 
of viral genomes are readily heavily methylated (Doerfler, 
1981; Yousoufian et al., 1982; Szyf et al., 1985). The 
observations that demethylation agents such as HMBA 
(Bernstein & Kappes, 1988; Stephanopolous et al., 1988) and 
5-azacytidine which functions to prevent methylation of DNA 
all induce reactivation of HSV from neural tissues have 
implied that the latent HSV genome was maintained in a 
transcriptionally quiescent state in neurons by extensive 
methylation. However, Dressier et al. (1987) subsequently 
demonstrated with methylation-sensitive restriction 
endonucleases that latent HSV-1 DNA was not extensively 
methylated in vivo. Consequently, reactivation of latent 
HSV using demethylation agents probably occurs indirectly 
by converting the host cell to a permissive state for HSV 
replication via cellular gene activation.
5.2. Viral Factors Affecting Reactivation
These factors have been investigated using the same
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virus deletion and insertion mutants described in section 
ID.4.1 when examining factors affecting establishment of 
latency. Steiner et al. (1990) demonstrated that HSV inl814 
(the Vmw65 insertion mutant) reactivated upon explantation 
as efficiently and rapidly as w t . This suggested that 
reactivation may be caused by the induction of cellular 
factors which complement the trans-inducing activity of 
Vmw65 and lead to expression of IE genes and viral 
replication. Since Vmw65 is not expressed during latency 
(Deatly et al., 1987; 1988; Spivak & Fraser, 1987; Stevens 
et al., 1987), and since during reactivation, IE genes 
would be expressed prior to Vmw65 (a late gene), Vmw65 is 
therefore unlikely to play any role in the initial events 
of the reactivation process.
The role of the HSV IE genes in reactivation has 
been examined by Leib et al. (1989). They showed that, as 
anticipated, null mutants in IE genes 2 and 3 (encoding 
Vmw63 and Vmwl75 respectively) failed to reactivate from 
latent infections. They also showed that, despite their 
replication competence, HSV strain KOS-derived VmwllO 
deletion mutants dlx0.7 and dlx3.1 failed to reactivate 
from standard explant cultures of latently infected 
ganglia. The dlx3.1 virus could, however, be reactivated by 
the addition of DMSO to the medium of explant cultures. 
Both mutants could be reactivated following superinfection 
with a complementing virus. By contrast, the HSV strain 17+ 
derived IE-1 deletion mutant dI1403 does reactivate in the 
absence of DMSO (Clements & Stow, 1989; Leib et al., 1989), 
therefore demonstrating that VmwllO may not be essential 
for reactivation. It is possible that the observed 
differences in reactivation phenotype of the KOS and 17 + 
derived mutants are strain specific which may allow 17+, 
but not KOS to reactivate in the absence of VmwllO. Indeed, 
major differences in the neurovirulence of strains 17 and 
KOS have been noted (Thompson et al., 1986). Alternatively, 
the reactivation phenotypes may arise from the differences
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between the deletions in VmwllO. Mutant dlxl>\ has a 2965 
bp deletion, including the transcriptional start site, and 
should not express any form of the IE-1 transcript or 
polypeptide, whereas, dlxO.l has a 798 bp deletion and 
would specify an amino-terminal 19 amino acid polypeptide 
encoded by the first exon. The 3 1 limit of the dlxO.l 
deletion lies in the second intron, such that the third 
exon is read out of frame. The <311403 mutant has an 
internal 2117 bp deletion and could specify the amino- 
terminal 105 amino acids encoded by the first, and part of 
the second intron. The carboxy-terminus of the third exon 
which is out of frame. It is possible that the 86 amino 
acids specified by the undeleted portion of the second exon 
of <331403, and not found in the other two deletions, are 
sufficient to render this mutant latency competent in vivo. 
By contrast, the 19 amino acids specified by the first exon 
of dlxO.l are apparently not sufficient to give this mutant 
the ability to establish or reactivate from latency 
effectively. The reason for the difference in latency 
competence between dlx0.7 and dlx3.1 is not clear. The 
possibility that other differences had occurred in these 
viruses during their construction cannot be dismissed, and 
therefore demonstrates the importance of characterizing 
rescued versions of such mutants when investigating their 
phenotypes. It is also possible that these differences may 
be a consequence of the deletion of the corresponding 
regions of the LAT transcript (see section ID.7.2). For 
example, the least latency-competent virus, dlxO.l, is the 
only mutant whose deletion did not cover the mapped 3' end 
of the 2 kb LAT transcript.
Further studies of dlx^>\ (Gordon et al., 1990) 
revealed that host species is also a factor in determining 
the ability to reactivate upon cocultivation. Reactivation 
could not be observed from CD-I and A/J mice, as opposed to 
30% of Balb/c mice and 22% of*NZ rabbits. They also showed 
that dlx3.1 could also reactivate and shed spontaneously
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from NZ rabbits. Interestingly, the wt KOS strain which 
could be reactivated by cocultivation from 88% of rabbits, 
did not shed spontaneously, nor could it be induced to shed 
by iontophoresis of adrenergic agents.
Other replication competent mutants that fail to 
reactivate from explanted ganglia in the mouse system 
include thymidine kinase negative (tk~) mutants (Coen et 
al. , 1989; Efsthatiou et al.f 1989; Leist et al., 1989;
Tenser et al., 1989) and ribonucleotide reductase negative 
(rr~) viruses (Jacobson et al., 1989). The tk- mutants can 
establish and maintain latency as evidenced by expression 
of latency-associated transcripts (Coen et al., 1989; Leist 
et al., 1989; Tenser et al., 1989) and by their ability to 
be rescued following superinfection of dissociated ganglia 
by a complementing virus (Coen et al., 1989; Efsthatiou et 
al. , 1989). Both tk and rr mutant genomes could be detected 
in latently infected ganglia by PCR (Katz et al., 1990). As 
both tk- and rr- mutants are also severely impaired for
acute ganglionic replication, their requirement for 
reactivation could be explained if there is a requirement 
for a sufficient pool of their enzymatic products in
nucleotide metabolism, in each of these settings to permit 
viral replication. Neurons, being non-mitotic, are likely
to harbour low levels of deoxyribonucleotides, therefore 
possibly explaining why HSV has enzymes dedicated to
nucleotide metabolism.
5.3. Cellular Factors and Reactivation
The observation that various treatments can enhance 
reactivation of latent HSV from latently-infected explanted 
ganglia, and in particular the reactivation of VmwllO 
deleted dlx.J\ by DMSO (Leib et al. , 1989), has suggested a 
possible role for cellular factors involved in the early
stages of reactivation. The mode of action of DMSO is
unknown, but is has been shown to affect a number of
cellular processes (De La Torre, 1983). It would be
75
interesting to speculate that DMSO may induce reactivation 
through induction of specific cellular genes. Indeed, host 
cellular trophic factors such as nerve growth factor 
(Wilcox & Johnson, 1987) and prostaglandins (Kurane et al., 
1984) have been shown to affect the reactivation of HSV-1 
from murine ganglia, presumably by perturbation of the host 
cell. In this respect, it is interesting to note that HIV-1 
gene expression in monocytes has been demonstrated to be 
activated following induction of the transcription factor 
NF-kB (Griffin et al., 1989).
ID.6. THE STATE OF THE LATENT VIRUS GENOME
Analysis of the physical structure of HSV DNA from 
latently infected neurological tissue may provide useful 
information concerning the molecular mechanisms involved 
in latency. Initial studies by Rock & Fraser (1983) 
indicated that viral DNA found in the murine trigeminal 
ganglion and brain stem was in a different state to that 
observed during acute infection, and was also different to 
that present in virions. These genomes lacked detectable 
termini, suggesting that they could be integrated into 
multiple sites in the host cell genome or were present in 
some extrachromosomal form. In the latter case, they could 
exist as multimeric linear or circular molecules or 
monomeric circles. These results were confirmed by 
Efsthatiou et al. (1986) who showed that virus genomes with 
similar properties were present in latently infected human 
trigeminal ganglia, and that all four DNA isomers could be 
found in latently infected tissues. Rock & Fraser (1985) 
subsequently demonstrated that the genomic termini of 
latent viral DNA were covalently linked; a result 
compatible with single copy plasmids or concatameric 
circular or linear molecules.
Mellerick & Fraser (1987), by subjecting the DNA 
present in murine brain stems to buoyant density gradient
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centrifugation, succeeded in separating the viral DNA from 
the cellular DNA, thus indicating that the viral DNA 
existed in an extrachromosomal state. This suggested that 
the most likely physical form of the viral DNA would be a 
circular episome. Finally, Deshmane & Fraser (1989) 
indicated that latent HSV-1 DNA has a nucleosomal structure 
similar to that of cellular chromatin, as determined by 
micrococcal nuclease digestion. All of the regions, 
including the transcriptionally active region of the genome 
were found to be associated with nucleosomes. This 
contrasts with HSV DNA found during lytic infection of 
tissue culture cells (Leibach & Summers, 1980; Seal et al.,
1988) and during acute infection of mice (Muggeridge & 
Fraser, 1986) where a small fraction (10-15%) of viral DNA 
is associated with nucleosomes. It is possible that this 
chromatin formation may be essential for the long term 
stability of viral DNA in the cell nucleus.
An accurate determination of the number of genomes 
per latently infected cell has proven difficult. Estimates 
using quantitative blot hybridizations include values of
0.01 to 0.4 genomes per cell in human trigeminal ganglia 
(Efsthatiou et al., 1986) and 0.015 to 0.1 copy per cell in 
various murine neural tissue (Cabrera et al., 1980; Rock & 
Fraser, 1983; Efsthatiou et al., 1986). Quantitative
polymerase chain reaction analysis of individual latently 
infected murine ganglia indicated values of between 0.01-1 
copy per cell (Katz et al., 1990). Assuming that one of 
these values represents the number of genomes actually 
present in a tissue, and that most of the genomes are non­
defective, the actual number of per latently infected 
neuron would be much larger. This is because neurons 
constitute only a minor proportion of the cells populating 
neural tissues (about 10% of the cells in spinal ganglia) 
and because not all of the neurons in a latently infected 
ganglion would be expected to harbour viral DNA. Taking 
these factors into consideration, and scoring for neurons
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expressing the latency-associated transcript (assuming that 
all latently infected genomes express LAT), Stevens (1989) 
calculated that there may be up to 20 copies of viral DNA 
per latently infected neuron.
Interestingly, in situ hybridisation, a technique 
which in other systems has been sufficient to detect viral 
genomes of less complexity and present at only one copy per 
latently infected cell (hepatitis B virus in hepatocytes; 
Blum et al. , 1983) has not been able to detect HSV DNA in 
latently infected neurons. The reason for this is not 
apparent; the DNA is possibly present in a complex that is 
not accessible when current methods of section preparation 
are used.
ID.7. LATENT HSV GENE EXPRESSION
7.1. The Search for Latent Viral Gene Expression
Various attempts have been made to define the
nature of HSV gene expression by latent viral genomes, and 
have employed such techniques as DNA/RNA hybridization and 
immunological procedures for the detection of virus-
specific proteins. There have been a few reports of 
detection of viral proteins during latency in animals
(Yamamoto et al., 1977; Green et al., 1981) and during
virus reactivation in humans (Vaifa et al., 1988), however, 
such reports have proven difficult to corroborate. Green et 
al. (1981) using immunofluorescence, detected Vmwl75 in 
latently infected trigeminal ganglia of rabbits, however, 
further studies failed to substantiate this (Pepose, 1986) 
and indeed, the transcript for this protein does not appear 
to be expressed during latency (Deatly et al., 1987, 1988; 
Stevens et al., 1987). It is possible that the detection of 
Vmwl75 was due to spontaneous reactivation in rabbits. 
Similarly, Yamamoto et al. (1977) reported the presence of 
enzymatically active HSV-specific tk in the sensory ganglia 
of latently infected mice, however, as with Vmwl75, tk mRNA
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expression cannot be detected in latently infected mouse, 
rabbit or human ganglia by in situ hybridization analysis 
(Deatly et al., 1987; Puga & Notkins, 1987; Rock et al., 
1987a; Stevens et al., 1987b; Steiner et al., 1988).
7.2. The Latency-Associated Transcript
A major development in the field of latency was the 
discovery by Stevens et al. (1987) that a unique transcript 
(now termed the latency-associated transcript; LAT) is 
synthesised in latently infected murine sensory neurons. 
This pattern of transcription is now known to take place in 
latently infected sensory neurons of mice (Puga & Notkins, 
1987; Spivak & Fraser, 1987; Stevens et al., 1987), rabbits 
(Rock et al., 1987b; Wagner et al., 1988b) and most
importantly, in humans (Croen et al., 1987; Gordon et al., 
1988; Steiner et al., 1988; Stevens et al., 1988; Wechsler 
et al., 1988a). In situ hybridization has demonstrated that 
this transcription unit maps to the long repeats of the 
HSV genome ^(Figure 5) and is localized exclusively to the 
nucleus.
The number of transcripts, their sizes and relative 
proportion to each other differs slightly between 
laboratories, and depends upon virus strain or experimental 
system utilized. The major transcript is approximately 2.0 
kb (Spivak & Fraser, 1987; Wechsler et al., 1988b) to 2.2 
kb (Wagner et al., 1988b) in length and consists of from 50 
to 90% of the total. The next most abundant (10 to 50% of 
the total) is a spliced derivative of the first and is 
about 1.5 kb long (Spivak & Fraser, 1987; Wagner et al. , 
1988b; Wechsler et al., 1988b). In addition to these two 
transcripts, a third, very minor transcript of 1.45 kb has 
been described by Spivak & Fraser, (1988a) and probably 
represents yet another spliced derivative of the primary 
transcript. As a group, these transcripts are minimally 
polyadenylated (Spivak & Fraser, 1987) or nonpolyadenylated 
(Wagner et al., 1988b).
Figure 5. Transcription patterns of the HSV-1 internal 
repeat region in productively and latently infected cells.
A diagram of the physical structure of the viral genome is 
represented at the top of the panel. Although not 
indicated, transcripts originating in IRl and IRs are also 
encoded by TRl and TRs. In latently infected cells, only 
transcripts originating from the repeat regions can be 
detected (Us and U l are silent). During acute infection of 
tissue culture cells, the following transcripts can be 
seen: a) transcripts known to be expressed only during
lytic infection; b) polyadenylated transcripts (m-LATs) 8.3 
kb in length, and c) unspliced, non-polyadenylated 2 kb LAT 
transcripts. In latently infected sensory ganglia, in 
addition to m-LAT (1) and the 2 kb LAT (2), the 
accumulation of a second (spliced) derivative of the 2 kb 
LAT (3) is observed.
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The most intriguing aspect of the LAT RNAs is that 
they are all transcribed from the DNA strand opposite 
(antisense to) that encoding the transcript for the 
immediate-early polypeptide VmwllO. The major LAT 
transcripts all begin approximately 1210 bp downstream of 
the IE-1 mRNA. The 3' end of LAT overlaps the 3' end of IE- 
1 by approximately 1000 nucleotides (Wechsler et al. 
1988b). There are two significant open reading frames which 
are not interrupted by the splice in the two major species 
of RNA (Wagner et al., 1988b; Wechsler et al., 1988b), but 
there is no evidence that a protein is encoded by these 
species. Indeed, sequence analysis of the LAT gene and its 
open reading frames by Perry & McGeoch (1988) revealed that 
the codon usage characteristics of the LAT ORFs were 
atypical for HSV and they concluded that it was unlikely 
that LAT encoded any proteins.
Small amounts of the unspliced transcript (also 
non-polyadenylated) are found in lytically infected tissue 
culture cells (Krause et al., 1988; Spivak & Fraser, 1987; 
Stevens et al., 1987; Wagner et al., 1988b). Analysis of 
the kinetics of their transcription has revealed that LAT 
does not appear to fit any of the typical kinetic classes 
of HSV transcripts previously described (Spivak & Fraser, 
1988a). A rough calculation by Wagner et al. (1988a) has 
indicated that the LATs as a group are present at 2xl04 to 
5xl04 molecules per latently infected murine neuron.
More recent evidence has suggested that the LAT 
transcription pattern is considerably more extensive than 
was previously thought. Additional weak hybridisation 
signals were detected by in situ hybridization which 
corresponded to transcription from DNA fragments adjacent 
to either side of the 2 kb LAT domain (Dobson et al., 1989; 
Mitchell et al., 1990; Zwaagstra et al. , 1990). A
combination of northern blot analysis (Zwaagstra et al., 
1990) and in situ analysis (Dobson et al., 1989; Mitchell 
et al., 1990; Zwaagstra et al., 1990) demonstrated the
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presence of an 8.3 kb transcript in latently infected 
neurons and lytically infected tissue culture cells. This 
RNA, termed the minor latency-associated transcript (m-LAT) 
was found to be the same sense as LAT, and extends from 660 
bp upstream from the 2 kb LAT to the first consensus 
polyadenylation signal in the short terminal repeat just 
downstream from the IE-3 gene. The 5' end of the m-LAT was 
mapped by primer extension of RNA of transfected cells to 
approximately 28 bp downstream from the first T of the TATA 
box (Zwaagstra et al. , 1990) of the putative LAT promoter 
(Wechsler et al., 1988b, 1989). Although not proven, it is 
likely that the 2 kb and 1.5 kb LATs are derived from the
8.3 kb LAT. Since mutants lacking the immediate region 
around the LAT promoter do not produce either the 8.3 kb 
LAT or the 2 kb and 1.5 kb LATs (Dobson et al, . 1989;
Mitchell et al., 1990b), it is possible that the 2 kb LAT 
is derived from the 8.3 kb LAT and that the other LAT
species are derived by splicing of the 2 kb LAT. This
raises the possibility that the 1.5-2.0 kb LATs are 
processing products (Dobson et al., 1989) or stable introns 
derived from the the larger transcript (Dobson et al., 
1989; Mitchell et al., 1990b). Indeed, a recent study by 
Devi-Rao et al., (1991) has demonstrated that LAT is 
uncapped, and that its 3 1 end maps to a canonical splice 
acceptor site 1,950 bases 3' of its 5' end. They also
identified a major species of poly(A)+ LAT equivelant to m- 
LAT. The idea that the 2 kb LAT is a stable intron has been 
confirmed by Farrell et al. (1991) who showed that when a
2.4 kb HSV-1 fragment encompassing the 2 kb LAT is cloned 
into the lacl gene in pCHHO, LAT was correctly spliced out 
giving rise to a processed fi-gal transcript and 2 kb LAT 
intron. All of these data hav* demonstrated that all latent 
phase transcription is via a single large primary 
transcript which is spliced to yield an abundant poly(A)- 
species; the LAT intron. The spliced polyadenylated product 
of this splicing reaction has, however, remained
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undetected.
7.3. A Function for LAT?
Since the discovery of the LATs, a great deal of 
effort has been employed in order to elucidate their 
function(s). It is possible that these transcripts could 
function in any of the stages of establishment of, 
maintenance of or reactivation from the latent state. To 
date, the majority of work dealing with this subject has 
focussed on the latency characteristics of various mutants 
with deletions or insertions in the LAT gene.
Javier et al. (1988) reported that an HSV-lxHSV-2 
recombinant (X10-13) which contains a small HSV-2 insert 
and a small deletion in the LAT sequences does not express
Gita
LATs but*establish latency after footpad inoculation. Since 
both X10-13 and wt virus could be recovered from lumbar 
ganglia of latently infected mice with equal frequency at 
similar times after explantation, it was concluded that the 
LATs are dispensable for the establishment of latent 
infections. Similarly, Sederati et al. (1989) using a LAT" 
KOS derivative (KOS 8117) and its LAT+ rescued derivative 
(KOS D362) found that both viruses latently infected the 
same number of neurons and contained the same copy number 
of genomes per infected cell. The amount of viral DNA did 
not differ over an 11 month period and therefore suggested 
that LAT has no effect on the establishment or maintenance 
of latency. They did notice, however, that the expression 
of lytic phase transcription of LAT" KOS 8117 during acute 
infection of ganglia was delayed when compared to w t . An 
HSV-1 insertion mutant, RH142 (Ho & Mocarski, 1989),
generated by placing the l a d  gene under LAT promoter 
control did not express LAT in latently or productively 
infected cells, however B-galactosidase was readily 
detected in sensory ganglia, but not Vero cells. This virus 
was able to establish and reactivate from the mouse eye 
mode latency system with the kinetics and efficiency of wt
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virus.
By contrast, other studies, while supporting a non- 
essential role in establishment and maintenance of latent 
infection, have suggested a role for the LATs in the 
reactivation process. HSV-1 variant 1704 which possesses a 
3.8 kb deletion in IRl and adjacent unique DNA sequences, 
and a 1.2 kb deletion in TRl (Maclean & Brown, 1987a), does 
not express LATs (Steiner et al., 1989) or m-LATs (Mitchell 
et al., 1990) in tissue culture or latent infection of 
mice. Although 1704 could establish latent infections in 
murine trigeminal ganglia, explant reactivation of the 
virus was significantly slower (31 days for 8/9 mice) than 
wt (100% within 7 days) (Steiner et al., 1989). The 
survival rate of 1704 infection (79%) was also 
significantly better than wt (38%). In addition, Leib et 
al. (1989) have reported that a KOS-derived LAT" deletion 
mutant (dILAT8.1) reactivates from explants less 
efficiently than its LAT* parent. Interestingly, Hill et 
al. (1990), also using HSV X10-13 (see above) and its 
rescued LAT+-derivative XC-20 showed that both viruses 
replicated in the rabbit eye and established latency with 
equal efficiency. Similar percentages of trigeminal ganglia 
latently infected with either virus produced HSV when 
cultivated in vitro, and a small proportion of rabbits 
latently infected with either virus spontaneously shed 
virus in their tear films episodically during the latent 
phase of infection. However, when reactivation was induced 
by iontophoresis of epirjphrine it was found that while 
rabbits infected with XC-20 reactivated with efficiencies 
similar to wt (18/20), the efficiency of X10-13 
reactivation (3/20) was significantly reduced.
The reason for the effect of LAT expression on the 
in vitro recovery of virus not being as marked as observed 
for induced reactivation in vivo is not clear. Explantation 
and maintenance of latently infected neurons in vitro for 
virus recovery subjects the cells to a number of insults,
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and it is possible that this may not fully reflect the 
processes occurring in the animal. In vitro reactivation of 
virus usually results in neuronal cell death, however, in 
vivo reactivation is more likely to require the survival of 
neurons, and that this could be the result of an alteration 
or attenuation of the normal lytic phase of viral 
replication; such conditions may not be obtainable during 
in vitro explantation. In this respect, it is interesting 
to note that Hill et al. (1987) reported that 10 strains 
of HSV demonstrated the same frequency of recovery from 
cultured latently infected trigeminal ganglia irrespective 
of whether the eyes had or had not shed virus 
spontaneously.
From a direct functional point of view, all 
available evidence indicates that LAT is in some way 
involved during reactivation from latency (Leib et al., 
1989; Steiner et al., 1989; Hill et al., 1990). Various 
hypotheses have been forwarded for its role. These include 
that the transcripts could function physically by somehow 
"scaffolding" latent viral DNA and making the genome 
available for reactivation or other processes related to 
reactivation (Hill et al. , 1990). A second model involves
some processed form of LAT which could function as an mRNA 
encoding a protein which facilitates reactivation (Stevens 
et al., 1987). This would predict that inactivation of one 
or more reading frames would interfere with reactivation. 
Indeed, a recent report by Doerig et al. (1991) has 
reported the detection of a 80kDa antigen with an antibody 
raised against a region of the larger of the two ORF's 
encoded by LAT in neuronal cell cultures latently infected 
with HSV-1. Finally, various data (Leib et al., 1989; 
Steiner et al., 1989; Block et al., 1990; Hill et al.,
1990) has ruled out an earlier suggestion (Stevens et al., 
1987), that LAT might act directly to facilitate latency by 
suppressing gene activation by VmwllO through antisense 
inhibition of IE-1 gene transcription. If this were the
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case, LAT deletion mutants might be expected to reactivate 
efficiently, or would not establish latent infections at 
all since there would be no LAT to suppress VmwllO gene 
transcription. It cannot be ruled out, however, that LAT 
might interact with the IE-1 transcript during the initial 
stages of reactivation to suppress full lytic gene 
expression in the reactivating neurons, thus preventing 
neuronal death.
That LAT must have a function is borne-out by the 
observations that other alphaherpesviruses have similar 
patterns of gene expression during latency. LATs have been 
identified in neurons latently infected with HSV-2 
(Mitchell et al., 1990c; Croen et al., 1991; Tenser et al.,
1991) which, similar to the HSV-1 LATs, map to the repeat 
regions of the viral genome. Such patterns of transcription 
have also been observed for bovine herpesvirus-1 (BHV-1) in 
rabbits and cattle (Rock et al., 1986, 1987a; Kutish et
al., 1990) and pseudorabies virus in swine (Cheung, 1989; 
Lokensgard et al., 1990; Priola et al., 1990). As with HSV- 
1, the LAT species of these viruses overlap immediate-early 
transcription units on the complementary strand (Cheung, 
1989; Kutish et al., 1990; Priola et al., 1990). It would 
seem highly unlikely that the LAT transcription pattern 
would be conserved in such diverse alphaherpesviruses if 
LAT were devoid of any important function. Clearly, more 
extensive studies are required to pinpoint their precise 
role and function in the pathogenesis of latent infections.
ID.8. IN VITRO LATENCY SYSTEMS
In order to circumvent the problems associated with 
the studies of latency in sensory ganglia maintained in 
vivo, an in vitro latency system would clearly be 
beneficial. Aside from the problems of proving that in 
vitro cultures are not producing low levels of virus, 
thereby perpetuating the infection, the major theoretical 
problem with the development of such systems is that
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insufficient information has been available from 'real' in 
vivo systems ie the fundamental characteristics of latent 
infection that should be attempted to be reproduced in 
cultured cells. From all of the information gathered so 
far, studies of cell? harbouring episomal DNA and expressing 
LAT should be the goal.
Over the years, there have been several attempts to 
study latency in in vitro systems, the most extensive 
reflecting those of Wigdahl et al. (1981) whose basic 
system involved infecting cultured cells (including 
cultured neurons) at temperatures supraoptimal for virus 
replication (40°C) and then adding inhibitors of viral 
replication. Once the 'latent' infection is established the 
supraoptimal temperature is sufficient to prevent viral 
replication; when the temperature is lowered to 37°C, virus 
replication ensues (Wigdahl et al., 1981, 1982, 1983,
1984a). In these systems, transcriptional patterns have not 
been reported, however, the virus genome appears to persist 
in some linear form (Wigdahl et al., 1984b).
A variation of the above theme is that employed by 
Russell & Preston (1986) whereby HSV-2 is converted to a 
'latent' state in human foetal lung fibroblasts by 
increasing the temperature of incubation to 42°C. Viral 
replication was not usually induced by downshift to 37°C 
but could be induced by superinfection with ts mutants of 
HSV-1 or with HCMV (Russell & Preston, 1986) . It was found 
that superinfection with tsK at 42°C resulted in the rescue 
of latent virus (presumably by complementation) suggesting 
that Vmwl75 is not necessary for reactivation (Russell et 
al., 1987b). Interestingly, a VmwllO mutant (dI1403) could 
not rescue 'latent' virus thereby suggesting that 
expression of VmwllO is necessary for reactivation in this 
system. Further investigation demonstrated that adenovirus 
recombinants expressing VmwllO could reactivate latent 
virus, whereas adenovirus alone could not (Harris et al.,,
1989). In addition, an HSV-1 mutant possessing a deletion
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in the carboxy-terminal region of VmwllO could reactivate 
'latent' HSV-2, while mutant HSV-1 FXE harbouring a 
deletion in the second exon (containing the putative VmwllO 
metal binding domain; see section IB.4.4) could not, 
therefore suggesting that this region is important for the 
reactivation process.
Another model developed by Cook & Brown, (1987), 
involved the use of supraoptimal temperatures and addition 
of acycloguanosine to corneal cells infected with HSV-1. 
Upon downshift and removal of the drug, virus reappeared in 
cultures where it could not be detected earlier.
In the most recently developed system, latent 
infection (in which no viral antigens could be detected) 
was established by incubation of HSV-1 infected primary rat 
sympathetic neurons in the presence of acycloguanosine and 
nerve growth factor. When anti-nerve growth factor antibody 
was added to the cultures, virtually all of the cells began 
producing viral antigens, and virus reappeared (Wilcox & 
Johnson, 1987, 1988). the state of the viral
genome h a s  n o t  b e e n  e s t a b l i s h e d ,  t h i s  s y s t e m  h a s  b e e n  shown  
to e x p r e s s  LATs ( D o e r i g  et al, , 1991).
The contribution of these systems to an 
understanding of latency may or may not be a direct one, 
however, it is certain that such studies will be 
informative with respect to the biology of HSV, 
particularly in relation to an understanding of viral gene 
expression in nonpermissive cells.
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CHAPTER 2: MATERIALS AND METHODS 
2A. MATERIALS
1. Chemicals
Chemicals were supplied by BDH Chemicals UK, Koch- 
Light Laboratories and Sigma (London) Ltd. Solvents were 
obtained from James Burroughs UK Ltd and Koch-Light 
Laboratories.
2. Radiochemicals
All radiochemicals were obtained from NEN Dupont 
and Amersham International pic.
3. Oligonucleotides
Synthetic restriction enzyme linker
oligonucleotides were obtained from New England Biolabs.
4. Enzymes
Restriction endonucleases, DNA modifying enzymes 
and enzyme buffers were obtained from Bethesda Research 
Laboratories, New England Biolabs, Nbl Enzymes Ltd. 
Boehringer Mannheim GmbH and Promega Biotech. DNase, RNase 
and lysozyme were supplied by Sigma.
5. Cells lines
i) BHK-21 clone 13 cells (Macpherson & Stoker, 1962), a 
fibroblastic cell line derived from baby hamster kidney 
cells were used routinely for growth and titration of virus 
stocks, viral gene expression experiments and short term 
transfection assays.
ii) Cl300 Neuro-2A cells, a murine neuroblastoma cell line 
obtained from PHLS, Porton Down via Dr. John Quinn (MRC 
Brain Metabolism Unit, Edinburgh), used for viral gene 
expression experiments.
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6. Tissue culture medium
BHK cells were grown in ETCio, consisting of 
Glasgow modified Eagle's medium (GMEM; Busby et al., 1964) 
supplied by Gibco Ltd, supplemented with 10% tryptose 
phosphate broth, 10% calf serum, 100 units/ml penicillin
and lOOpg/ml streptomycin.
C1300 cells were grown in Dulbeccos modified
Eagle's medium (supplied by Gibco Ltd), supplemented with 
10% foetal calf serum, 4mM L-glutamine, 100 units/ml 
penicillin and lOOpg/ml streptomycin.
7. Viruses
All HSV-1 viruses and HSV-1 mutants used or
constructed in this study were derived from Glasgow strain 
17syn+ (Brown et al., 1973).
8. Plasmids The following plasmids were kindly supplied by 
the acknowledged authors:
pFJ5 (Rixon & McLauchlan, 1990) was obtained from F.J.
Rixon.
pFJ7 (Rixon & McLauchlan, 1990) contains the promoter of 
the gene encoding the HSV-2 ribonucleotide large 
subunit fused to the CAT gene in pFJ5. 
pFJIO (Rixon & McLauchlan, 1990) contains the promoter of 
the gene encoding the HSV-2 IE-4/5 gene fused to the 
CAT gene in pFJ5. 
pUC19 and pUC8, E.coli cloning vectors supplied by 
Bethesda Research Laboratories. 
pT7T3 A dual T7/T3 RNA polymerase expression vector used 
for sequencing and synthesis of single-stranded 
radioactive probes supplied by Bethesda Research 
Laboratories .
pl75 (Everett, 1987b) containing the HSV-1 IE-3 gene 
under the control of the SV40 early promoter and
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enhancer.
pill (Everett, 1987b) contains the HSV-1 IE-1 gene under
the control of its own promoter. 
pgDCAT (Everett, 1986) contains the promoter of the gene
encoding gD (Us6) fused to the CAT gene in the
vector pBLW2 (Gaffney et al., 1985). 
pJR3 obtained from C. Preston.
pGX48 supplied by F.J. Rixon. Contains the HSV-1 BaniRl b
restriction fragment cloned into pAT153. 
pHNF-L (Julien et al., 1987a) contains the coding sequences 
and 5' flanking sequences of the gene encoding the 
human neurofilament (large subunit).
9. Bacterial Strains
All plasmids used in this study were propagated in 
E. coli K12 strain DH5a (F~, endkl, hsdRll, supE44, thi-1, 
recA, gyrkSS, relAl, del(argF-lac zya)U169, 08OdlacZ M15 
(Hanahan, 1983). Library efficiency E.coli DH5a competent 
cells were supplied by Bethesda Research Laboratories.
10. Bacterial Culture Medium
L. Broth 10g/l NaCl, 10g/l bactopeptone and 5g/l
yeast extract.
L. Broth agar L. Broth plus 1.5% w/v agar.
Ampicillin, where appropriate, was added to 
L. Broth or L. Broth agar at 50pg/ml.
11. Commonly-Used Solutions
Bradford's reagent: 0.01% coomassie brilliant blue G,
0.003% SDS, 4.75% (v/v) ethanol, 8.5%
(v/v) phosphoric acid.
CLB: 0.5% SDS, 20mM Tris HC1 (pH7.5), 2mM
EDTA.
50x Denhardt1s : 1% Polyvinylpyrrolidone, 1% BSA, 1%
Ficoll
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Giemsa Stain:
2xHeBS:
5x Gel loading buffer: 5x TBE, 50% glycerol, bromophenol
blue, xylene cyanol.
1.5% suspension of Giemsa in glycerol, 
heated to 50°C for 2h and diluted with 
an equal volume of methanol.
260mM NaCl, 9.8mM KC1, 1.6mM Na2HP04 , 
llmM D-glucose, 42mM HEPES .t$Vn Vl-) 
Hybridization mix: 6x SSC, 5x Denhardt's , 0.1% SDS,
50pg/ml denatured calf thymus DNA.
0.5M Tris HC1 (pH7.5), lOOmM MgCl2, 
lOOmM DTT, 500^g/ml BSA.
170mM NaCl, 3.4mM KC1, lOmM Na2HP04,2mM 
KH2P04 (pH7.2).
PBSA plus CaCl2.H 20 and MgCl2.6H20 both 
at lg/1.
174 g/1 NaCl, 88.2 g/1 Trissodium
citrate.
125mM Tris, 40mM Boric acid, 2.7mM 
EDTA, not pH'd.
lOmM Tris HC1 ImM EDTA, pH8.0.
150mM NaCl, 40mM Tris HC1, ImM EDTA, 
pH7.5.
0.25% w/v trypsin dissolved in tris- 
saline.
0.6mM EDTA dissolved in PBSA containing 
0.0002% w/v phenol red.
lOx NT buffer
PBSA:
PBS:
20xSSC:
TBE:
TE:
TEN:
Trypsin: 
Versene:
12. Animals
Balb/c mice, obtained from Bantin & Kingman Ltd 
(England), were used for all animal latency experiments.
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2B. METHODS
2B.1. CONSTRUCTION AND PREPARATION OF PLASMIDS
1.1. Restriction Enzyme Digests
Diagnostic restriction enzyme digests were 
generally carried out in 20|jl1 volumes of the appropriate 
buffer as specified by the manufacturers. The number of 
units of enzyme added was dependent on the activity of the 
enzyme and the amount of DNA being digested. Reaction 
mixtures were generally incubated at 37°C for lh. 
Preparative restriction enzyme digestions used increasing 
amounts of DNA and restriction enzyme under similar 
conditions in 50^1 volumes. \ \
For the production o f i n e a r  molecules, DNA
(2^g) was digested with 2 units of enzyme in the presence 
of 10 to 500 ng/ml of ethidium bromide to identify the 
optimum conditions for production of a maximum of singly 
cut molecules.
1.2. Separation of DNA Fragments by Non-Denaturing Gel 
Electrophoresis
a) Agarose crels; 200ml horizontal slab gels 
(260mmxl60mmx5mm) containing 0.8% to 1% (w/v) agarose were 
electrophoresed submerged in lx TBE plus 0.5^ig/ml ethidium 
bromide at up to 12V/cm. Samples were loaded in 0.2 vol 
loading buffer. Gels were run until the bromophenol blue 
ran almost the whole length of the gel. DNA was examined 
and photographed with short-wave uv transillumination (long 
wave was used to reduced DNA damage when preparative gels 
were being analysed.
50ml 'mini' agarose gels (100mmx70mmx7mm) were also 
used, typically for analysis of mini-prep DNA. Typically, 
these gels were electrophoresed in TBE at 100V for lhr.
b) Polyacrylamide gels: In order to accurately resolve DNA 
fragments of 40-400bp in length, 5% polyacrylamide
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(acrylamide:bis-acrylamide, 19:1) gels were run in lx TBE. 
Gels were prepared in 1.5mm thick vertical glass plate 
sandwiches, and cross-linked with 0.001 vol TEMED, 
catalysed with 0.01% APS. Samples were loaded as above and 
electrophoresed at a maximum voltage of 16V/cm, and DNA 
visualised by autoradiography or EtBr staining.
1.3. Purification of DNA Fragments from Gels
a) Agarose gels: The agarose slice containing the required 
DNA fragment was removed from the gel. The gel slice was 
placed in dialysis tubing and the DNA isolated from the 
agarose by electroelution in lxEEB at 50V for lhr. The EEB 
containing the DNA was removed from the dialysis tubing, 
extracted with phenol/chloroform and precipitated with 2 
volumes of ethanol at -20°C for l-2hr.
b) Polyacrylamide gels: The polyacrylamide slice containing 
the appropriate fragment was cut into small pieces, and the 
DNA eluted into TE by shaking overnight at 37°C. The TE was 
then removed, extracted with phenol/chloroform and 
precipitated with 2 volumes of ethanol at -20°C for l-2hrs.
1.4. DNA Ligation
DNA ligations were performed in 20p.l lx ligase 
buffer, with 0. 5mM ATP, 50-500ng DNA and 1 unit of T4 DNA 
ligase. To prevent self-annealing of the vector, it was 
usually treated with calf intestinal phosphatase during the 
preceding restriction enzyme digestion.
Staggered cut termini of DNA fragments were 
converted to blunt-ends by treatment with T4 DNA 
polymerase. Reactions contained 0.5 to 1. 0p.g DNA, 33mM Tris 
HC1 (pH7.8), 66mM potassium acetate, lOmM magnesium 
acetate, 100^g/ml BSA, 200^M dCTP, dGTP, dATP, dTTP plus 4 
units of T4 DNA polymerase and were incubated at 15°C for 
3hrs.
Phosphorylated oligonucleotide linkers were 
inserted into plasmids by ligation with linear molecules
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using the same procedure as for vector/fragment ligations. 
A 50-fold molar excess of linker over plasmid DNA was used.
1.5. Transformation of competent E. coli
1 |jig of ligation mix was added to 20|-il of competent 
DH5a cells and incubated on ice for 30 mins. The mixture 
was then heat-shocked at 42°C for 45 secs and added to 80^1 
of SOC medium (2% bactopeptone; 0.5% yeast extract; lOmM
NaCl; 2.5mM KC1; lOmM MgCl2; 10mM MgS04 ; 20mM glucose). 
Cultures were then agitated at 37°C for lhr, and 
subsequently spread on L. Broth agar plates containing 
ampicillin. If blue/white selection was used as in the case 
of pUC cloning vectors, 10^1 of 150mg/ml X-gal diluted in 
lOOp.1 ethanol was spread on the amp plates and allowed to 
dry prior to spreading of cultures. The plates were then 
incubated at 37°C overnight.
1.6. Mini-Prep Analysis of Transformed E. coli Colonies
Mini-prep DNA was prepared by the alkaline lysis 
procedure. Colonies were picked from agar plates into 5ml 
of L. Broth containing ampicillin and shaken at 37°C 
overnight. The following day, E. coli cells from 1ml of the 
overnight culture were pelleted at 5,000rpm for Imin in a 
benchtop microfuge. The pellet was resuspended in lOOpl of 
solution 1 (50mM glucose, lOmM EDTA, 25mM Tris pH8.0)
containing lmg/ml lysozyme and incubated at RT for 5min. 
200^1 of solution 2 (0.2M NaOH, 1% w/v SDS) was then added 
and the mixture vortexed. 150^1 of solution 3 (3.0M KAc,
11.5% v/v glacial acetic acid) was then added, and
following vortexing, was incubated on ice for 10 mins. This 
mixture was centrifuged at 13,000rpm for 5min and the 
pellets discarded. The supernatant was precipitated with an 
equal volume of isopropanol at -20°C for 20mins. After 
centrifugation at 13,000rpm for 5min in a benchtop
microfuge, the pellets were washed in ethanol, dried and
resuspended in 50|jl 1 of H 20.
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Mini-prep DNA was stored at -20°C and 5\xl used for 
restriction enzyme analysis. 0.2pl of lmg/ml RNase was 
added to digestions of mini-prep DNA. Samples were 
generally assayed for the insertion of a fragment by 
screening for an increase in size compared with the vector 
DNA. Further analysis was carried out by restriction enzyme 
digestion of positive samples.
For long term storage, glycerol stocks of positive 
cultures were made by pelleting 1ml of culture by 
centrifugation at 6,000rpm in a benchtop microfuge and 
resuspending in 500|jl 1 bactopeptone plus 500^1 80% glycerol. 
Glycerol stocks were stored at -70°C.
1.7. Large Scale Preparation of Plasmid DNA
Transformed bacteria from the appropriate glycerol 
stock were picked and inoculated into 10ml of L. Broth 
plus ampicillin and incubated at 37°C overnight. 0.5ml of 
this stock was used to inoculate 300ml of L. Broth plus 
ampicillin and the culture shaken shaken at 37°C for 8h. 
Chloramphenicol was then added to a final concentration of 
25|jig/ml and incubation continued overnight. The culture was 
pelleted by centrifugation at 7,000rpm for lOmin in a 
Sorval GS3 rotor. After decanting the supernatant, the 
pellet was resuspended in 7.5ml of solution 1 containing 
lmg/ml lysozyme. After leaving at RT for 5min, 14ml of 
solution 2 was added, and following vortexing, was left in 
ice for lOmin. 15ml of solution 3 was subsequently added, 
and following further vortexing, was left on ice for a 
further 15min. This was then centrifuged at 17,000rpm for 
30min in a Sorval SS34 rotor to pellet out the cell debris 
and cellular DNA. The supernatant containing the plasmid 
DNA was precipitated with an equal volume of isopropanol at 
-20°C. DNA was pelleted by centrifugation at 3,000rpm for 
15min in a Sorval RT6000B benchtop centrifuge, washed in 
ethanol, dried and resuspended in a total volume of 1ml of 
H 20.
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This solution was prepared for caesium banding by- 
dissolving 1.15mg of CsCl and adding 50p.l of lOmg/ml EtBr 
per ml of DNA. This was transferred to a Beckman TLV-100 
ultracentrifuge tube and topped up with stock solution 
containing similar amounts of CsCl and EtBr. The 
ultracentrifuge tube was then heat-sealed and centrifuged 
for 4.5h at 100,000rpm or 16h at 80,000rpm at 20°C in a 
Beckman TL100 benchtop ultracentrifuge. DNA was visualised 
by daylight or long wave uv transilluminator and the lower 
supercoiled plasmid DNA band recovered with a large bore 
needle and syringe. The DNA was extracted three times with 
isopropanol/saturated CsCl solution to remove EtBr, and its 
volume increased by a factor of three with H 2O, and 
precipitated with ethanol. Once resuspended in TE, the DNA 
was treated with 50p.g RNAase (lh/65°C) before extraction 
with phenol/chloroform and chloroform and precipitation 
with ethanol. The DNA was lyophilized, resuspended in H20 
and its concentration determined by
spectrophotometry (OD26O 1.0=50^g DNA/ml).
2B.2. FUNCTIONAL ANALYSIS OF PLASMIDS
2.1. Transfection of Plasmid DNA into Cells
Plasmid DNA was transfected into BHK cells using a modified
version of the calcium phosphate technique used by Shen et
al. (1982). 3^g of plasmid was typically used for each
transfection. 3^g of plasmid DNA was made up to 57p.l in 
deionised H 2O, and 66p.l of 2xHeBS added. 9^1 of 2M CaCl2 
was squirted in, and the samples immediately vortexed. The 
tubes were allowed to stand at room temperature for lOmins. 
The medium was then removed from 80% confluent cell 
monolayers grown in 35mm petri dishes, and overlayed with 
the calcium phosphate precipitate and incubated at 37°C for
45mins with intermittent rocking.
2ml of medium (consisting of multiples of: 18.75
conditioned medium, 20ml ETC1 0 / 2ml 2xHeBS, 0.25ml CaCl2 ,*
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the latter added just before overlaying on cells) was added 
to each monolayer and the incubation continued for a 
further 3-4h at 37®. The medium was then removed from the 
cells and 25% v/v dimethyl sulphoxide in lxHeBS applied for 
4 min at room temperature (Stow & Wilkie, 1976). The DMSO 
was removed and the cells washed twice with ETCio; a 
further 2ml of ETCio was added and the monolayers incubated 
at 38.5°C. Infection with virus, when required, was 
performed after lh. Incubation was then continued overnight 
at 38.5°C.
2.2. Preparation of CAT Extracts
Extracts were prepared by washing the cells in PBSA 
then scraping into 2ml of TEN and transferring to 15ml 
falcon tubes. The cells were pelleted at 2000rpm/4°C/lmin 
in a Sorval RT6000B centrifuge and resuspended in 75^1 
0.25M Tris pH7.8 and lysed by sonication. The sonicates 
were then transferred to 1.5ml eppendorff tubes and 
centrifuged at 13,000rpm for 2min in a benchtop microfuge 
to remove cell debris. The cell extract supernatants were 
stored at -20°C.
2.3. CAT Assays
Cell sonicates were assayed for chloramphenicol 
acetyltransferase activity essentially as described by Seed 
& Sheen, (1988). Assay mixtures containing ljxl 25mM N- 
butyryl-CoA, 0.5^1 stock [14C]CAP (45|xCi/mft) , 5^1 250mM
Tris HC1 pH7.8 and 18.5^1 H 2O together with 20^1 neat or 
diluted sonicate. After incubation for 30 or 60min at 37°C, 
the products were extracted with 150p.l TMPD/Xylenes (2:1 
mixture respectively). The percentage conversion to product 
was determined by scintillation counting of 1 <40^ x1 of the 
TMPD/Xylenes extract in 3ml ecoscint as a fraction of the 
total counts in the assay (the total number of counts in a 
parallel control reaction). The protein concentration of 
the extract was determined by the method of Bradford
97
(1976). CAT activities were expressed as the percentage 
[14C] chloramphenicol converted to the butyrylated form per 
(jlct protein per h.
2.4. Determination of Protein Concentration in Cell 
Extracts
The protein concentration of CAT extracts was 
determined by the method of Bradford (1976). 2.5—5fjil of
extract was made up to lOOpl in 0.05M Tris.HCl pH7.8 and 
1ml of Bradford's reagent added and mixed. After 15min 
incubation, the OD595 was measured in disposable plastic 
cuvettes by spectrophotometry. The protein concentration 
per p.1 of extract was determined from a standard curve 
constructed using serial dilutions of BSA from 5 to 
80pg/ml.
2.5. In Vitro Transcription of Plasmids
Plasmids were digested with a restriction enzyme to 
produce linear molecules that were cleaved 3 1 to the coding 
sequence. In vitro transcription was performed using the 
T7T3 Riboprobe system (Bethesda Research Laboratories) 
following the manufacturers protocol, lpl of linear DNA was 
mixed at RT with 5\xl SP6 buffer (200mM Tris.HCl (pH7.5), 
30mM MgCl2 , lOmM spermidine), 0.01% BSA, lOmM DTT, 0.4mM 
ATP, UTP, CTP, GTP, 0.5mM 6(5')ppp(3'), 40 units RNAasin
(Promega Biotech) and 10 units T7 RNA polymerase in a total 
volume of 25|jil. The reaction mixtures were incubated at RT 
for lh.
2.6. DWA Sequencing
DNA fragments cloned into pT7T3 were sequenced 
using the Pharmacia T7 sequencing™ kit consisting of 
dideoxy sequencing reactions using T7 DNA polymerase. This 
was carried out according to manufacturers instructions.
2.7. Denaturing Polyacrylamide Gels
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An Acrylamide solution was prepared which contained 
9ml of 40% acrylamide/ N, N 1-methylene-bisacrylamide 
(20:1), 28.8g Urea, 3ml lOxTBE, 25ml H20, 100^1 25% APS and 
100p.l TEMED. This solution was poured into a mould 
(230mmx450mmx0.35mm), and after polymerisation was prerun 
at 40W for 30min prior to loading of samples. 
Electrophoresis was performed in 0. 5x TBE at 40W for 
approximately 2h.
2B.3. CONSTRUCTION AND PREPARATION OF VIRUSES
3.1. Tissue culture
BHK cells were routinely passaged in 850cm2 roller 
bottles seeded with approximately 2xl07 cells at 37°C in 
100ml ETCio and an atmosphere of 5% C02 in air. Confluent 
monolayers were harvested in 20ml ETCio after two versene 
washes and brief trypsinization with trypsin:versene (1:4). 
Cells were resuspended by pipetting and remained viable for 
at least 5 days stored at 4<>C.
C1300 cells were routinely passaged in 175cm2 
(Nunclon) flasks in DMEM and harvested in 10ml. C1300 cells 
did not remain viable at 4°C and for long term storage, 
harvested cells were pelleted and resuspended in medium 
plus 5% glycerol and 15% foetal calf serum, aliquoted and 
frozen slowly to -140°C. Recovery was by rapid thawing and 
resuspension in growth medium.
3.2. Preparation of Stocks of Infectious Virus
80% confluent monolayers of BHK cells were seeded 
with 4xl04 pfu of virus per roller bottle in 40ml ETCio 
medium (a moi of 0.002pfu/cel1) and incubated for 4-5 days 
at 31°C until the cells exhibited obvious cpe (31°C rather 
than 37°C was found to be better for growth for high titre 
viral stocks). The cells were shaken into medium and 
pelleted at l,000rpm/ 5min/ 4°C. Cell associated virus 
(CAV) was prepared by sonicating the pellet in 2ml ETCio.
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Cell released virus (CRV) was pelleted from the supernatant 
at 9 /000rpm/ 2hours/ 4°C and gently resuspended in 2ml 
ETCio and sonicated. Sterility checks were performed by 
streaking virus preparations on blood agar plates and 
incubating at 37°C. Virus stocks were stored at -70°C.
3.3 Purification of Virus Particles
Virions were prepared from monolayers of BHK cells 
grown in roller bottles. Once the cells exhibited obvious 
cpe, cells were shaken into the medium, and cell debris 
removed by low speed centrifugation (5000 rpm for 10 min at 
4°C) , and the virus particles in the clarified medium were 
pelleted by centrifugation (12,000 rpm for 2h at 4°C). The 
pellet was then gently resuspended in 1 ml of Eagle's A + B 
(without phenol red and calf serum) and layered onto a 35 
ml preformed gradient of 5 to 15% Ficoll 400 (Sigma) 
suspended in this medium. After centrifugation in a swing- 
out rotor (12,000 rpm for 2h at 4°C in an AH627 cellulose 
nitrate tube), the lower particle band was withdrawn by 
side punctures. These virions were pelleted by 
centrifugation (21,000 rpm for 2h at 4°C in an AH627 tube), 
gently resuspended in 200pl of modified medium and either 
used immediately or stored at -70°C.
3.4. Preparation of virion DNA
DNA was extracted from purified virions by 
treatment with SDS and proteinase K (0.5% and 50 mg/ml 
respectively) for lh at 37°C, followed by phenol/chloroform 
extraction (3 times) and precipitation by addition of 2 
volumes of ethanol. For the purposes of the HSV vector, 
purified DNA was digested to completion with Xbal, divided 
into aliquots, and stored at -20«>C.
3.5. Titration of virus stocks
BHK cells were seeded at 2xl06 cells per 50mm plate 
in 5ml medium. The following day( cells were infected with
100
serial 10-fold virus dilutions in 0.1ml of PBS/ 10% newborn 
calf serum. After lh adsorption time, plates were overlaid 
with 4ml 0.6% Noble agar medium (100ml 1.3x Eagle's A, 20ml 
Eagle's B without phenol red, 30ml 3.2% Noble agar, 5ml 
serum) to prevent secondary plaque formation, and 
incubating for 2-3 days at 37°C prior to fixing with Cidex 
and staining with Giemsa stain. The plates were washed 
after 15min and plaques counted using a plate microscope.
3.6. Construction and Screening of Recombinant Virus
Plasmid DNAs cleaved with Xbal were electrophoresed 
on agarose gels from which the appropriate fragments were 
isolated and purified. These fragments were ligated with 
Xbal-digested virus DNA prior to transfection onto 
monolayers of BHK cells. Transfections were performed using 
the calcium phosphate precipitation/DMSO method described 
by Stow & Wilkie (1976). This was essentially as described 
in section 2B.2.1, except that 2. O^ ig of calf thymus DNA was 
used as carrier and precipitates were gently mixed upon 
addition of CaCl2 and not vortexed. Following transfection, 
the cells were either overlaid with 0.6% Noble agar medium 
(100ml 1. 3x Eagle's A, 20ml Eagle's B without phenol red, 
30ml 3.2% Noble agar, 5ml serum) or were overlaid with 
ETCio for subsequent harvesting and titrating of progeny 
virus. Titrations were performed under agar medium. Two 
days after transfection or infection, a further 2ml of agar 
medium containing 0.75mg/ml X-gal was added to each plate. 
After incubation overnight, plaques expressing 6- 
galactosidase were picked. All viruses were purified to 
homogeneity typically through three to four rounds of 
plaque purification.
2B.4. ANALYSIS OF VIRAL DNA
4.1. Preparation of Total Infected Cell DNA
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10mm linbro wells were seeded with about 4xl05 BHK 
cells and infected the following day with half of a picked 
plaque or a moi of 1 pfu/cell. After about 2 days when cpe 
became apparent, the supernatant was removed and stored as 
CRV stock. 0.2ml of cell lysis buffer (CLB) containing 
0.25mg/ml proteinase K was added to the cell monolayer and 
incubated at 37°C for 3-5h. The glutinous extract was 
transferred to 1.5ml Eppendorff tubes and 15pl 5M NaCl 
added. DNA was extracted with phenol/chloroform followed by 
precipitation with 2.5 volumes of ethanol. The pellet was 
then washed with 70% ethanol, dried, and finally 
resuspended in 50p.l H 2O.
4.2. Internal Labelling of Probes by Nick Translation
DNA was labelled with 32P as described by Rigby et 
al. (1977). 1. 0p.g of plasmid DNA was incubated in a
reaction mix containing 40mM dATP, 40mM dTTP, 2 . 5|jl1 of lOx 
NTB (5M Tris HC1 (pH7.5), 1M MgCl2, 1M DTT and 5mg/ml BSA) 
and 2xl0“4^g DNAase at RT for 3min. The mix was placed on 
ice and diluted to 25|jl1 by the addition of 30^iCi of both ci­
ts 2p]-dCTP and a- [32p]-dGTP, 3units of E.coli DNA 
polymerase I plus distilled H 20. The reaction was incubated 
at 15°C for lh. 32p labelled DNA was then separated from 
unincorporated triphosphates by running through a 10ml 
Sephadex (medium) G50 column in a 10ml pipette plugged with 
siliconized glass wool. Columns were loaded with the sample 
with bromophenol blue dye and the fastest eluting fractions 
(detected by Geiger counter) taken as purified DNA.
4.3. Transfer of DNA to Nitrocellulose
The method used was essentially that of Southern, 
(1975) . The agarose gel to be blotted was shaken for 45min 
in Gel Soak I (200mM NaOH, 600mM NaCl), then for a further 
45min in Gel Soak II (1M Tris HC1 (pH8.0), 0. 6M NaCl) at 
room temperature. The gel was transferred to two sheets of 
Whatman 3MM filter paper, supported by a glass plate, the
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edges of the filter paper were dipped into a tray
containing 6x SSC. A sheet of nitrocellulose, the same
dimensions as the gel was placed on top, covered by three 
sheets of 3MM paper and a stack of paper towels, also cut 
to size. The towels were weighted and the blot left
overnight to allow the DNA to transfer to the
nitrocellulose. The following day, the nitrocellulose was 
removed and allowed to dry in air and baked at 80°C for 2h.
4.4. DNA/DNA Hybridisation
Hybridisations were carried out under conditions of 
high stringency by the method of Southern et al. (1975).
The nitrocellulose bearing separated DNA L fragments, was 
prehybridised in 100ml 6xSSC, 5x Denhardt' s and 20jjig/ml 
denatured calf thymus DNA at 65°C for 2h in a sealed 
polythene bag. The probe was meanwhile denatured by 
incubation in 0. 2M NaOH for lOmin at RT, followed by 
neutralisation by the addition of 0.2M HC1.
The prehybridisation mixture was removed and 
replaced with the denatured probe in a mix of same final 
composition as the pre-hybridisation solution. The 
nitrocellulose filter was shaken overnight at 65°C, then 
washed in lOx denhardt' s , 4x SSC for 30min at RT, followed 
by three washes in 0. 3x SSC, 0.1% SDS at 65°C. The filter 
was then air dried and autoradiographed.
2B.5. ANIMAL STUDIES
5.1. Footpad Inoculation
Female weanling (3-4 weeks) Balb/c mice were 
injected with the appropriate dose of virus (in 25^1) into 
the right rear footpad using a 26G (3/8) needle. The
remaining virus suspension was titrated on BHK cells after 
each inoculation. Mice were examined daily for the first 
two weeks after inoculation for signs of paralysis; any 
showing any ill-effect were immediately put down.
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5.2. Explantation and Cultivation of Dorsal Root Ganglia 
from Latently Infected Nice >-------------  ---------------- IWvjV i t')
Latently infected mice * were sacrificed by 
chloroform inhalation and fixed on a dissection board in a 
dorsal ventral position. The back of the mouse was 
carefully washed in 70% alcohol. The skin was dissected 
away from the body, and the spinal column cleared of fat 
and supporting muscle. A transverse cut was made through 
the vertebral column at the level of the neck, and the 
dorsal lamina of the vertebral column separated and 
removed. The spinal cord was then carefully removed and the 
dorsal root ganglia identified under a dissecting 
microscope.
5.3. DRG Organ Culture
Nine DRG' s were explanted from the right hand side 
comprising the last two thoracic ganglia, all six lumbar 
ganglia, and the first sacral ganglia. Lumbar ganglia from 
the left hand side were also explanted as internal 
controls. The explanted DRG were,** Sashed separately in 
PBS/10% foetal calf serum, then placed into separate wells 
of a microtitre plate containing 1 50(jl1 EFC50 per well. The 
microtitre plates were incubated at 37°C in a humidified 
incubator under an atmosphere of 5% in air. The explanted 
ganglia were screened daily for the presence of released 
HSV by plating 0.1ml of culture supernatant onto BHK cells 
and observed for cpe.
5.3. In Situ Hybridisation
a) Pretreatment
Ganglia were fixed in freshly made 4% 
paraformaldehyde in 0. 1M phosphate buffer for lh at 4°C. 
The fixative was prepared by dissolving lg of 
paraformaldehyde in 10ml dH20 with 2 drops of 1M NaOH added 
and heating to 60°C, then cooled and 12.5ml 0.2M phosphate 
buffer (9.5ml 0.4M NaH2P04 + 40.5ml Na2HP0 4 , made up to
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100ml and pH adjusted to 7.4) added. The paraformaldehyde 
was made up to 25ml with dH20 and pH adjusted to 7.3. The 
ganglia were then washed in 70% ethanol and embedded in 
blocks of 1% noble agar. The agar blocks were then further 
paraffin embedded.
The paraffin embedded sections were dewaxed with Xylenes, 
and rehydrated in absolute alcohol, 95% alcohol, saline, 
and PBS for 5mins each. These were post-fixed in 4% 
paraformaldehyde (5min), washed twice in PBS (2mins each) 
and digested in 20pg/ml proteinase K (in lOmMTris pH7.4, 
2mM CaCl2) for 7*$ mins. Following washing in PBS, the 
sections were again post-fixed in 4% paraformaldehyde 
(5min). The sections were then acetylated by treatment 0.1M 
triethanolamine with acetic anhydride being added to 0.25% 
(with stirring for 5min) and then a further aliquot of 
acetic anhydride being added to 0.5% (stirred again for 
5min). The sections were then dehydrated by washing in PBS 
(2min), saline (2min), 95% alcohol (2min), and absolute
alcohol (5min) . The slides were then air dried and stored 
at RT until ready for hybridization.
b) Hybridization
The radiolabelled probe (specific activity greater 
than 0.2x108; 2.5x10s precipitatable counts per section)
was made up in hybridization solution (2xSSC, 50% 
Formamide, lOmM Tris pH7.4, ImM EDTA, lx Denhardts, 10% 
Dextran sulphate). This was heated to 100®C for 30sec, 
quenched on ice, and DTT added to lOmM final concentration. 
5pl of this mix was added to each section and a coverslip 
placed on top. The slides were sealed in a box with a 
tissue soaked in 50% formamide, and incubated at 50°C for 
18h.
c) Post-Hybridisation Washes
Following hybridization, the slides were washed in 
wash solution 1 (5xSSC, lOmM DTT at 50°C) for lOmin, then
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wash solution 2 (50% Formamide, 2xSSC, lOmM DTT at 65°C)
for 20min, then wash solution 3 (0.5M NaCl, lOmM Tris
pH7*.5, 5mM EDTA at 37°C) for 5min, then again in fresh 
solution 3 for a further 5min. The sections were then 
treated in with RNAase (20pg/ml in solution 3) at 37°C for 
30min, then further washed in solution 3 (37°C, lOmin),
solution 2 (65°C, 20min), 2xSSC (lOmin at RT) , O.lxSSC
(lOmin, RT) then dehydrated in 30%, 60%, 80%, 90% and 100% 
alcohol (each containing 0. 3M NH4AC) for 2min each, and 
finally absolute alcohol (2min). The slides were air dried 
overnight at RT, and stored for up to 2 days in a dust free 
container.
d) Dipping into Photographic Emulsion
This procedure was carried out in a dark room with 
all lights (including safety lights) out. K5 emulsion 
(Amersham) (enough for 7.5 ml) was melted in a water bath 
pre-warmed to 45°C and gently mixed with an equal volume of 
glycerol/H20 (pre-warmed to 45°C). This mixture was 
pipetted slowly (to avoid bubbles) into an Amersham dipper. 
The slides were dipped slowly into the emulsion, and 
removed slowly in one motion. The slides were left to dry 
for 3h, then placed in a light proof box with silica 
granules, and put at 4°C until development.
e) Development of Emulsion
Slides were developed in D19 developer (Ilford) for 
4min, washed in H 2O for 30sec, then fixed in hypam (Ilford) 
(1 in 5 dilution with H 2O) fotr 4min. All these steps were 
carried out at 16°C. The slides were washed in running 
water, wiped, and examined under a microscope for grains.
f) Counterstaining Slides
The slides were washed in haematoxylin (5min), 
rinsed in tap water, then hard water (2-3min until they 
turned blue). They were then washed in Eosin (3-5min),
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rinsed briefly in H 2O and dehydrated in 95% and 100% 
alcohol (2min each) then histoclear (3min). The sections 
were then mounted in DPX by touching the slide onto a DPX 
coated coverslip.
5.5 HISTOCHEMICAL STAINING OF GANGLIA
Spinal ganglia were removed from mice and fixed for 
lh in paraformaldehyde in 0.1% phosphate buffer. Ganglia 
were then rinsed in PBS and incubated for 4-6h at 31°C in a 
solution containing l.Omg/ml X-gal, 0.1% sodium
deoxycholate, 0.02% Nonidet P-40, 5mM potassium
ferricyanide, 5mM ferrocyanide and 2mM magnesium chloride 
in PBS. Incubation for any longer than 6h led to a high 
level of background staining. Controls without X-gal were 
run since blue/green colour can be produced by Fe3+ in 
cells reacting with ferrocyanide (ferricyanide catalyses 
oxidation of liberated indolyl to insoluble indigo dye; 
ferrocyanide prevents further oxidation to a colourless 
dehydroindigo compound). The tissues were thoroughly rinsed 
in PBS and examined as whole mounts. They were then wax- 
embedded and sectioned at 6^m7 counterstained with eosin 
and evaluated by light microscopy.
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CHAPTER 3: RESULTS
3A. OBJECTIVES
The aim of the work presented in this thesis was to 
investigate the cis-acting control sequences of HSV and 
non-HSV promoters under conditions which are permissive and 
non-permissive for viral replication. The ultimate 
objective was to introduce promoter/reporter gene fusions 
into the genome of a virus vector developed by Rixon & 
McLauchlan (1990), and examine their expression in the 
context of virus genome.
When HSV-1 establishes latency in peripheral 
nervous system ganglionic neurons, detectable RNA 
transcription is confined to one locus of the virus genome. 
As described in section ID.7.2, this results in a family of 
co-1inear RNAs termed the latency associated transcripts 
(LATs; see section ID.7.2). Being the only gene transcribed 
from the latent HSV-1 genome suggests that its controlling 
elements must differ considerably from those controlling 
lytic cycle gene expression. A substantial body of work 
presented in this thesis is therefore devoted to the 
mapping and characterisation of the LAT promoter. This was 
carried out by sequence analysis, coupled with the cloning 
of various upstream sequences of the LAT gene and 
examination of their ability to drive expression of an 
adjoining reporter gene in transient transfection assays, 
and when introduced into the viral vector, during infection 
of tissue culture cells. During the course of this study, 
the discovery by other groups of an 8.3 kb LAT demonstrated 
that the LAT gene transcription pattern is more extensive 
than previously thought. For the purposes of this study, 
though, reference will only be made to the 2 kb LATs, since 
the strategy for mapping the LAT promoter was based upon 
the mapping of these original transcripts. The relevance of 
the more extensive pattern of LAT transcription will be 
discussed later.
Since HSV establishes latency in neurons, an
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intriguing question to ask is how an endogenous neuronal 
promoter would behave in the context of the latent HSV 
genome. To this end, the upstream sequences of the human 
neurofilament light-chain (HNF-L) gene were acquired and 
characterised for promoter activity in transfection assays. 
When introduced into the viral vector genome, NF-L 
promoter/reporter gene constructs were further 
characterised during lytic infection of tissue culture 
cells and in animal latency systems.
3B. CHARACTERISATION OF THE LAT PROMOTER
3B.1. Sequence Numbering Convention
Throughout the following sections dealing with HSV- 
1 LAT promoter characterisation, the sequence numbering 
convention used is such that the mapped 5' end of the 2kb 
LAT, ie the distal G residue in the sequence 5'-..AGGT..- 
3', at position 119461 of the published HSV-1 sequence 
(Perry & McGeoch, 1988) is referred to as position zero.
3B.2. Sequence Analysis of the Putative LAT Promoter Region
Examination of the HSV-1 strain 11* sequence 
immediately upstream of the 5' end of the 2 kb LAT does not 
reveal any reasonable consensus RNA polymerase II promoter 
elements. Indeed, the first recognisable pol II elements 
occur much further upstream than expected for a normal 
lytic cycle gene. The salient features of this potential 
promoter are a TATA box at position -689 to -681 
(...CCTTTATAAAAG C ...), a CAAT box at position -818 to -815 
(...ATCAATCC...) and two putative Spl-binding sites at 
positions —864 to —859 (. . .CCCCGCCCCG . . .) and —887 to —882 
(...CCCCGCCCCC...). A further putative Spl site is located 
downstream of the TATA box at position -590 to -585 
(...CGGGGCGGCC...). The combination of these sequence 
motifs, together with their positions relative to each 
other, earmark this region as an excellent candidate for an
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RNA polymerase II promoter. Wagner et al. (1988) when 
analysing the DNA sequence immediately surrounding the LAT 
5 f terminus of HSV-1 strain KOS(M) identified other 
sequences which contained some minimal features of a pol II 
promoter. These included a possible TATA box homologue at 
position -24 to -16 (...GTTTCAACAAAG A ...) and potential
CAAT box homologies at positions -50 to -47 
(. ..CCCACTC G ...) and -86 to -83 (...CCCAGTAC...). Another
potential promoter within the LAT region is located far 
downstream of the LAT 5' terminus and consists of a TATA 
homologue at position 827 to 830 (...CCTATAGT ...) with
accompanying putative Spl binding sites at positions 733 to 
738 (...CTCCGCCCCA...), 794 to 799 (...TCCCGCCCCG...), 848 
to 853 (...CCCCGCCCTT...) and 883 to 888
(...CCGGGCGGGC...). Although it is possible that these 
elements could form a pol II promoter, their positions 
relative to the 5' end of LAT suggest that it is highly 
unlikely that they could have any part to play in 
transcriptional regulation of the LAT gene.
3B.3. Comparison of HSV-1 and HSV-2 Upstream LAT Sequences
Since LATs are now known to be transcribed from 
latent HSV-2 genomes (Mitchell et al. , 1990; Croen et al. , 
1991; Tenser et al. , 1991), the sequences responsible for
transcriptional regulation of the HSV-1 and HSV-2 LAT genes 
are presumably conserved to some degree. A direct sequence 
comparison of the corresponding LAT regions of HSV-1 and 
HSV-2 should therefore reveal conserved sequences which 
could be considered as candidates for the LAT promoter 
region.
A sequence comparison was therefore carried out 
using sequencing data from HSV-1 strain 17+ (Perry & 
McGeoch, 1988) and unpublished sequencing data of the R l 
region of HSV-2 strain HG52 (kindly supplied by Dr. Duncan 
McGeoch). Sequences were compared with the Vax GCG program 
Compare and plotted on a panel illustrated in Figure 6
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using the GCG program Dotplot. The results of this sequence 
comparison resemble those of an analysis carried out by Dr. 
Duncan McGeoch. HSV-1 is on the horizontal axis which 
consists of 1600 bp corresponding to bases 118000 to 119600 
of the published HSV-1 sequence. A schematic representation 
of the major features of this region is shown above the 
horizontal axis. The mapped 5' terminus of LAT is indicated 
at position 0 and corresponds to HSV-1 residue 119461. The 
corresponding region of HSV-2 is on the vertical axis.
This comparison indicates that large regions of Rl 
around the 2 kb LAT specifying sequences are widely 
diverged; the only detectable related sequences are 
numbered on Figure 6. Interestingly, the 2 kb LAT
specifying sequences fail to show any degree of significant 
conservation, indeed, the only conserved region downstream 
from the 5' terminus of LAT is that corresponding to the 
IE-gene 1 protein coding region (data not shown). All of 
the conserved loci are upstream from the mapped 5' end of 
the 2 kb LAT and include the region bearing most 
resemblance to a pol II promoter. In all, there are 9 short 
conserved loci designated 1 through to 9 as indicated on 
Figure 6. An alignment of the actual sequences 
corresponding to these loci is shown on Figure 7; HSV-1
sequence is the upper, HSV-2 is the middle and the
consensus is shown on the bottom line. Figure 7 is an
extended version (by 180 bp) of a sequence comparison 
generated by Dr. Duncan McGeoch using the GCG program Gap.
Both Figures 6 and 7 demonstrate a complete lack of 
homology in the sequences immediately surrounding the HSV-1 
LAT 5' terminus. This made it unlikely that the putative 
elements identified by Wagner et al. (1988) formed the bona 
fide LAT promoter. The upstream consensus motifs are, 
however, well conserved. The predicted TATA box at -689 to 
-681 occurs within consensus locus 6 and is perfectly 
conserved in the HSV-2 sequence. The predicted HSV-1 CAAT 
box located between conserved loci 4 and 5 has no HSV-2
Figure 6. Sequence comparison of R l regions of HSV-1 17+ 
and HSV-2 HG52. Sequences were compared with the GCG 
program Compare, and plotted on the panel illustrated using 
the GCG program Dotplot. The HSV-1 sequence on the 
horizontal axis consists of 1600 bp corresponding to 118000 
to 119600 of the published HSV-1 sequence (Perry & McGeoch, 
1988). A schematic representation of the major features of 
this region including positions of various putative 
promoter elements and restriction enzyme sites are shown 
above the horizontal axis. The mapped 5' terminus of the 2 
kb LAT is indicated at position 0, and corresponds to HSV-1 
residue 119469. The corresponding region of HSV-2 is on the 
vertical axis. The unpublished HSV-2 sequence was kindly 
supplied by Dr. Duncan McGeoch. The comparison indicated a 
series of short conserved loci, and are numbered on the 
panel from 1 through to 9.
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Figure 7. Alignment of HSV-1 and HSV-2 sequences upstream 
of the 2 kb LAT specifying region (three pages). This is an 
extended version of a sequence alignment generated by Dr. 
Duncan McGeoch using the GCG program Gap. The HSV-1 
sequence is shown on the upper line, the HSV-2 sequence on 
the middle line and the consensus on the lower line. HSV-1 
sequence numbering is with respect to the position of the 
mapped 5' end of the 2 kb LAT which is indicated at 
position 0. The locations of the consensus loci identified 
in Figure 6 are indicated by dotted lines underneath the 
consensus. Putative promoter elements identified in the 
HSV-1 sequence are indicated in bold letters, and labelled 
above the HSV-1 sequence. The positions of three ATG codons 
in the HSV-1 sequence downstream of the TATA box are 
indicated by bold lettering.
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homologue. Both of the HSV-1 putative Spl binding sites 
harbour single base pair substitutions in the HSV-2 
sequence: The proximal Spl site at -864 to -859 located in 
conserved locus 4 has a single 5'G replacing a C residue 
(...GCCGGCCCCA...) while the distal Spl site at position - 
887 to -882 has the 3'C replaced by a G residue 
(...TCCCGCCGG C ...).
The occurrence of this putative RNA polymerase II 
promoter within a region of significant HSV-l/HSV-2 
homology suggested that these sequences were of functional 
significance. The most logical conclusion was that they 
were involved in transcriptional control of the LAT gene. 
The TATA box may form the central feature of a core 
promoter, the activity of which is enhanced by upstream 
sequences (the CAAT and Spl binding sites perhaps), or 
perhaps by other sequences located around conserved loci 1 
to 9.
3B.4. Identification of Neuronal Specific Sequences within 
the LAT Region
Since tissue specific expression of many genes is 
often governed by cis-acting elements located within their 
5' flanking region, and LAT gene expression appears to be 
relatively neuronal specific, a comparison of the LAT 5' 
flanking region with the flanking regions of neuronal 
specific cellular genes may well reveal the presence of 
interesting sequence homologies. While studies have yet to 
reveal sequence elements responsible for directing neuronal 
specific gene expression, homologous sequences in the 5' 
flanking regions of genes expressed in brain and PC12 
neuroblastoma cells which may be of general importance for 
neuronal-specific expression of proteins have been 
identified.
Maue et al, (1990), when comparing the 5' flanking 
regions of the rat type II sodium channel gene with other 
neuronal specific genes whose levels of expression are
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similarly increased during NGF treatment of PC12 cells, 
identified a short region of homology based around a core 
5'-CCAGG-3f consensus motif. The sequence of this region of 
the type II sodium channel together with the homologous 
regions of the rat peripherin gene containing two separate 
sequences with 92% and 100% identity, the mouse 
neurofilament gene (77% identity), and the drosophila dopa
decarboxylase gene (86% identity) are displayed on Figure
8. In the case of the drosophila dopa decarboxylase gene, 
this element has been shown to be necessary but not 
sufficient for expression in the central nervous system of 
drosophila. (Scholnick et al., 1986; Johnson et al., 1989). 
While the homologues among the other neuronal specific 
genes are intriguing, it has yet to be determined whether 
they are of functional significance. Analysis of the HSV-1 
LAT sequence reveals two potential homologues (see Figure 
8) of this motif at -915 to -911 (..CCAGC..) and -731 to - 
727 (..CCACG..). The former sequence shares 81% identity
(9/11 bases; from -915 to -905) with the type II sodium
channel and occurs in a region of high homology (conserved
locus 3) with the HSV-2 sequence. The latter sequence 
shares 12/14 bases; from -731 to -718 with a gap, with the 
sequence of the type II sodium channel gene, and while this 
also occurs in a region of HSV-l/HSV-2 homology (conserved 
locus 6) , the actual sequence around the core homology is 
less well conserved. This shows that the HSV sequences arew 
homologous to the neuronal sequences as the neuronal 
sequences are to each other. Analysis of the rest of the 
HSV-1 sequence failed to find any other significant 
homologues. The identification of these two sequences which 
bear striking resemblance to a consensus possibly involved 
in transcriptional regulation of neuronal genes is 
intriguing, and it is interesting to note that Zwaagstra et 
al., (1991) have identified a LAT promoter binding factor
(LPBF), present in neuronal and non-neuronl cell lines, 
which binds to a palindromic sequence based around the
Figure 8. Homology between two regions of the putative LAT 
promoters of HSV-1 and HSV-2, and the 5' flanking sequences 
of neuronal specific genes. The rat type II sodium channel 
sequence is between nucleotides -60 and -34. The drosophila 
sequence is between nucleotides -61 and -72 on the opposite 
strand. The rat peripherin sequences represent nucleotides 
-163 to -154 and -72 to -62 respectively. The mouse 
neurofilament sequence is from -73 to -62. The HSV-l/HSV-2 
homologues are shown below, and refer to nucleotides -921 
to -899 (-262 to -240 with respect to the 5' end of m-LAT) 
and -737 to -716 (-78 to -57) of the HSV-1 sequence
respectively. The CCAGG consensus identified by Maue et al. 
(1990) is indicated on the top line.
CCAGG Core consensus motif
ACTTGTGACCAGGAGATGGAGCTGTCG 
ACTTG G CCAGGA
ACCAGGAGAGGGA 
CCAGG TGGAGCCGCAG 
CGCGGGCCAGCAGACGGCCCGCG 
CGCGGGCCAGCAGACGG CCGCG 
ACCTACCCACG TGGTGCTGTGG 
CCCGCCCGCG TGTTGCTGTGG
Rat type II sodium channel 
Drosophila dopa decarboxylase 
Rat peripherin 
Mouse neurofilament 
H S V -1  LAT ( - 9 2 1  to - 8 9 9 )
H S V -2  LAT
H S V -1  LAT ( - 7 3 7  to - 7 1 6 )
H S V -2  LAT
CCACG TGG LPBF motif
113
CCAGG homologue; "CCACGTGG"; located at -731 to -724. Gel 
shift assays with a probe containing the distal CCAGG 
homologue did not, however, identify any prominent bands.
3C. ANALYSIS OF THE PUTATIVE LAT PROMOTER IN TRANSIENT 
EXPRESSION ASSAYS
3C.1. Strategy
In order to physically characterise the putative 
LAT promoter region, various sequences around and upstream 
of the mapped 5' end of the 2 kb LATs were cloned and 
examined for their ability to drive expression of an 
adjoining reporter gene in transient expression assays. 
This work is presented in four sections. The first three 
will concentrate on the 1141 bp region between the Hinfl 
site at -940 and Nae I site at +201 and encompassing 
conserved loci 3 to 9. These sections examine the effects 
on promoter activity of removal of sequences from the 5' 
end, the 3' end and the centre of this region respectively. 
The fourth section examines the effect of addition of an 
upstream region extending back to the Dral site at -1459 
which contains consensus loci 1 and 2. These sequences, 
together with conserved loci and restriction sites are 
displayed on Figure 9. Since reference will constantly be 
made to this sequence and it s restriction sites, for ease 
of reference, it is provided in pull-out form in the back 
cover of the thesis.
3C.2. Deletions from the 5* End
2.1. Cloning of Putative Promoter Fragments
In order to examine the effect on promoter activity 
of removal of 5' sequences from the 1141 bp Hinfl-Nael 
region, a series of DNA fragments were cloned into the 
chloramphenicol acetyltransferase (CAT) containing vector 
pFJ5 (Rixon & McLauchlan, 1990; see Figure 10). These
Figure 9. Nucleotide sequence of the 5' flanking region of 
the 2 kb LAT (next two pages). The 5' end of the 2 kb LAT
is marked at position 0. The locations of the conserved 
loci identified in Figure 6 are indicated by dotted lines 
underneath the sequence. Putative promoter elements are 
indicated by bold lettering and labelled above the 
sequence, as are the positions of all of the restriction 
enzyme sites used in construction of clones for 
characterisation of the LAT promoter. The G immediately 
downstream of the TATA box was found to be changed to an A 
when one of the clones constructed for LAT promoter 
analysis was sequenced (see Figure 16). This Figure is also 
provided in the back cover of this thesis.
Dral
-14 61 t t t a a a t a a a c c a a t g t c g g a a t a a a c a a a c a c a a a c a c c c g c g a c g g g g g g a c g g a g g g 
-14 01 g a c g g a g g g a g g g g g t g a c g g g g g a c g g g a a c a g a c a c a a a a a c a a c c a c a a a a a a c a a c
-13 41 CACCCACCGACACCCCCACCCCAGTCTCCTCGCCTTCTCCCACCCACCCCACGCCCCCAC
-12 81 TGAGCCCGGTCGATCGACGAGCACCCCCGCCCACGCCCCCGCCCCTGCCCCGGCGACCCC
-12 21 CGGCCCGCACGATCCCGACAACAATAACAACCCCAACGGAAAGCGGCGGGGTGTTGGGGG
-1161 AGGCGAGGAACAACCGAGGGGAACGGGGGATGGAAGGACGGGAAGTGGAAGTCCTGATAC
< ----------------------------------------------
-1101 CCATCCTACACCCCCCTGCCTTCCACCCTCCGGCCCCCCGCGAGTCCACCCGCCGGCCGG 
--------------Conserved locus 1  > <-------------
-10 41 CTACCGAGACCGAACACGGCGGCCGCCGCAGCCGCCGCAGCCGCCGCCGACACCGCAGAG
—  Conserved locus 2 --->
Hinfl
-9 81 CCGGCGCGCGCACTCACAAGCGGCAGAGGCAGAAAGGCCCAGAGTCATTGTTTATGTGGC
<------------------
Spl
-921 CGCGGGCCAGCAGACGGCCCGCGACACCCCCCCCCCGCCCGTGTGGGTATCCGGCCCCCC
-  Conserved locus 3 — > <--------------------
Spl CAAT
-8 61 GCCCCGCGCCGGTCCATTAAGGGCGCGCGTGCCCGCGAGATATCAATCCGTTAAGTGCTC 
Conserved locus 4 -> <------
PstI
-8 01 TGCAGACAGGGGCACCGCGCCCGGAAATCCATTAGGCCGCAGACGAGGAAAATAAAATTA 
  Conserved locus 5 -------------------------------------------->
LPBF CRE TATA
-7 41 CATCACCTACCCACGTGGTGCTGTGGCCTGTTTTTGCTGCGTCATCTCAGCCTTTATAAA 
<----------- Conserved locus 6-----------------------
Pvul
-6 81 agcgggggcgcggccgtgccgatcgcgggtggtgcgaaagactttccgggcgcgtccggg 
 >
PstI
- 6  2 1  TGCCGCGGCTCTCCGGGCCCCCCTGCAGCCGGGGCGGCCAAGGGGCGTCGGCGACATCCT
Nael
-561 CCCCCTAAGCGCCGGCCGGCCGCTGGTCTGTTTTTTCGTTTTCCCCGTTTCGGGGGTGGT
-501 GGGGGTTGCGGTTTCTGTTTCTTTAACCCGTCTGGGGTGTTTTTCGTTCCGTCGCCGGAA
Smal
-441 TGTTTCGTTCGTCTGTCCCCTCACGGGGCGAAGGCCGCGTACGGCCCGGGACGAGGGGCC
<----- Conserved
Nael
-3 81 CCCGACCGCGGCGGTCCGGGCCCCGTCCGGACCCGCTCGCCGGCACGCGACGCGAAAAAG 
locus 7 ----- > <---------------
-321 GCCCCCCGGAGGCTTTTCCGGGTTCCCGGCCCGGGGCCTGAGATGAACACTCGGGGTTAC 
  Conserved locus 8 ------------->
Nael
-2 61 CGCCAACGGCCGGCCCCCGTGGCGGCCCGGCCCGGGGCCCCGGCGGACCCAAGGGGCCCC
<---------  Conserved locus 9------------
SphI
-201 GGCCCGGGGCCCCACAACGGCCCGGCGCATGCGCTGTGGT T TTTT T T TCCTCGGTGT TCT 
 >
-141 GCCGGGCTCCATCGCCTTTCCTGTTCTCGCTTCTCCCCCCCCCCTTCTTCACCCCCAGTA
-81 CCCTCCTCCCTCCCTTCCTCCCCCGTTATCCCACTCGTCGAGGGCGCCCCGGTGTCGTTC
I—  5' end of 2 kb L A T  >
-21 AACAAAGACGCCGCGTTTCCAGGTAGGTTAGACACCTGCTTCTCCCCAATAGAGGGGGGG
3 9 GACCCAAACGACAGGGGGCGCCCCAGAGGCTAAGGTCGGCCACGCCACTCGCGGGTGGGC
Hinfl
9 9 TCGTGTTACAGCACACCAGCCCGTTCTTTTCCCCCCCTCCCACCCTTAGTCAGACTCTGT
Nael
159 TACTTACCCGTCCGACCACCAACTGCCCCCTTATCTAAGGGCCGGCTGGAAGACCGCCAG
219 GGGGTCGGCCGGTGTCGCTG
Figure 10. Structure of plasmid pFJ5. Derivations of this 
plasmid was used for characterisation of the LAT promoter 
in transfection assays. pFJ5 contains the E.coli l a d  gene 
driven by the SV40 early promoter and terminating with the 
SV40 polyadenylation sequences. The CAT gene is inserted 
immediately downstream of a polylinker sequence (shown 
below the plasmid) and is terminated by the HSV-2 IE-5 
polyadenylation sequence. A thorough account of the 
construction of pFJ5 is given in Rixon & McLauchlan (1990).
8081
Xbol(6)8000
10007000
pFJ5
8081
2000
6000
3000
6000'
4000
HfndllXhotSail
Xbal Sstll Bglll BamHI
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fragments are presented diagrammatically in Figure 11. The 
precise location of the various restriction enzyme sites 
can be found on Figure 9.
pLATICAT: pLATlCAT contains a 1091 bp fragment which
extends from -939 to +151 of the LAT sequence and contains 
all of the recognisable putative promoter elements. To 
construct pLATICAT, the 1091 bp HinfI-HintI fragment was
excised and purified from plasmid pGX48 which consists of 
the HSV-1 BamRI b restriction fragment cloned into the 
BamRI site in pAT153. This Hinf 1/Hinf I fragment was 
subsequently blunt-ended with T4 DNA polymerase and ligated 
into BamHI-digested, T4 DNA polymerase-treated pUC19 to 
generate plasmid pLATl. The EcoRl site present in the pUC19 
multicloning site of pLATl was converted to a Bglll site by 
EcoRl digestion, T4 DNA polymerase treatment and subsequent 
ligation of a phosphorylated Bglll linker 5 1-CAGATCTG-3', 
thus yielding plasmid pLATl+Bglll. This treatment 
regenerated EcoRl sites on either side of the Bglll linker
insertion. The LAT1 sequence was excised from pLATl+Bglll
as a Sail/Bglll fragment and subsequently ligated into 
5aJI/BgiII digested pFJ5 DNA to generate pLATICAT.
PLAT2CAT: pLAT2CAT contains 949 bp of LAT sequence which 
extends from the PstI site at -798 to the Hinfl site at 
+151, and is deleted for the CAAT and Spl homologies. These 
sequences were cloned from pJR3 which consists of the 
Sstl/PstI fragment from IRl (spanning the complete IE-1 
gene to the PstI site at -798 of the LAT sequence) cloned 
into pUC9. To construct pLAT2CAT, pJR3 was digested with 
Bindlll and Hinfl; the 950 bp fragment was purified and 
blunt-ended with T4 DNA polymerase. This fragment was 
ligated into Xhol-digested and T4 DNA polymerase-treated 
pFJ5 to generate pLAT2CAT.
PLAT3CAT; pLAT3CAT contains 746 bp of LAT sequence which
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spans from the PstI site at -595 to the Hinfl site at +151 
and does not contain any of the putative LAT promoter 
elements. To construct pLAT3CAT, pJR3 (described above) was 
digested with PstI and Hinfl. The 746 bp fragment was 
purified, blunt-ended with T4 DNA polymerase and ligated 
into Bamlil digested/T4 DNA polymerase treated pUC19 DNA to 
generate pLAT3. The SstI site in the pUC19 polylinker of 
pLAT3 was converted to a Bglll site by SstI digestion and 
T4 DNA polymerase treatment followed by ligation of the 
phosphorylated Bglll linker 5 1-CAGATCTG-3' to generate 
plasmid pLAT3-SstI+BgrIII. The LAT3 sequence was excised 
from pLAT3-SstI+PgIII as a Sail/Bglll fragment and ligated 
into Sail/Bglll digested pFJ5 DNA to generate pLAT3CAT.
pIF5: pIF5 contains 402 bp of LAT sequence spanning from 
the Nael site at -251 to the Hinfl site at +151. To 
generate pIF5, pLATICAT was digested with Sal I and Nael, 
blunt-ended with T4 DNA polymerase and religated.
PLAT5CAT: pLAT5CAT contains 452 bp of LAT sequence which 
spans the Nael sites at -251 and +201. To construct 
pLAT5CAT, pJR3 (described above) was digested with Nael. 
The appropriate 452 bp fragment was purified, blunt-ended 
with T4 DNA polymerase and ligated into BairiRI and T4 DNA 
polymerase treated pUC19 DNA to generate pLAT5. The EcciRI 
site in the pUC19 polylinker of pLAT5 was converted to a 
Bglll site by EcoRl digestion, followed by blunt-ending 
with T4 DNA polymerase and subsequent ligation of the Bglll 
linker 5'-CAGATCTG-3' to generate pLAT5+PglII. The LAT5 
fragment was excised from pLAT5+PgrIII as a Sail / Bglll 
fragment and subsequently ligated into Sail/Bglll digested 
pFJ5 DNA to generated pLAT5CAT
Test restriction digests demonstrating the 
integrity of the above LATCAT plasmids, together with those 
described in preceding sections are shown on Figures 12 and
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13. Other constructs used as controls in the subsequent 
transfection assays are as follows:
pFJ5: Negative control plasmid which does not have any
promoter driving CAT activity.
pFJIO: Has the promoter for the HSV-2 IE 4/5 promoter
fused to the CAT gene in pFJ5. (Rixon & McLauchlan,
1990).
pcrDCAT: Has the promoter for the glycoprotein D (gD) gene
of HSV-1 fused to the CAT gene in pUC9 (Everett,
1986).
Plasmids pFJIO and pgDCAT contain examples of HSV 
immediate-early and early genes respectively, and are 
normally active during the lytic stage of HSV infection.
2.2. Expression Assays Using LATCAT Plasmids
The promoter activity of the above constructs were 
determined by quantitation of CAT activity in short term 
transfection assays. 3^g of each plasmid was transfected 
into BHK monolayers using a modified version of the calcium 
phosphate technique used by Shen et al. (1982). CAT 
extracts were made and assayed for CAT activity as 
described by Seed & Sheen, (1988) . The results illustrated 
in columns 2 and 3 of Table 3 give the mean of at least 
four independent determinations along with the standard 
error of the mean. These, and all other results from 
transfection experiments were calculated relative to the 
promoter activity of pLATICAT which was included in every 
experiment. The CAT activities from each transfection 
experiment were calculated as percentage conversion per 
hour per ^g protein, and then normalised relative to the 
CAT activity exhibited by pLATICAT whose activity was 
assigned the nominal value of 1. An example of this 
calculation using original data is shown on Figure 14. This
Figure 11. Schematic representation of LAT promoter 
fragments with deletions from the 5' end. The top line 
indicates the relative positions of the putative promoter 
elements and 5' end of 2 kb LAT. The LAT1 fragment extends 
from -940 to +154, the LAT2 fragment from -798 to +154. the 
LAT3 fragment from -595 to +154, IF5 from -251 to +154, and 
LAT5 from -251 to +201.
Table 3. Relative CAT activities exhibited by LAT promoter 
plasmids. The CAT activities exhibited by each of the LAT 
promoter plasmids, along with controls pFJ5, pgDCAT and 
pFJIO were determined and calculated relative to the CAT 
activity exhibited by pLATICAT which was given the nominal 
value of 1. The mean of at least four independent 
determinations is given (column 2) with the standard error 
of the mean (SEM) (column 3). Column 4 records the relative 
CAT activity exhibited upon infection of transfected cells 
with 5pfu/cell HSV-1 17+ for 18h, with the SEM given in 
column 5. The level of induction of CAT activity upon 
infection, relative to uninfected cell CAT activity is 
given in column 6.
Sp 1 Sp1
^  ^CAAT TATA 5’ LAT RNA
LAT 1
LAT 2
LAT 3
IF5
LAT 5
P la s m id
Relative C A T  Activity
In d u c tio n
Uninfected Std. Error 
(+/-)
Infected Std. Error 
(+/-)
pFJ5 0.11 0.04 0.92 0.15 8.3
pFJIO 48.32 8.5 612.3 89.59 12.7
pgDCAT 4.4 0.79 534.9 94.8 121.56
pLATICAT 1 0.28 3.69 0.54 3.69
pLAT2CAT 0.14 0.02 1.52 0.21 10.8
PLAT3CAT 0.02 0.009 0.37 0.12 15.8
pIF5 0.38 0.17 3.57 0.43 9.39
pLAT5CAT 0.04 0.02 4.5 1.85 112.5
Figure 12. Restriction digest profiles of LAT promoter 
plasmids. Plasmids pLATICAT (lane 1) to pLAT7CAT (lane 7) 
were digested with Hin&III and Xbal and run on a 1% agarose 
gel along with 123 bp ladder size markers (lane S). The top 
two fragments in each of the plasmid lanes represent vector 
sequences. The third fragment co-migrating in all tracks is 
the 797 bp Hin&III fragment containing the CAT gene. The 
Hin&III/Xbal LAT promoter fragments marked (P) all migrate 
distances consistent with their expected sizes. Note that 
the LAT3 promoter fragment co-migrates with the CAT 
fragment.
Lane S: 123 bp ladder
Lane 1: pLATICAT
Lane 2: pLAT2CAT
Lane 3: pLAT3CAT
Lane 4: pLAT4CAT
Lane 5: pLAT5CAT
Lane 6: pLAT6CAT
Lane 7: pLAT7CAT
vector
Figure 13. Restriction digest profiles of LAT promoter
plasmids. The plasmids indicated were digested with Hin&III
and Xbal and run on a 1% agarose gel along with 123 bp
ladder size markers (lane S). The top two fragments in each 
of the plasmid lanes represent vector sequences. The third 
fragment co-migrating in all tracks is the 797 bp Hin&III 
fragment containing the CAT gene. The Hin&III/Xbal LAT 
promoter fragments marked (P) all migrate the correct
distances consistent with their expected sizes.
Lane S: 123 bp ladder 
Lane 1: pLAT8CAT 
Lane 2: pIF5 
Lane 3: pLAT4/5CAT 
Lane 4: pAlCAT 
Lane 5: pA2CAT 
Lane 6: p£3CAT 
Lane 7: pLATOCAT 
Lane 8: pLAT60CAT

Figure 14. CAT Activity: Original data sample. This gives 
an example of how the relative CAT activities from the 
transfection assays were calculated from original data. CAT 
assays were carried out as described by Seed & Sheen 
(1988). Reactions were carried out for lh at 37°C, then 
extracted with a 2:1 mixture of TMPD/Xylenes. The cpm from 
the organic phase (0) and aqueous phase (A) of a control 
(blank) reaction were determined. Percentage conversion per 
h per pg protein, was calculated as shown. The CAT 
activities of all of the plasmids were finally calculated 
relative to the CAT activity exhibited by pLATlCAT which 
was given the nominal value of 1.
CAT ACTIVITY: ORIGINAL DATA
Organic phase counts (0): 128.
Aqueous phase counts (A): 98,452.
counts per min. (extract diln) Protein conc.
UI I UI I
pFJ5 263 2253 380 95
pgDCAT 4000 (xlO) 8817 (x600) 240 85
pFJIO 8271 (xlOO) 11604 (x600) 230 80
pLATlCAT 1676 (xlO) 2868 (xlO) 200 85
pLAT2CAT 3844 1494 (xlO) 210 85
pLAT3CAT 482 5943 220 110
pLAT4CAT 1820 (xlO) 2665 (x20) 200 125
pLAT5CAT 305 6543 (xlO) 145 125
pLAT6CAT 1979 (x20) 6468 (xlOO) 145 110
pLAT4/5CAT 2652 (xlO) 4021 (x400) 185 100
% conversion/h= [(cpm-0)/A]xlOO
%conversion/h/p.g protein= %conversion/protein conc.
% conversion/h/ Normalised for
pg protein pLATlCAT=l
UI I UI I
pFJ5 0.0003 0.022 0.004 0.028
pgDCAT 0.164 62.25 2.09 792.9
pFJIO 3.596 87.37 45.8 1113.1
pLATlCAT 0.078 0.327 1 4.16
pLAT2CAT 0.017 0.162 0.228 2.06
pLAT3CAT 0.001 0.054 0.020 0.687
pLAT4CAT 0.086 0.411 1.09 5.23
pLAT5CAT 0.001 0.520 0.015 6.62
pLAT6CAT 0.259 5.850 3.30 74.5
pLAT4/5CAT 0.138 15.80 1.75 201.3
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calculation variability between
different sets of CAT assays arising from the \Ju-\X\f~ 
nature of the short term transfection assay which is due to 
factors such as transfection efficiency. The data from all 
of the transfection experiments were then pooled, and the 
mean and standard error calculated for each construct. The 
results presented for pLATlCAT in Table's 3, 4, 5 and 6
were calculated only from data from experiments where the 
other constructs had been included, thereby explaining the 
slight differences in value for pLATlCAT activities in each 
table.
As observed from the results on Table 3, the 
control plasmids pgDCAT and pFJIO exhibited relatively high 
levels of constitutive activity, with pFJIO being 11-fold 
higher than pgDCAT. PLATlCAT exhibited a level of activity 
(about 23% of pgDCAT) which indicates that the LAT1 
fragment contains sequences that can perform as a promoter 
in this assay. pLAT2CAT exhibits a 7-fold lower activity 
than pLATlCAT while pLAT3CAT and pLAT5CAT exhibited 
negligible activity. The differences in activity between 
LATs 1, 2 and 3 indicate that the sequences important for 
promoter activity in LAT1 are located upstream of the Pstl 
site at -595 ie the region containing the recognisable 
putative promoter elements. It is therefore reasonable to 
conclude that the activity exhibited by the LAT2 fragment 
is due to the presence of the TATA box at position -689 to 
-681 which may form the basis of a core promoter, which is 
enhanced by upstream sequences between the Pstl site at - 
595 and Hinfl site at -940 (the CAAT box and putative Spl 
binding sites, perhaps) as in LAT1. It is not clear, 
however, why pIF5 exhibits such relatively high activity 
(about 38% of pLATlCAT); the only difference between pIF5 
and pLAT5CAT being additional 50 bp extension in pLAT5CAT.
2.3. Infection Studies on Promoter Activity
In addition to the transient expression assays
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detailing constitutive promoter activity of the putative 
promoter clones, the effect on promoter activity of 
infecting the transfected cells with HSV-1 was 
investigated. The results from infection with wt HSV-1 are 
shown on columns 4 and 5 of Table 3, together with the
level of induction above constitutive activity indicated in 
column 6.
Plasmids pgDCAT and pFJIO exhibit induction to very 
high levels of CAT activity as would be expected for early 
and immediate-early promoters in response to HSV-1 trans­
acting factors. The control plasmid pFJ5 also exhibits a 
response to infection, an effect probably due to the
presence of cryptic promoters in the vector sequence.
pLATlCAT exhibits a relatively poor response to infection, 
being induced only 3.7-fold. pLAT2CAT was induced 11-fold 
to a level still less than that of induced pLATlCAT.
pLAT3CAT was induced 16-fold but yielded very little 
activity upon infection (cf pFJ5) thus confirming that this 
clone is devoid of sequences capable of functioning as a 
promoter in these assays. pIF5 was induced 3.57-fold to a 
level roughly similar to that of induced pLATlCAT. 
Interestingly, LAT5 which yielded negligible constitutive 
activity, exhibited a 112.5-fold stimulation to a level 
greater than that of stimulated pLATlCAT. It is clear from 
this result that LAT5 contains sequences which, though not 
capable of exhibiting any constitutive activity, respond 
strongly in the presence of HSV-1 trans-acting factors.
3C.3. Deletiona from the 3 1 end of the LAT Region
The following section examines the effect on 
promoter activity of deletion of sequences from the 3' end 
of the 1141 bp Hinfl/Nael region of the LAT sequence. As in 
section 3C.2, a series of DNA fragments were constructed 
and cloned into pFJ5. The location of these fragments are 
diagrammatically represented in Figure 15.
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3.1. Cloning of the Promoter Sequences
PLAT7CAT; Plasmid pLAT7CAT contains all 1141 bp of the LAT
sequence between the Hinfl site at -940 and the NaeI site
+201. To construct pLAT7CAT, pLATl was digested with SphI, 
releasing a single SphI fragment spanning from the SphI 
site 5' to the LAT1 insert in the pUC19 polylinker to a 
SphI site at position -171 in the LAT sequence. This 
fragment was ligated into Sphl-digested pLAT5+BglII DNA 
where the corresponding smaller SphI fragment had been 
removed, thus generating plasmid pLAT7. The LAT7 sequence 
was excised from pLAT7 as a Sail/Bglll fragment and ligated 
into Sail/Bglll digested pFJ5 DNA to generate plasmid 
pLAT7CAT.
PLAT4CAT: Plasmid pLAT4CAT contains 545 bp of LAT sequence
spanning the Hinfl site at -940 to the Smal site at -395,
and like pLAT8CAT and pLAT6CAT, contains all of the 
recognised putative promoter elements, but not the mapped 
5 1 end of the 2kb LAT RNA, nor conserved loci 7, 8 or 9. To 
construct pLAT4CAT, pLATl+Bglll was digested with Smal and 
religated. This treatment deleted all of the LAT sequence 
between the Smal site at -394 to the Smal site in the pUC19 
polylinker of pLATl+Bglll, thus generating plasmid pLAT4. 
The LAT4 sequence was excised from pLAT4 as a Sail/Bglll 
fragment and ligated into Sail/Bglll digested pFJ5 DNA to 
generate plasmid pLAT4CAT.
PLAT8CAT: Plasmid pLAT8CAT contains 391 bp of LAT sequence 
encompassing the region between the Hinfl site at -940 and 
the Nae I site at -549. To construct pLAT8CAT, pLATlCAT was 
digested with Nae I and Bglll, blunt-ended with T4 DNA 
polymerase and religated. This treatment removed all of the 
LAT sequence from the Nae I site at -549 to the Bglll site 
in the pFJ5 polylinker in pLATlCAT, thereby generating 
plasmid pLAT8CAT.
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PLAT6CAT: Plasmid pLAT6CAT contains 279 bp of LAT sequence 
encompassing the region between the Hinfl site at -940 and 
the Pvul site at -659. To construct pLAT6CAT, pLATl+Bglll 
was digested with Hindi and Pvul. The 281 bp fragment was 
purified, blunt-ended with T4 DNA polymerase and ligated 
into Hindi digested pUC8 DNA to generate pLAT6. The 
Sail/Bglll fragment of the appropriately orientated insert 
in pUC8 was isolated and ligated into Sail/Bglll digested 
pFJ5 DNA to generate plasmid pLAT6CAT.
3.2. The Sequence of pLAT6CAT
Since the LAT6 sequence includes all the putative 
promoter elements, it was sequenced to determine their 
integrity. This was performed by excising the LAT6 sequence 
from pLAT6CAT as a Sail/Bglll fragment and ligating it into 
Sail/PamHI digested pT7T3 19U. This enabled sequencing of 
the LAT6 sequence from either end of the clone. The 
sequencing gel, shown on Figure 16 indicates a single 
deviation from the published HSV-1 sequence. This is a base 
substitution at position -680 (G to A) which, despite it s 
proximity to the TATA box, does not seem to affect the 
promoter activity exhibited by the LAT6 clone (see 
following sections). This position is also not conserved in 
the HSV-2 sequence with the G being substituted for a C, 
thereby suggesting that it is not crucial for LAT promoter 
activity. While not actually determined, it is likely that 
all of the other LAT clones harbouring this sequence will 
be the same except for perhaps pLAT2CAT which was 
independently cloned directly from pJR3 (section 3C.2.1).
3.3. Expression Assays
The promoter activity of the above constructs were 
determined by quantitation of CAT activity in short term 
transfection assays. The results are shown in columns 2 and 
3 of Table 4. As before, the data were normalised relative
Figure 15. Schematic representation of LAT promoter 
fragments with increasing deletions from the 3' end. The
top line indicates the relative positions of the putative 
promoter elements and 5' end of 2 kb LAT. The LAT1 fragment 
extends from -940 to +151, the LAT7 fragment from -940 to 
+201, the LAT4 fragment from -940 to -395, LAT8 from -940 
to -549, and LAT6 from -940 to -659.
Table 4. Relative CAT activities exhibited by LAT promoter 
plasmids. The CAT activities exhibited by each of the LAT 
promoter plasmids were determined and calculated relative 
to the CAT activity exhibited by pLATlCAT which was given 
the nominal value of 1. The mean of at least four 
independent determinations is given (column 2) with the 
standard error of the mean (SEM) (column 3) . Column 4 
records the relative CAT activity exhibited upon infection 
of transfected cells with 5pfu/cell HSV-1 17+ for 18h, with 
the SEM given in column 5. The level of induction of CAT 
activity upon infection, relative to uninfected cell CAT 
activity is given in column 6.
S p l  S p l
^  ( C A A T  T A T A 5 ’ L A T  R N A
LAT 1 
LAT 7 
LAT 4 
LAT 8 
LAT 6
P la s m id
Relative CAT Activity
In d u c tio n
Uninfected Std. Error (+/-) Infected
Std. Error 
(+/-)
pLATlCAT 1 0.11 3.62 0.61 3.62
pLAT7CAT 0.19 0.05 2.18 0.42 11.47
pLAT4CAT 1.28 0.29 4.03 1.00 3.14
pLAT8CAT 2.79 0.27 13.35 1.95 4.7
pLATSCAT 5.14 1.73 47.11 19.3 9.2
pFJ5 0.11 0.04 0.92 0.15 8.3
pFJIO 48.32 8.5 612.3 89.59 12.7
pgDCAT
L ,
4.4 0.79 534.9 94.8 121.56
Figure 16. The sequence of the LAT6 fragment. The LAT6 
sequence was determined from both ends in pT7T3. The first 
four tracks give the sequence of the opposite (antisense) 
strand to the sequence displayed on Figure 9. The positions 
of the various identifiable putative promoter elements are 
indicated. The position of a C to T transition (G to A on 
the sense strand) is shown at position -680.
A C G T  A C G T
| CAAT
CAAT |-----1
TA TA  Box
C to T  T rans ition
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to the promoter activity of pLATlCAT.
The difference in activity between LAT1 and LAT7 
indicates that addition of the 50 bp sequence between the 
Hinil site at +151 and the NaeI site at +201 effects an 8- 
fold reduction in constitutive activity. A similar result 
is observed when comparing pIF5 and pLAT5CAT (which have 
the same 50 bp difference) constitutive activity. The 
results of pLAT4CAT, pLAT8CAT and pLAT6CAT demonstrate that 
as the 3' end of the LAT sequence is deleted towards the 
putative promoter elements, the level of CAT activity 
increases, with the level of pLAT6CAT activity being 
greater than that exhibited by pgDCAT (Table 4). This 
observation is consistent with the notion that these 
elements form a bona fide promoter which exhibits a 
distance effect, ie, that the measured promoter activity 
increases as the distance between the promoter and reporter 
gene decreases.
3.4. Infection Studies
As in section 3C.2, the effect on promoter activity 
of infecting the transfected cells with HSV-1 was 
investigated. These results are shown in columns 4 and 5 of 
Table 4, together with the level of induction above 
constitutive level of activity indicated in column 6.
The pLAT7CAT result indicates that the 50 bp 
sequence at its 3' end appears to confer a high amount of 
relative inducibility (11.5-fold) when compared to pLATlCAT 
(3.6-fold), although the actual level of induced pLAT7CAT 
activity is still less than (60% of) that of pLATlCAT. This 
observation reflects the result obtained with pLAT5CAT 
which also exhibits high inducibility, although to a level 
greater than that of pLAT7CAT. The infected activity of 
pLAT4CAT, pLAT8CAT and pLAT6CAT again reflects the 
importance of the putative promoter elements in directing 
promoter activity from the LAT sequence. The infected 
activity increases, again, as the 3' end is deleted towards
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the promoter elements, consistent with the distance effect 
described above. The activity of the strongest LATCAT 
construct, pLAT6CAT which was induced 9.2-fold, is still, 
however, less than a tenth of the activity exhibited 
following infection of cells transfected by either of the 
lytic cycle promoter constructs (see Table 3 and Figure 14).
3C.4. Deletions from the Centre of the LAT Region
The following section examines the effect on 
promoter activity of removal of DNA sequences from the 
centre of the 1141 bp Hintl/Nael LAT region. These 
experiments were performed at a time before identification 
of the 8.3 kb LAT, when it was not clear why the promoter 
was so far upstream from the apparent 5' end of the 2 kb 
LAT. It was therefore considered that splicing out of a 5 1 
leader sequence between the promoter and 5' end of LAT 
might be occurring. As in the previous sections, a series 
of DNA fragments were cloned into pFJ5 and assayed for CAT 
activity in transfection assays. The location of these 
fragments are diagrammatically represented in Figure 17; 
their construction is described below.
4.1. Cloning- of the Promoter Sequences
pAlCAT. pA2CAT, pA3CAT; These three plasmids consist of the 
LAT region between the Hinfl sites at -940 and +151 with 
various internal deletions between NaeI sites at -549, -341 
and -251. These plasmids were generated by partially 
digesting pLATlCAT with Nael and religating. Following 
transformation, colonies were screened and revealed the 
presence of all three possible permutations resulting from 
deletions between the Nael sites. Plasmid pAlCAT has a 90 
bp deletion between the Nael sites at -341 and -251. 
Plasmid pA2CAT has a 208 bp deletion between the Nael sites 
at -549 and -341. Plasmid pA3CAT has a 298 bp deletion 
between the Nael sites at -549 and -251. The deletions in 
pAlCAT and pA2CAT remove all of conserved loci 8 and 7
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respectively, (see Figure 9) while the deletion in p&3CAT 
removes both conserved loci.
PLAT4/5CAT: Plasmid pLAT4/5CAT essentially contains the
LAT4 and LAT5 sequences fused together to generate a 
construct similar to LAT7 with a central 144 bp between the 
Smal site at -395 and Nae I site at -251, thus deleting 
conserved loci 7 and 8. To construct pLAT4/5CAT, the 
HincII/Kpnl fragment excised from pLAT4 containing the LAT4 
sequence was blunt-ended with T4 DNA polymerase and ligated 
into HinclI-digested pLAT5 DNA to generate plasmid pLAT4/5. 
The LAT4/5 sequence was excised from pLAT4/5 as a 
Sall/Bglll fragment and subsequently ligated into 
Sail/Bglll-digested pFJ5 DNA to generate plasmid
pLAT4/5CAT.
4.2. Expression Assays
The promoter activity of the above constructs were 
measured by quantitation of CAT activity in short term 
transfection assays. The results are shown in columns 2 and 
3 of Table 5. As before, the data were normalised relative 
to the promoter activity of pLATlCAT.
The results indicate that the CAT activity
exhibited by pAlCAT is essentially equal to that of
pLATlCAT, thereby demonstrating that the deletion in ptlCAT 
which removes conserved locus 8 has no effect upon promoter 
activity exhibited by the LAT sequence. Intriguingly, 
however, the other constructs, p&2CAT, pA3CAT and 
pLAT4/5CAT exhibit a relatively high level of constitutive 
CAT activity, much higher indeed than any of the other 
LATCAT constructs and pgDCAT. This suggests that the
deletions in these constructs have removed some sequence 
that has a negative effect upon promoter activity. The area 
of deletion common to all three constructs is a 54 bp 
sequence between the Smal site at -395 and the Nael site at
Figure 17. Schematic representation of LAT promoter 
fragments with internal deletions. The top line indicates 
the relative positions of the putative promoter elements 
and 5' end of 2 kb LAT. The LAT1 fragment extends from -940 
to +151. & 1, 1^ 2 and A 3 are all derived from LAT1 by
internal deletions: /\l has a 90 bp deletion from -341 to 
-261; & 2  has a 208 bp deletion from -549 to -341; ^3 has a 
298 bp deletion from -549 to -251. pLAT4/5CAT is 
essentially similar to pLAT7CAT with a 144 bp deletion 
between -395 and -251.
Table 5. Relative CAT activities exhibited by LAT promoter 
plasmids. The CAT activities exhibited by each of the LAT 
promoter plasmids were determined and calculated relative 
to the CAT activity exhibited by pLATlCAT which was given 
the nominal value of 1. The mean of at least four 
independent determinations is given (column 2) with the 
standard error of the mean (SEM) (column 3) . Column 4 
records the relative CAT activity exhibited upon infection 
of transfected cells with 5pfu/cell HSV-1 17+ for 18h, with 
the SEM given in column 5. The level of induction of CAT 
activity upon infection, relative to uninfected cell CAT 
activity is given in column 6.
Spl Spl
\
f  CAAT TATA 5’ LAT RNA1 | 1
LAT 1 
A1 
A2 
A3
LAT 4 /5
P la s m id
Relative CAT Activity
In d u c tio n
Uninfected Std. Error 
(+/-)
Infected Std. Error 
(+/-)
pLATlCAT 1 0.37 4.12 1.09 4.12
A1CAT 1.14 0.38 2.6 0.86 2.27
A2CAT 18.14 7.4 11.05 2.67 0.43
A3 CAT 14.01 6.9 12.04 2.92 0.57
pLAT4/5CAT 7.76 3.04 95.45 29.29 12.3
pFJ5 0.11 0.04 0.92 0.15 8.3
pFJIO 48.32 8.5 612.3 89.59 12.7
! pgDCAT 4.4 0.79 534.9 94.8 121.56
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-341. Examination of the LAT sequence (Figure 9) shows that 
this is the area of sequence harbouring conserved locus 7. 
Since regions of HSV-l/HSV-2 sequence homology are perhaps 
conserved due to some functional importance, it would be 
interesting to speculate that conserved locus 7 may 
function as a repressor of <K^ eSi>Vov\ from the LAT
promoter region.
4.3. Infection Studies
The effect on promoter activity of infecting cells 
transfected with the above constructs was investigated. The 
results are shown in columns 4 and 5 of Table 5 together 
with the level of induction indicated in column 6.
The results show that, as in the uninfected cells, 
the CAT activity exhibited by p/\lCAT is essentially similar 
to that of pLATlCAT, thus confirming that the deletion of 
the sequence containing conserved locus 8 has no effect 
upon promoter activity exhibited by the LAT sequence. 
Plasmids pA2CAT and pA3CAT exhibit slight reductions of 
0.43 and 0.57-fold respectively, thus demonstrating that 
infection, in contrast to all others, has little effect on 
the promoter activity exhibited by these constructs. 
Plasmid pLAT4/5CAT does, however, exhibit an increase of 
12.3-fold in CAT activity upon infection. This relatively 
high level of induction parallels those obtained with 
pLAT5CAT and pLAT7CAT and again indicates that the 50bp 
region between the Hinfl site at +151 and NaeI site at +201 
contains some sequence capable of responding strongly to 
HSV-1 infection.
3C.5. Effect of “upstream” sequences on LAT promoter 
activity
The following section examines the effect on 
promoter activity of the addition of sequences upstream of 
the Hinfl site at -940 to the Dral site at -1459, and
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therefore containing conserved loci 1 and 2. Two clones 
were constructed which essentially contained this upstream 
sequence fused to the LAT1 and LAT6 sequences, and assayed 
for CAT activity in transfection assays. A schematic 
representation of these clones is shown on Figure 18.
5.1. Cloning of the Promoter Sequences
pLATOCAT: Plasmid pLATOCAT consists of 1620 bp of LAT
sequence encompassing the Dral site at -1459 and Hinfl site 
at +151, and thus contains all of the recognised putative 
promoter elements and all of the conserved loci. To
construct pLATOCAT, the 638bp Dral/EcoRV fragment 
(corresponding of -1459 to -821 of the LAT sequence) was 
excised from the BamHI b containing plasmid pGX48. This 
fragment was ligated into Hincll/EcoRV digested pLATl+Bgrlll 
to yield plasmid pLATO. The Bindlll site in the pUC19 
polylinker in pLATO was converted to a Sail site by Hindlll 
digestion and T4 DNA polymerase treatment followed by 
ligation of the phosphorylated Sail linker 5'-GGCGACC-31 to 
generate plasmid pLATO-tfindlII + SaJI. The LATO sequence was 
excised from pLATO-tfindlll + Sall as a Sall/Bgrlll fragment
and subsequently ligated into Sail/Bglll digested pFJ5 DNA 
to generate pLATOCAT.
PLAT60CAT: Plasmid pLAT60CAT contains 798 bp of LAT
sequence spanning the Dral site at -1459 and Pvul site at - 
659, and contains all of the putative promoter elements and 
conserved loci 1 through to 6. To construct pLAT60CAT, the 
661bp Sail/ EcoRW fragment was excised from pLATO-
Hindlll+Sall and ligated into SalI/£coRV digested pLAT6 to 
generate plasmid pLAT60. The LAT60 sequence was excised 
from pLAT60 as a 5alI/«BgrlII fragment and then ligated into 
Sall/Bgrlll digested pFJ5 DNA to generate pLAT60CAT.
5.2. Expression Assays
The promoter activity of the above constructs were
Figure 18. Schematic representation of LAT promoter 
fragments with addition of "upstream" sequences. The top
line indicates the relative positions of the putative 
promoter elements and 5' end of 2 kb LAT. The LAT1 fragment 
extends from -940 to +151, the LATO fragment from -1459 to 
+ 151, the LAT6 fragment from -940 to -659, and the LAT60 
fragment from -1459 to -659.
Table 6. Relative CAT activities exhibited by LAT promoter 
plasmids. The CAT activities exhibited by each of the LAT 
promoter plasmids were determined and calculated relative 
to the CAT activity exhibited by pLATlCAT which was given 
the nominal value of 1. The mean of at least four 
independent determinations is given (column 2) with the 
standard error of the mean (SEM) (column 3) . Column 4 
records the relative CAT activity exhibited upon infection 
of transfected cells with 5pfu/cell HSV-1 17+ for 18h, with 
the SEM given in column 5. The level of induction of CAT 
activity upon infection, relative to uninfected cell CAT 
activity is given in column 6.
Spl Spl
T A T A  
C A A T  |
LAT1
LATO
LA.T6
LAT60
P la s m id
Relative CAT Activity
In d u c tio n
Uninfected Std. Error (+/-)
Infected Std. Error (+/-)
pLATlCAT 1 0.54 3.92 1.19 3.92
pLATOCAT 2.74 1.19 5.98 1.34 2.42
pLAT6CAT 11.45 2.91 136.5 32.12 11.8
pLAT60CAT 19.61 1.98 152.25 34.45 7.76
pFJ5 0.11 0.04 0.92 0.15 8.3
pFJIO 48.32 8.5 612.3 89.59 12.7
pgDCAT 4.4 0.79 534.9 94.8 121.56
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measured by quantitation of CAT activity in transfection 
assays. The results are shown in columns 2 and 3 of Table 
6. As before, all the data were normalised relative to the 
promoter activity exhibited by pLATlCAT.
The results indicate that the effect of addition of 
upstream sequences to LAT1 and LAT6 in LATO and LAT60 
respectively is to slightly enhance CAT activity; 2.74-fold 
in the case of pLATOCAT and 1.71-fold in the case of 
pLAT60CAT. This demonstrates that sequence elements 
upstream of the Hinfl site at -940, perhaps present in 
conserved loci 1 and/or 2, form cis-acting sequences which 
function to slightly enhance LAT promoter activity in this 
assay.
5.3. Infection Assays
The effect on promoter activity of infecting cells 
transfected with the above plasmids was investigated. The 
results are shown in columns 4 and 5 of Table 6, together 
with the level of induction indicated in column 6.
The results show that the level of CAT activity 
exhibited by pLATOCAT when infected is 1.5-fold more than 
that of induced pLATlCAT, although the actual level of 
induction is slightly lower (2.4-fold as opposed to 3.92- 
fold) . The level of activity exhibited by pLAT6CAT and 
pLAT60CAT when infected are similar, although the actual 
level of induction from constitutive activity is 66% less 
for pLAT60CAT. This demonstrates that the upstream 
sequences do not contribute to the level of infected cell 
CAT activity; all of the sequences responsible for the 
response to virus infection are therefore confined to the 
LAT6 fragment.
3C.6. Effect of VmwllO and Vnwl75 on LAT Promoter Activity
The aim of this section is to examine the effect of 
the HSV-1 immediate-early trans-activating polypeptides 
VmwllO and Vmwl75 upon LAT promoter activity. 3^g of the
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plasmids pLAT6CAT and pLAT8CAT, chosen since they exhibited 
high amounts of constitutive CAT activity, and control 
plasmid pgDCAT were each co-transfected with equal amounts 
(3pg) of pill (expressing VmwllO), pl75 (expressing Vmwl75) 
or both pill and pl75. A total of 9pg was used to transfect 
each BHK monolayer, with pUC19 being used to equalise the 
amount of DNA in each experiment. The results, normalised 
for the constitutive activity exhibited by pLATlCAT are 
shown on Table 7; standard errors are shown in brackets.
The results show that, as predicted, the gD 
promoter exhibits a marked response when co-transfected 
with either pill or pl75, being induced approximately 11- 
fold and 30-fold respectively. The gD promoter also 
exhibits the characteristic synergistic effect when co­
transfected with both pill and pl75, being induced 138- 
fold. These data essentially reflects those previously 
described by Everett, (1984b, 1986).
The LAT6 promoter clone exhibits a much weaker 
response when co-transfected with either pill or pl75 
(being induced 1.7-fold and 2.2-fold respectively) with no 
synergistic effect being observed when co-transfected with 
both plasmids. The LAT8 promoter fragment exhibits an 
approximate 5-fold increase in CAT activity when co­
transfected with pill. Intriguingly, however, when pLAT8CAT 
is co-transfected with pl75, CAT activity is actually 
reduced to a level only 78% that of constitutive activity. 
To further investigate the apparent negative regulatory 
effect of Vmwl75 on CAT expression driven by the LAT8 
promoter clone, CAT activity exhibited by pLAT8CAT, 
pLAT6CAT and control plasmid pIE3CAT was titrated against 
increasing amounts of pl75. The effect of adding increasing 
amounts of Vmwl75-expressing plasmid on the level of IE-3 
promoter activity (Paterson & Everett, 1988a), is to 
increase the level of repression.
Here, 3pg of each of pLAT6CAT, pLAT8CAT and pIE3CAT 
were transfected with increasing amounts (1, 2, 4 and 9^g)
Table 7. The effect of VmwllO and Vmwl75 on LAT promoter 
activity. The CAT activities exhibited by pLAT6CAT, 
pLAT8CAT and pgDCAT were determined when transfected alone 
(constitutive activity; column 2), and when co-transfected 
with VmwllO-expressing plasmid pill (column 3) , Vmwl75- 
expressing plasmid pl75 (column 4) or both pill and pl75 
(column 5) . The mean of 3 independent determinations is 
given together with the standard error of the mean (shown 
in brackets). These data were calculated relative to the 
constitutive activity exhibited by pLATlCAT (data not 
shown) which was given the nominal value of 1.
Figure 19. Repression of the LAT promoter by Vmwl75. BHK
cells were transfected with 3pg of either pIE3CAT, 
pLAT6CAT, or pLAT8CAT, and increasing amounts (1, 2, 4 and 
9pg) of pl75. The total amount of DNA in each transfection 
was equalised to 12|Jig with pUC19. Cell extracts were 
prepared 24h after transfection, and their CAT enzyme 
activities determined, normalised for protein concentration 
and calculated as a percentage of that obtained in 
transfections without pl75. The symbols representing each 
plasmid are given in the legend beside the graph.
P la s m id
Relative CAT Activity
Constitutive + p l l l +p l75 + p l l l  +pl75
pgDCAT
pLAT6CAT
pLAT8CAT
3.4 (0.59) 
14.3 (4.8) 
4.2 (0.32)
36.4 (4.4) 
24.2 (5.9) 
21.6 (2.9)
99.6 (7.9) 
31.2 (2.3) 
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of pl75 in a total of 12pg of DNA; pUC19 DNA was again used 
to equilibrate the amount of DNA in each experiment. The 
results are represented in graphical form (Figure 19) and 
calculated as a percentage of CAT activity obtained in
transfections without pl75. The results show that CAT 
activity exhibited by pLAT6CAT gradually increases with the 
amount of pl75 to a level almost 80% more than that of 
uninhibited activity. This increase in activity, albeit 
small, precludes the possibility of any promoter 
competition effects between the LAT6 promoter and SV40 
early promoter and enhancer driving Vmwl75 expression in 
plasmid pl75 (Everett, 1987). The results clearly show 
that, in accordance with previously published results 
(Paterson & Everett, 1988a), IE3CAT activity is highly 
repressed. They also demonstrate that, in contrast to
pLAT6CAT, pLAT8CAT promoter activity is reduced in a 
similar manner to that of the IE-3 promoter. This confirms 
that LAT8 promoter activity is repressed by Vmwl75 in
vitro, and that this effect must be mediated through the
LAT sequence between the PvuI site at -659 and NaeI site at 
-549.
The ability of Vmwl75 to repress transcription from 
the IE-3 promoter is well documented, (O'Hare & Hayward, 
1985) and it has been shown that this effect is mediated 
through Vmwl75 interacting at a specific DNA binding site 
containing the consensus ATCGTC at the cap site of the IE-3 
promoter (Muller, 1987). It was subsequently found that 
both the integrity of this binding site together with the 
ability of Vmwl75 to bind it were essential for repression 
(DeLuca & Schaffer, 1988; Paterson & Everett, 1988a, b; 
Roberts et al., 1988; DiDonato & Muller, 1989). Sequence 
analysis of the LAT region between the Pvul site and Nae I 
site reveals that the closest similarity to the core 
Vmwl75-binding consensus is located at -659 to -654 
(..ATCGCG..). This homologue occurs at the blunt-ended Pvul 
site (CGAT'CG) in the LAT6 clone whose 3' terminal residue
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is a G immediately preceding the core ATCGTC homologue. A 
comprehensive sequence comparison is shown on Figure 20 and 
compares the IE-1 and IE-3 sequences with those of the HSV- 
1 17+, KOS and HSV-2 HG52.^sequences. The comparison shows 
that this sequence, occurring in conserved locus 6 has the 
preceding three 5' flanking bases and first four bases of 
the core repression element ie, (..CCGATCG..) of HSV-1 17+, 
KOS, and HSV-2 HG52 identical to that of the HSV-1 IE-3 
sequence. The 3 1 terminal C residue present in strain KOS 
increases its homology to the core consensus of the Vmwl75 
binding site.
It is possible that the occurrence of this 
potential Vmwl75 binding site homology within a region 
required for Vmwl75-mediated repression of expression from 
the LAT8 promoter is of significance in terms of regulation 
of LAT gene expression at some crucial point of the virus 
life cycle.
Figure 20. Vmwl75 binding site homology in the LAT 
promoter. The sequences surrounding the Vmwl75 binding 
sites (ATCGTC) of the HSV-1 IE-3 and IE-1 genes are shown 
on the top two lines respectively. The Vmwl75 homologues in 
the LAT prorrftjer regions of HSV-1 17+, KOS, and HSV-1 HG52 
are shown on the lower three lines respectively. The ATCGTC 
core homology is shown on the top line.
ATCGTC Core consensus mot
GCCCCGATCGTCCACACGGAG
GGGGGAATCGTCACTGCCGCC
GTGCCGATCGCGGGTGGTGCG
GTGCCGATCGCCGGTGGTGCG
AGGCCGATCGAGAGGGACTCC
H S V -1  I E - 3  
H S V -1  I E - 1  
H S V -1  17 LAT 
H S V -1  KOS LAT 
H S V -2  HG52 LAT
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3D. ANALYSIS OF THE LAT PROMOTER IW A VIRUS VECTOR
3D.1. Introduction
The aim of this study was to examine the ability of 
the LAT promoter sequences to drive reporter gene 
expression in the context of the HSV-1 genome during lytic 
infection of tissue culture cells. The strategy employed 
was to take LAT promoter/reporter gene fusions selected on 
their ability to drive gene expression in short term 
transfection assays (section 3C) and introduce them into 
the genome of the HSV-1 vector developed by Rixon & 
McLauchlan, (1990). These recombinant viruses were then 
used for further characterisation of the LAT promoter 
constructs during lytic infection of various cell lines.
The following sections offer a brief description of 
the vector, followed by an account of the construction and 
analysis of the various recombinants employed for the 
analysis of the LAT promoter.
3D.2. Description of the HSV-1 Vector
The virus vector used in this study employs a 
system where DNA sequences can be introduced into the HSV-1 
genome by direct ligation. This system was developed by the 
engineering of a single Xbal site into an intergenic region 
of the Xbal deficient virus 1702 (MacLean & Brown, 1987b). 
The Xbal site was inserted between Us genes 8/9 and 
10/11/12 which are encoded by convergently transcribed 
genes (Figure 21) and whose 3' termini are separated by 
some 400 bp of DNA (Rixon & McGeoch, 1985).
A series of plasmids were developed which allows 
DNA sequences to be placed under the control of various 
promoters. Each plasmid yields an Xbal fragment containing 
the promoter/gene of interest and the E.coli lacZ gene 
under control of the simian virus 40 (SV40) early promoter. 
The prototype plasmid used for much of the current work is 
pFJ5 (Figure 10; Rixon & McLauchlan, 1990) which contains
Figure 21. Strategy for insertion of DNA fragments into 
HSV-1 1802 DNA. The short region of the HSV-1 genome is 
shown in the prototype orientation and the Xbal sites are 
indicated by upward-facing arrows. The inverted repeats 
(IRs and TRs) are represented by open boxes and Us by a 
single line. The mRNAs (8/9 and 10/11/12) immediately 
flanking the cloning site are shown. The B-galacosidase 
gene is represented by lacZ and X denotes any additional 
sequences inserted along with B-galacosidase. This Figure 
is taken directly from a Figure originally published in 
Rixon & McLauchlan (1990), with permission.
TRs
Xba I Digest
t 1
X . lac z
Mix and Ligate — 1----- *
X | lac z
t t
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the chloramphenicol acetyltransferase reporter gene to 
assay promoter activity. This was also used as the cloning 
vehicle for the short term transfection assays described in 
section 3C. The Xbal fragment yielded by this plasmid can 
be ligated into Xbal digested vector DNA, designated 1802 
(Figure 21), and following transfection, expression of B- 
galactosidase by recombinant virus in the presence of X-gal 
results in the production of blue plaques which can be 
picked and purified.
Rixon & McLauchlan, (1990) placed the CAT reporter 
gene under the control of HSV IE and early promoters and 
showed that they were correctly expressed in lytically 
infected tissue culture cells in both wild-type and tsk 
versions of the vector.
3D.3. Construction of Recombinant Viruses
In the preliminary vector experiments, the Xbal 
fragments from the initial series of LAT plasmids 
constructed, (pLATlCAT, pLAT2CAT, pLAT3CAT, pLAT4CAT and 
pLAT5CAT) were introduced into the 1802 virus vector.
The plasmids were cleaved with Xbal and the 
appropriate fragments isolated and purified. Between 0.5- 
ljjig of each fragment was ligated into 0. 5p.g of Xbal- 
digested HSV-1 1802 DNA prior to transfection onto 
monolayers of BHK cells. Transfections were performed using 
the calcium phosphate precipitation/DMSO method described 
by Stow & Wilkie (1976). The progeny virus were harvested 
and titrated under agar medium. Upon the appearance of 
virus plaques, typically after 2 days, a further 2ml of 
agar medium containing 0.75mg/ml X-gal was added to each 
plate. After incubation overnight, plaques expressing B- 
galactosidase were picked. All viruses were purified to 
homogeneity typically through three to four rounds of 
plaque purification. All viruses were designated "vLC" eg, 
the virus derived from plasmid pLATlCAT is termed vLCl.
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3D.4. CAT Expression from Recombinant Viruses
The levels of CAT activity produced by the LATCAT 
fusion viruses along with controls vFJ5, vFJ7 and vFJIO 
were determined at 6, 12, 24 and 48 hours after infection 
with a moi of 5 at 37°C. The controls vFJ7 and vFJIO have 
the HSV-2 ribonucleotide reductase small subunit (early 
gene) and HSV-2 IE-4/5 promoter (immediate-early gene) 
promoters driving CAT activity respectively, while vFJ5 has 
no promoter to drive CAT activity. A typical set of data is 
shown on Figure 22. For sake of clarity the data is 
presented as a whole on a logarithmic plot (Figure 22(a)) 
while the data for the vLC viruses alone are presented on a 
linear plot (Figure 22(b)).
Figure 22(a) shows that vFJ7 and vFJIO exhibit 
essentially similar patterns of CAT activity in agreement 
with Rixon & Mclauchlan (1990). Their activity is 2-3 logs 
higher than that exhibited by any of the vLC viruses. This 
result parallels those obtained with the infected 
transfection assays (see Tables 3 and 4) where CAT 
activities exhibited by pFJIO and pgDCAT were similarly 
between 2 and 3 logs greater than those obtained with any 
of the corresponding LATCAT plasmids. The vFJ5 control 
virus exhibits negligible activity, thereby confirming that 
the activity exhibited by infected pFJ5 (Table 3) is a 
consequence of cryptic promoters within the pFJ5 vector 
sequence. Figure 22(b) shows that the activities exhibited 
by the vLC viruses do not reach appreciable levels until 
24h pi, whereas the lytic promoters reach a plateau of 
activity by 12h pi. vLCl yields a level of CAT activity, 
which, as similarly observed in the transfection assays 
(Table 3), is reduced by two-thirds in vLC2, and further 
reduced in vLC3. This confirms that the sequences capable 
of functioning as a promoter in the context of the virus 
genome are similar to those defined by the transfection 
assays. While vLC4 and vLC5 exhibit rather less activity
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relative to vLCl than their counterparts in the 
transfection assays, vLC5 still exhibits a relatively high 
activity, thus confirming the results of the infected 
transfection assays (Table 3), that the LAT5 clone contains 
sequences that can function as a promoter in the context of 
viral infection.
These results demonstrate that the LAT constructs 
behave in a similar fashion in the context of the virus 
genome, thus maintaining the same general conclusions 
arrived at from the transfection assays, ie, that the 
sequences responsible for promoter activity within the LAT 
sequence are within the region harbouring the recognisable 
putative promoter elements.
3D.5. Analysis of Virus Genomes
The introduction of a third copy of the LAT 
sequences into the virus vector genome raised the 
possibility of genome rearrangements occurring as a result 
of homologous recombination, thus making the interpretation 
of any results obtained with these viruses liable to 
substantial error. To determine the genome structure of 
the 1802-based LAT promoter/CAT fusion viruses, each 
purified virus was used to infect 35mm dishes of BHK cells. 
When complete cpe was observed, total DNA was extracted and 
analysed by restriction digestion with Hindlll and Xbal, 
run on a 1% agarose gel alongside the corresponding 
Hindlll/Xbal digested LATCAT plasmids, followed by Southern 
transfer to nitrocellulose filters and probing with the 
nick translated Xbal/Hindlll LAT promoter fragment derived 
from pLATlCAT (Section 3C.2.1). Figure 23 shows that all 
viral DNAs yield LAT promoter fragments of similar size to 
those from their corresponding plasmids. Perhaps 
suprisingly, there are no obvious signs of viral genome 
rearrangements, thereby demonstrating that CAT activity 
derived from these viruses give; a true reflection of the 
relative promoter activities exhibited by the various LAT
Figure 22. CAT activities produced by recombinant 1802 
viruses at various times after infection. a) . CAT
activities generated by vFJ5, vFJ7, vFJIO and LAT promoter 
viruses vLCl to vLC5 shown on a logarithmic scale, b) CAT 
activities generated by the LAT promoter viruses alone, 
shown on a linear scale. CAT activities were determined at 
6, 12, 24 and 48 h following infection and expressed as the 
percentage [ i *C] chloramphenicol converted per h per |j.g 
protein. The symbols representing each virus are given in 
the legends beside each graph.
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Figure 23. Southern blot analysis of the 1802-derived LAT 
promoter/CAT fusion viruses. Viral DNA was prepared from 
infected cells when extensive cpe was apparent. Each viral 
and corresponding plasmid DNA was digested with Xbal and 
Hindlll and subjected to Southern blot analysis using a 
nick translated Xbal/Hindlll LAT promoter probe derived 
from pLATlCAT.
Track 1 vLCl infected cel 1 DNA
Track 2 pLATlCAT
Track 3 vLC2 infected cell DNA
Track 4 pLAT2CAT
Track 5 vLC3 infected cel 1 DNA
Track 6 pLAT3CAT
Track 7 vLC4 infected cel 1 DNA
Track 8 pLAT4CAT
Track 9 vLC5 infected cell DNA
Track 10: pLAT5CAT
\o«l\
cw
The positions of the LAT promoter fragments from each 
recombinant virus are indicated (from PI to P5) . The 
strongly hybridizing bands at the top of each virus 
infected cell DNA track is due to hybridization of the LAT 
promoter probe to the endogenous HSV-1 LAT sequences. The 
CAT band shows up in lanes 9 and 10 due to contamination of 
the probe with CAT sequences from pLATlCAT in that 
particular experiment.
1 2 3 4 5 6 7 8  9 10
P i
P2
P3
P4
CAT
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promoter/CAT fusions in the context of each recombinant 
virus genome.
3E. CONSTRUCTION OF A LAT-DELETED VERSION OF HSV-1 1802
3E.1. Strategy
Although the genome structures of the above viruses 
appeared normal, it was nevertheless decided to constuct a 
version of the vector in which the endogenous LAT sequences 
are deleted, thus allowing a more confident interpretation 
of any results obtained when characterising viruses 
containing LAT promoter/ CAT fusion sequences.
The strategy involved deleting a proportion of the 
LAT sequences from HSV-1 BamRI b and e of the virus genome 
by co-transfection of LAT-deleted BamHI b DNA with 1802 DNA 
and screening progeny plaques for virus harbouring 
deletions in both copies of the LAT gene. The sequence 
deleted from BamRI b was a 2466bp region spanning from the 
Dral site (HSV-1 sequence position 118002; also the 5' 
terminus of the LATO and LAT60 clones) to a Hpal site (HSV- 
1 sequence position 120468) 370bp downstream of the 3' end 
of the IE-gene 1 mRNA, thereby deleting all of the 
endogenous HSV-1 sequences under examination for LAT 
promoter activity. Figure 24 presents a diagrammatic 
representation of the deletion from the HSV-1 genome and 
summarises the construction of the LAT-deleted BamHI b 
plasmid.
3E.2. Construction of pBdelLAT
As BamRI b contains three additional Hpal sites, a 
straightforward Dral/Hpal digestion and religation was not 
feasible. Instead, BamRI b in pAT153 was excised from pGX48 
as a BamRI fragment and ligated into the BamRI site of the 
pUC19 polylinker whose additional restriction sites made 
further manipulations easier to perform. The chosen
Figure 24. Construction of LAT-deleted BamHI b. The top
line depicts the HSV-1 genome. The location of BamHI b is 
shown and expanded on the line below. The U l region is 
shown as a single line and IRl as a box. The relative 
positions of the 2kb LAT and IE-1 mRNA are shown above the 
box. The shaded region within R l represents the Dral/Hpal 
region to be deleted. A partial restriction map of BamHI b 
is shown on the next line below. BamHI b was excised from 
plasmid pGX48 as a BamHI fragment and ligated into the the 
BamRI site of pUC19 in the orientation indicated. As shown 
in the lower right hand side of the Figure, this plasmid 
(pBamB) was PstI digested and ligated, thus removing 
sequences between the PstI site in the pUC19 
polylinker and proximal PstI in BamHI b, thereby generating 
plasmid pBdelPst. This plasmid was digested with Hindlll 
and Hpal, thereby removing the sequences between the 
Hindlll sites in the pUC19 polylinker and 3 1 Hpal site in 
BamHI b. This vector was mixed and ligated with a 
Dral/Bindlll fragment purified from pBamB (see lower left 
hand side of the Figure) to generate plasmid pBdelLAT. A 
partial restriction enzyme map of pBdelLAT is shown on the 
bottom line.
aBamHI b
IE-1 mRNA T V y
LAT
PstI PstI
Sail Hpal Hpal Dral Hpal Hpal Sail
 H in d lll SphI PstI S a il X b a l B am H I Sm al K pnl S stl E c o R I  pU C 19 polyllnker
Pu rify  D ra l/H in d lll fragm ent PstI digest &  rellgate
Sail
 I_
Hpal Hpal (Dral) PstI Hpal Hpal Sail
B del Pst
H p a l/H in d lll digest
(Hpal) Sail
M ix &  Ligate
B del LAT
Sail
I
Hpal
 I_
(Dral)
Hpal (Hpal) Sail
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Figure 25. Restriction enzyme analysis of LAT-deleted BamHI 
b plasmids. Plasmids pBamB, pBdel Pst and pBdelLAT were 
digested with Sail and run on a 1% agarose gel along with 1 
kb size markers (lane 4). Plasmid pBdelPst (lane 2) has a 
single Sail site, and as expected, runs as a single band of 
7198 bp. The parental plasmid pBamB (lane 1) which has the 
complete BamHI b sequence runs as 3 bands of 6283, 5248 and 
1196 bp. The LAT-deleted pBdelLAT (lane 3) has a 2466 bp 
deletion from the 6283 bp fragment thus giving rise to a 
3817 bp band on the gel.
1 2  3  4
7198
6283
5248
3817
, 7.127
6.108
5.090
4.027
+ —  3.054
2.030
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1.018
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orientation of BamHI b in pUC19 is shown in Figure 24. This 
plasmid (pBamHIb) was digested with PstI and religated, 
thereby deleting all sequences between the PstI site in the 
pUC19 polylinker and the distal PstI site in BamHI b. The 
resulting plasmid, (pBdelPst), was digested with Bindlll 
and Hpal, then ligated with the purified Bindlll/Dral 
fragment from pBamHIb to generate pBdelLAT. Diagnostic 
restriction enzyme digests of pBamB, pBdelPst and pBdelLAT 
are shown on Figure 25.
3E.3. Construction of the LAT-Deleted HSV-1 Vector
0 . 5|Jig of plasmid pBdelLAT (digested with BamHI) was 
co-transfected with 0. 5p.g of HSV-1 1802 DNA onto eight 50mm 
plates of BHK monolayers. A total of 96 progeny plaques (12 
from each plate) were picked, and a quarter of each pooled 
into 16 groups of 6. Each group was then used to infect 
50mm dishes from which DNA was prepared and analysed for 
recombinant plaques.
Ball digested viral DNA was analysed by Southern 
blotting and probing with the nick-translated 6283bp Sal I 
fragment isolated and purified from BamHI b. The genomic 
location of the probe used for screening the desired 
recombinant is illustrated on Figure 26. The parental 1802 
virus yields 2 bands of 8768 and 6385 bp (one from each 
repeat unit; see Figure 24), while virus with the 2466bp 
deletions from BamHI e and BamHI b gives rise to Sail 
fragments of 6302 and 3919 bp respectively. The upper bands 
on the Southern blot will appear fainter due to the 
relatively short area of homology between the BamHI b- 
derived probe and the homologous region between the Sal 
site and terminus of TRl in BamHI e.
Using this diagnostic test, four groups of plaques, 
nos. 1(7-12), 5(1-6), 7(7-12) and 8(1-6) were positive
(Figure 26). The original plaques from each group were then 
further tested, and from these, five plaques were positive 
(1/9, 5/3, 5/5, 7/11 and 8/5; see Figure 27). These plaques
136
were titrated out, and a further five progeny plaques 
picked, termed 1/9(A to E) etc. As indicated on Figure 28, 
all 1/9 plaques, 5/5A, 5/5D and 8/5C look as if they
carried the deletion. Examination of the 1/9 genome by 32P 
DNA labelling revealed that 1/9 had gained an extra Xbal 
site. A further 10 plaques from 8/5C were therefore picked 
and DNA made from 35mm plates. Nos. 5, 6, 7 and 9 (Figure 
29) all carried the deletion and had been purified to 
homogeneity. One of these was chosen and designated 1804. 
This LAT" virus was used for all subsequent analysis of the 
LAT promoter constructs.
3F. Analysis of the LAT Promoter in the 1804 Vector 
3F.1. Introduction
In the following series of experiments, it was 
decided to characterise the LAT constructs centred around 
the LAT promoter as defined by the transfection 
experiments. To this end, the Xbal fragments from plasmids 
pLATlCAT, pLAT4CAT, pLAT8CAT, pLAT6CAT and pLAT60CAT were 
isolated, purified and introduced into the 1804 vector as 
described in section 3D.3. All of these 1804-derived 
viruses were designated with the prefix "v", such that, for 
example, the virus derived from pLATlCAT is designated 
vLATlCAT. These viruses were subsequently used for further 
characterisation of the LAT promoter during lytic infection 
of BHK and C1300 neuroblastoma cell lines.
3F.2. Analysis of Viral Genomes
Total DNA was prepared from BHK monolayers prepared 
with each purified virus and analysed by restriction enzyme 
digestion with Hindi II/XbaI, running on a 1% agarose gel 
alongside the corresponding Hindlll/Xbal digested LATCAT 
plasmids, followed by Southern transfer to nitrocellulose 
filters and probing with the nick translated Xbal/Hindlll 
LAT promoter fragment derived from pLATlCAT (Section 
3C.2.1). Figure 30 shows that all LATCAT viral DNAs yield
Figure 26. Screening for LAT-deleted virus. A schematic
representation of the long region of the HSV-1 genome, 
together with specified restriction enzyme sites, are shown 
on the top line. The shaded areas in TRl and IRl represent 
the Dral/Hpal regions to be deleted. The region to be 
deleted from TRl lies in BamHI e, and that from IRl from 
BamHI jb. Recombinant virus genomes were screened by Sail 
digestion and probing with a Sail probe derived from BamHI 
b. The parental 1802 virus should give rise to Sail 
fragments of 8768 and 6385 bp, while viruses carrying 2466 
bp deletions from both BamHI b and BamHI e should give rise 
to Sail fragments of 6302 and 3919 bp. Since the 6385 and 
6302 bp fragments co-migrate with each other on the gels, 
recombinant viruses were initially screened for the
presence of the 3919 bp band.
The blots below show the screening of the original 
96 picked plaques (12 from each of the original plates 
transfected). Fractions of each group of twelve were pooled 
into 2 groups of 6. 'A' represents pooled plaques nos. 1 to
6, and 'Bf, nos. 7 to 12. This gave a total of 16 pooled
groups. The digests of viral DNA were compared with
similar digests of pBamB (in the lane marked BamB) and 
pBdelLAT (in the lane marked Bdel). The sizes of the
various bands are given on the right hand side of each 
blot. The 6302 and 6385 bp bands are indistinguishable on 
these blots. The band marked 'vector' is the pUC19 backbone 
of the plasmid from which the probe was excised before
radioactive-labelling. This band shows up on this blot due
to contamination with vector sequences during purification 
of the probe.
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Hpal SailBamHI Dral Dral BamHI
BamHI Sail BamHI Sail
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Figure 27. Screening of original picked plaques. The
original plaques from each pooled group which appeared to 
harbour the appropriate deletions (Figure 26) were further 
tested, and compared with Sail digests of plasmids pBamB 
(lane BamB), and pBdelLAT (lane Bdel). The sizes of the 
various bands are given on the right hand side of each 
blot. This analysis indicated that five plaques (1/9, 5/3, 
5/5, 7/11, and 8/5) were positive.
B a m B  Bdel 7
8768
6385
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vector
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Figure 28. Sreening of second round of picked plaques. The
positive plaques from the first round of plaque-picking 
(Figure 27) were titrated out, and a further five progeny 
plaques (termed A to E) picked. These were again compared 
to similar digests of pBamB (lane BamB) and pBdelLAT (lane 
Bdel) . The sizes of the relevant bands are again given 
beside each blot. This analysis demonstrated that all 1/9 
plaques, 5/5A, 5/5D and 8/5C were positive.
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6385
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3919'
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Figure 29. Titration of 8/5C. 8/5C (Figure 28) was
titrated, and a further 10 plaques (designated 1 to 10) 
picked and tested. These were again compared to similar 
digests of pBamB (lane BamB) and pBdelLAT (lane Bdel). The 
sizes of the relevant bands are again given beside the 
blot. This analysis demonstrated that nos. 5, 6, 7 and 9
were pure.
8/5C
BamB Bdel 1 2 3 4 5 6  7 8 9  10
8768 
6385 
• 6302'
Figure 30. Southern blot analysis of DNA prepared from 
1804-derived virus infected cells. Viral DNA was prepared 
from infected cells when extensive cpe became apparent. 
Each viral and corresponding plasmid DNA was digested with 
Xbal and Hindlll and subjected to Southern blot analysis 
using a nick translated Sail /EcoRl LAT promoter probe 
(containing all of the LAT promoter sequences) derived from 
pLATl (see Section 3C.2.1).
Gay\l Go A
Track 1 vLATlCAT infected cell DNA
Track 2 pLATlCAT
Track 3 vLAT4CAT infected cell DNA
iLflTrack 4 pLAT4CAT
Track 5 vLAT6CAT infected cel 1 DNA
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Track 6 pLAT6CAT
Track 7 VLAT8CAT infected cell DNA
5 UTrack 8 pLAT8CAT
Track
Track
9
1(
vLAT60CAT 
): pLAT60CAT
infected cell DNA
k K
The positions of the LAT promoter fragments from each 
recombinant virus are indicated (from PI to P60). Note that 
the lack of extensive hybridization at the top of each 
viral DNA track (compared with Figure 23) is further 
confirmation that the 1804-derived viruses are deleted for 
the endogenous LAT sequences.
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LAT promoter fragments of similar size to those from their 
corresponding plasmids. The LAT promoter probe also, as 
expected, fails to detect any of the endogenous LAT 
sequences which have been deleted from the 1804 vector.
3F.3. CAT Expression from Recombinant Viruses
3.1. BHK Cells. The levels of CAT activity produced by the 
LATCAT viruses and controls vFJ5, vFJ7 and vFJIO were 
determined at 6, 12, 24 and 48 hours post infection at a
moi of 5 at 37°C. A typical set of data is shown of Figure 
31. As in section 3D.4, for sake of clarity, the data is 
again presented as a whole on a logarithmic plot (Figure 
31(a)) while the data from the LATCAT viruses alone are 
presented on a linear plot (Figure 31(b)).
Figure 31(a) shows that the CAT activities 
exhibited by the lytic cycle promoters in vFJ7 and vFJIO 
are at least a log greater than that exhibited by the 
strongest of the LATCAT viruses (vLAT6CAT). This, as with 
the 1802 vector results, parallels those obtained with the 
corresponding plasmids in the transfection experiments. 
This pattern is maintained when examining the relative CAT 
activities of the LATCAT viruses. Figure 31(b) shows that 
vLAT4CAT exhibits increased levels of activity over 
vLATlCAT, and that this activity is increased as the 
distance between the LAT promoter and CAT reporter gene is 
reduced in the LATCAT fusions as observed with vLAT8CAT and 
vLAT6CAT. vLAT60CAT exhibits slightly less activity than 
vLAT6CAT, thereby confirming the transfection results 
(Table 6) , demonstrating that sequences upstream of the 
LAT6 clone are not necessary for LAT promoter activity in 
BHK cells.
In conclusion, these results demonstrate that the 
LAT promoter constructs behave in a similar manner in the 
context of the HSV-1 genome as they do in the transfection 
assays, and that the sequences sufficient and necessary for 
LAT promoter expression during lytic infection of tissue
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culture cells lie within the 277bp Hinfl/Pvul LAT6 
sequence.
3.2. C1300 Cells. Since the LAT gene is the only HSV-1 gene 
active during latency in neuronal cells, it was considered 
interesting to determine the behaviour of the LATCAT 
viruses in neuronally-derived cell lines. Short term 
expression assays in neuronal cells have proven difficult 
in the past due to their low susceptibility to standard 
transfection procedures. In this respect, the 1802/1804 
vectors provide ideal vehicles for introducing 
promoter/reporter gene fusions into neuronal cells for such 
assays. Unfortunately, the amount of material available 
from primary cultures of sensory neurons were insufficient 
for such experiments. In this study, the C1300 mouse 
neuroblastoma cell line (Augest-Tocco & Sato, 1969) has
therefore been employed. This cell line has been reported 
to be non-permissive for lytic infection with HSV (Vahlne & 
Lycke, 1977, 1978), an effect mediated by failure at the
level of viral immediate-early gene transcription (Kemp & 
Latchman, 1989; Kemp et al., 1990).
As in the BHK cells above, the levels of CAT
activity produced by the LATCAT viruses together with vFJ5, 
vFJ7 and vFJIO were determined at 6, 12, 24 and 48 hours
post infection with a moi of 5 at 37°C. A typical set of
data is shown on Figure 32, which again, for sake of
clarity, is presented on both logarithmic and linear plots. 
Figure 32(a) shows that the HSV lytic cycle promoters 
maintain their 1-3 log superiority over the LATCAT 
constructs, and that this activity is similar to that 
exhibited in BHK cells (although direct comparison of 
promoter activity in different cell lines is difficult).
This activity displayed by the lytic cycle promoters, and
the IE-4/5 promoter in particular, is intriguing since at 
up to 6 hours pi, Kemp & Latchman, (1989) could detect
virtually no IE mRNA in HSV-1 infected C1300 cells. The IE-
Figure 31. CAT activities produced by recombinant 1804- 
derived LAT promoter/CAT fusion viruses at various times 
after infection of BHK cells, a) CAT activities generated 
by vFJ5, vFJ7, vFJIO, vLATlCAT, vLAT4CAT, vLAT6CAT, 
vLAT8CAT and vLAT60CAT shown on a logarithmic scale, b) CAT 
activities generated by the LAT promoter viruses alone, 
shown on a linear scale. CAT activities were determined at 
6, 12, 24 and 48 h post infection and expressed as the
percentage [14C]chloramphenicol converted per h per pg 
protein. The symbols representing each virus are indicated 
in the legends beside each graph.
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Figure 32. CAT activities produced by recombinant 1804- 
derived LAT promoter viruses at various times after 
infection of neuroblastoma C1300 cells, a) CAT activities 
generated by vFJ5, vFJ7, vFJIO, vLATlCAT, vLAT4CAT, 
vLAT6CAT, vLAT8CAT and vLAT60CAT shown on a logarithmic 
scale, b) CAT activities generated by the LAT promoter 
viruses alone, shown on a linear scale. CAT activities were 
determined at 6, 12, 24 and 48 h post infection and
expressed as the percentage [14C]chloramphenicol converted 
per h per pg protein. The symbols representing each virus 
are indicate in the legends beside each graph.
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4/5 promoter activity observed here could be explained as a 
result of a higher moi overcoming the non-permissivity of 
C1300 cells. Indeed, Kemp & Latchman (1989) demonstrated 
that increasing the amounts of virus and the incubation 
time, led to a majority of cells staining with anti-Vmwl75 
antibody by 48h pi.
The pattern of CAT activity exhibited by the LATCAT 
viruses (Figure 32(b)), shows a strikingly different 
pattern to that observed in BHK cells. While the relative 
activities displayed by vLATlCAT, vLAT4CAT, vLAT8CAT and 
vLAT6CAT are essentially similar to those in BHK cells, the 
activity exhibited by vLAT60CAT is at least 3 times greater 
than vLAT6CAT. This contrasts with the results from BHK 
cells, and demonstrates that sequences upstream of the LAT6 
clone (perhaps those in conserved loci 1 and 2), while not 
contributing to LAT promoter activity in BHK cells, enhance 
LAT promoter activity in neuroblastoma cells, and may 
therefore contain elements which contribute to neuronal 
specific expression of the LAT gene.
3G. DISCUSSION
3G.1. Identification of the LAT Promoter
A prerequisite to understanding the seemingly 
complex nature of LAT gene expression is the mapping of the 
basic promoter elements necessary for LAT promoter 
function. To this end, this study has employed a 
combination of in vitro and in vivo expression assays based 
on sequence analysis to define upstream regions of the LAT 
gene capable of functioning as a promoter when fused to the 
CAT reporter gene.
Sequence analysis has demonstrated that, in 
agreement with other investigations, (Wechsler et al. , 
1988, 1989) the first identifiable RNA polymerase II
promoter elements comprising TATA and CAAT box homologies
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and two potential Spl binding sites occur approximately 
700bp upstream of the mapped 5 1 end of LAT. These putative 
promoter elements occur in regions of HSV-l/HSV-2 homology, 
while the region immediately upstream, and indeed, 
downstream of the 5' end of LAT shows no appreciable 
homology whatsoever (Figures 6 and 7). The HSV-l/HSV-2 
homologies comprise 9 regions of conserved loci, mostly 
centred around and upstream of the putative promoter 
elements, while only 3 loci are located downstream of the 
TATA box. Of the known promoter elements themselves, only 
the TATA box is perfectly conserved in the HSV-2 sequence 
(Figure 7).
Results from the short term transfection assays 
(section 3C) concur with an accumulating body of evidence 
(Javier et al. , 1988; Dobson et al. , 1989; Steiner et al. , 
1989; Batchelor & O'Hare, 1990; Zwaagstra et al., 1990, 
1991; Devi-Rao et al., 1991) that the determinants of LAT 
gene expression are indeed located around the putative RNA 
pol II promoter region. Data from the transfection assays 
(Tables 3 to 6) demonstrate that the main determinants of 
in vitro promoter activity map to a 279 bp region between 
-940 and -661 (the LAT6 clone) containing all of the 
putative promoter elements, thereby agreeing with Zwaagstra 
et al. (1989) who independently used the same construct in 
Vero cells. The transfection assays with pLATlCAT, pLAT2CAT 
and pLAT3CAT (Table 3) demonstrate that deletion from the 
Hinfl site of the LAT1 clone (-940 to +151) to the PstI 
site at -798 (LAT2) , thereby removing the CAAT and Spl 
homologies, reduces promoter activity 7-fold. Promoter 
activity is virtually abolished on further deletion to -595 
(LAT3) which removes the TATA box. This, together with the 
LAT6 (-940 to -661; Table 4) result which maps the right 
hand site of the LAT promoter demonstrates that the 
determinants of core promoter activity map to the 137bp 
region flanked between the PstI site at -798 and Pvul site 
at -661.
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In their study, Batchelor & O'Hare, (1990), using a 
similar strategy in Hela cells, mapped the main 
determinants of LAT promoter activity to the 140bp region 
between the PstI site at -798 and Pvul site at -659, (their 
clone being constructed differently to LAT6), and showed 
that this activity increased only marginally (2-fold) on 
addition of sequences upstream to a NaeI site at -980. They 
also observed that the NaeI fragment spanning -251 to +201, 
similar to the LAT5 clone, and in agreement with the 
results in Table 3, exhibited negligible constitutive 
promoter activity. Devi-Rao et al. (1991), also employing a 
similar strategy, but in rabbit skin cells, noted that a 
352bp Eagl fragment (-1022 to -670; roughly equivalent to 
LAT6) exhibited a 5-fold higher activity than a _1063bp 
Eagl/Pssl fragment (-1022 to +41; roughly equivalent to 
LAT1). Similarly, pLAT6CAT exhibited a 9 to 11-fold higher 
activity than pLATlCAT in BHK cells (Tables 3 and 6) . They 
also demonstrated that a 636bp Pstl/Pssl fragment (-595 to 
+41; similar to LAT3) exhibited negligible activity in the 
neuronal derived cell line Neuro2A.
While the results of Table 6 show that an 
additional 519bp upstream from the Hinfl site at -940 
(LAT60; -1459 to -661) marginally increases LAT promoter 
activity (by 50%), Zwaagstra et al., 1990) showed that 
clones with an additional 331bp (-1271 to -662) and 1652bp 
(-2592) fused to their version of LAT6 reduced promoter 
activity by 3-fold in BHK cells and mouse L-cells and 6-12 
fold in Vero and CV-1 cells. Batchelor & O'Hare, (1990) 
however, found that upstream sequences extending back to 
-1267 from the Nael site at -979, effected a minor decrease 
in activity. These results, as a whole, indicate that 
sequences upstream from the Hinfl site at -940 can exert 
only a minor influence (depending on laboratory and cell 
line), upon LAT promoter activity in non-neuronal derived 
cell lines.
In terms of promoter strength, the constitutive
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activity displayed by the LAT6 promoter was approximately 
2.3 times that of the HSV-1 gD promoter, though 5 times 
weaker than the HSV-2 IE-4/5 promoter. Batchelor & O'Hare, 
(1990) , showed that their Pvul (-1267 to -650) fragment 
promoter was at least as strong as the SV40 
enhancer/promoter and HSV-1 IE-1 and IE-3 promoters, while 
Devi-Rao et a l . (1991) showed that their equivalent of LAT6 
(the isagrl -1022 to -671 fragment) was 10-fold stronger than 
the HSV-1 dUTPase (Ul50) promoter.
While the evidence described above demonstrates 
that the putative promoter region is functional during in 
vitro expression assays, the most compelling evidence that 
this region comprises the bona fide LAT promoter comes from 
in vivo studies with recombinant viruses. Dobson et al. 
(1989) showed that a B-globin gene, when inserted 19bp 
downstream of the TATA homology at position -670, 
selectively expressed B-globin mRNA in latently infected 
sensory neurons. They also showed that a second recombinant 
virus deleted for the 203bp PstI region (and therefore the 
TATA box), abolished any apparent LAT gene expression. 
Steiner et al. (1989) showed that HSV-1 variant 1704 which 
is deleted for one complete copy of the LAT gene- 
promoter and 5' portion of the other copy (-2559 to +564 
and -1235 to -293 respectively) also failed to express 
detectable levels of LAT during latency in the mouse. 
Similarly, Javier et al. (1988) with HSV-1 variant X10-13 
which harbours a deletion of the LAT promoter (31 terminus 
between -263 and -225) is also unable to express the LAT 
gene. All current evidence therefore demonstrates that the 
bona fide LAT promoter is located in this upstream location 
rather than adjacent to the mapped 5' end of LAT.
The finding that the LAT promoter was located in 
this upstream location relative to the mapped 5' end of the 
2kb LAT suggested that the LAT transcription pattern was 
more extensive than previously thought. While earlier 
mapping studies of the LAT transcript had scored the region
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between the TATA box and 5' end of LAT as negative, it 
became increasingly apparent that the presence of very 
faint in situ signals (Wechsler et al., 1988b) were 
indicative of an unstable or low abundance transcript in 
this region. Subsequent work (Dobson et al., 1989; Mitchell 
et al., 1990a; Zwaagstra et al., 1990), demonstrated that 
these additional weak hybridisation signals corresponded to 
a poly(A)+ 8.3kb transcript (m-LAT) extending from the
vicinity of the TATA box to a polyadenylation site 
immediately downstream from the 3 ’ end of the IE-3 gene. 
The 5 1 end of m-LAT was mapped by primer extension 
(Zwaagstra et al. , 1990) to approximately 28bp downstream
of the first T of the TATA box at position -659 
(...CGATCGCG...). Devi-Rao et al. (1991) when performing 
RNase protection analysis of poly(A)+ RNA from HSV-1 
infected cells mapped the 5* end of m-LAT to approximately 
position -657 (...CGATCGCG...). They also showed that the 2 
kb LAT is uncapped and maps between 5 1 splice donor and 3 ’ 
splice acceptor 1950 bp apart, and this, together with the 
results of Farrell et al. (1991) who showed that the 2 kb 
LAT can be spliced out of a fi-gal/LAT fusion, confirmed 
earlier suspicions that the poly(A)- LAT is a stable intron 
derived from the splicing of a large primary transcript. 
The presence of a spliced polyadenylated product of this 
splicing reaction, ie 6.3kb, has however, yet to be 
demonstrated.
Comparison of the HSV-1 and HSV-2 LAT sequence 
(Figures 6 and 7), fails to demonstrate any homology 
indicative of the presence of conserved reading frames. 
This view is engendered by the lack of any ATG codons in 
the HSV-2 m-LAT sequence between the TATA box and 
corresponding 5 1 end of the 2 kb LAT (the HSV-1 sequence 
has 3 ATG's). While it seems that the LATs, as a whole, do 
not code for any proteins, it is almost certain that they 
must possess some subtle, although perhaps critical role in 
the pathogenesis of natural latent infections. While the
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characterisation of any processed forms of the primary 
poly(A)+ LAT (possibly by the cloning of associated cDNAs) 
will be of interest per se, it seems that any search for an 
associated LAT polypeptide will not prove fruitful.
The observation in section 3C.4 that deletion of 
sequences downstream of the primary LAT RNA cap site can 
affect CAT activity was particularly intriguing. While the 
90 bp deletion (-341 to -251) in plasmid pfilCAT (Figures 9 
and 17) which removes conserved locus 8 had no apparent 
effect on CAT activity, the activity exhibited by plasmids 
P&2CAT, p&3CAT and pLAT4/5CAT significantly greater
than that exhibited by pLATlCAT. Since the effect generated 
by these deletions Woo generally similar, it was 
interesting to note that the only similarity in the 
respective deletions is a 54bp sequence between the Smal 
site at -395 and Nael site at -341, a region encompassing 
conserved locus 7. If conserved locus 7, and indeed, 8 and 
9 are involved in LAT gene regulation, their location 
approximately 300 bp downstream of the m-LAT cap site makes 
it difficult to envisage how they could directly influence 
events occurring at the LAT promoter. It is possible that 
their influence on CAT activity is exerted at the 
translational level or in mRNA stability or processing, 
however, it is difficult to envisage how this relates to in 
vivo LAT expression since it appears that LATs may not code 
for any polypeptides. Indeed, the observation by Devi-Rao 
et al. (1991), that a virus (8117) with an 897 bp deletion 
360 bp downstream from the primary transcript cap site 
which does not express the 2 kb LAT, but still expresses 
mLATs, indicates that sequences downstream from the cap 
site have no critical role to play in LAT gene expression. 
The level at which these deletions exert their influence 
could be differentiated by performing primer extension, 
Northern or SI assays to measure the in vitro level of 
transcription and comparing them with CAT activity. Another 
possibility is, of course, that the apparent increase in
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CAT activity is generated by artefactual means. Inspection 
of the LAT1 sequence reveals that it contains 3 ATG codons 
(at -442, -279 and -173; one in each frame), and that the 
reading frames specified by each are terminated by stop 
codons within the LAT1 sequence (at -276, +69 and +7
respectively). It is a distinct possibility that these 
reading frames interfere with translation of the CAT 
reading frame, and that the removal of ATGs in plasmids
P&2CAT, pA3CAT and pLAT4/5CAT could relieve this 
interference, thereby allowing increased translation of the 
CAT reading frame and therefore giving rise to increased 
levels of CAT activity. This possibility could be examined 
by removal of the ATG's from the LAT1 sequence by site
directed mutagenesis, or alternatively, by generating 
similar constructs from the corresponding HSV-2 sequence
which lacks ATG codons.
The existence of these conserved loci in the 
primary LAT transcript which is otherwise devoid of HSV- 
l/HSV-2 homology, seems indicative that, like those 
upstream around the LAT promoter, they are of functional 
significance. It will be interesting to see if future 
studies prove this to be the case.
3G.2. Regulation of the LAT Promoter
To assess LAT promoter response to HSV-1 regulatory 
proteins, BHK cells transfected with the LATCAT plasmids 
were infected with virus. The gD and IE-4/5 promoters 
exhibited a characteristic induction (160-fold and 10-fold 
respectively) expected as their response to regulation in 
trans by virus encoded factors. The LATCAT plasmids 
exhibited a generally low, but positive response to virus 
infection. The infected cell CAT activities exhibited by 
pLATlCAT, pLAT2CAT, and pLAT3CAT (Table 3), confirm that 
the reporter elements responsible for promoter activity in 
the LAT1 clone are upstream of the Pstl site at -595; while 
the level of induction of pLAT2CAT and pLAT3CAT were
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relatively high (11 and 16-fold respectively), the levels 
of CAT activity attained by these plasmids were still very 
low (approximately 2.5 and 10-fold less than that exhibited 
by pLATlCAT respectively). Of the clones centred around the 
LAT promoter region itself, (pLAT4CAT, pLAT6CAT, and 
pLAT8CAT), pLAT6CAT exhibited the greatest response (9.2 to 
11.8-fold; Tables 4 and 6), compared with 3.14-fold for 
pLAT4CAT and 4.7-fold for pLAT8CAT. The increase in 
response between the LAT4, the LAT8 and the LAT6 clones 
could be the result of a distance effect such that as the 
distance between the reporter gene and the promoter 
elements decreases, the level of response to infection 
increases. Also, since the level of LAT6 induction is twice 
that of LAT8 induction, it is possible that the difference 
in response to HSV-1 infection between these clones is due 
to the presence of a negative regulatory element, the 
putative Vmwl75 binding site perhaps, (section 3C.6; see 
below) which confers a negative regulatory effect on LAT 
promoter activity during the HSV-1 lytic cycle. The 
observation that the addition of upstream sequences to the 
LAT6 clone (in LAT60) does not lead to any significant 
change in response to HSV-1 infection confirms that the
sequences elements responsible for LAT promoter induction 
are confined to the LAT6 clone.
The most intriguing results of the infected 
transfection assays are those obtained with clones 
(pLAT5CAT, pLAT7CAT, and pLAT4/5CAT) containing sequences 
between +151 and +201 of the LAT sequence. The LAT5 clone 
(-251 to -201) which exhibited negligible constitutive CAT 
activity, displayed a relatively high response to viral
infection (112.5-fold; Table 3). A similar kind of
response, though not quite as high, was observed with the
LAT7 and LAT4/5 clones (Tables 4 and 5 respectively). 
Indeed, the superinfected CAT activity exhibited by 
pLAT4/5CAT was the highest observed for any of the LATCAT 
plasmids. These observations suggest that the 150bp region
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between +151 and +201 of the LAT sequence harbours an 
regulatory that exerts an influence on LAT promoter 
activity during the HSV-1 lytic cycle. Examination of this 
region of the LAT sequence, however, fails to reveal any 
obvious relationship with known sequence motifs, and 
indeed, this particular region is not highly conserved 
between the HSV-1 and HSV-2 sequences.
While Devi-Rao et al. (1991), found that their LAT 
promoter clones behave in a similar fashion to those 
described here, with the LAT6 equivalent (the -1022 to -671 
Eagrl fragment), being stimulated 3.5-fold, Batchelor & 
O'Hare (1990) showed that promoter activity exhibited by 
their LAT clones (the -1267 to -658 Pvul fragment and -797 
to -595 Pstl fragment) after infection was 4-5 fold lower 
than observed in mock-infected cells. These conflicting 
results are perhaps a consequence of cell-specific effects; 
Batchelor & O'Hare (1990), used Hela cells for their 
assays, while Devi-Rao et al. (1991) used rabbit skin 
celIs.
To examine regulation of the LAT promoter by 
individual HSV-1 regulatory proteins, plasmids pLAT6CAT, 
pLAT8CAT and pgDCAT were co-transfected with plasmids pill 
and pl75, specifying VmwllO and Vmwl75 respectively, both 
alone and in combination. While the control pgDCAT plasmid 
exhibited a characteristically positive response when co­
transfected with either pill or pl75 and synergistic 
response when co-transfected with both plasmids, pLAT6CAT, 
by contrast, exhibited a weak response. PLAT6CAT was 
stimulated 1.7-fold with pill and 2.2-fold with pl75, in 
agreement with Zwaagstra et al. (1989), who performed 
similar experiments on an identical clone in Vero cells. In 
addition, both Zwaagstra et al. (1989) and Batchelor & 
O'Hare (1991) showed that despite the presence of a 
sequence bearing similarity to the Vmw65-response TAATGARAT 
consensus element, their LAT promoter constructs exhibited 
no significant increase in activity when co-transfected
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with a Vmw65-expressing plasmid.
Most significantly, however, was the demonstration 
that the activity exhibited by the LAT8 clone was repressed 
by Vmwl75 ( \<\) . A dose response curve which titrated 
pLAT6CAT, pLAT8CAT and pIE-3CAT activity against increasing 
amounts of pl75 demonstrated that this repression is as 
efficient as Vmwl75-mediated autoregulation of the IE-3 
promoter, and that this effect must be mediated by
sequences between the 3' ends of the LAT6 and LAT8 clones. 
This finding is in complete agreement with Batchelor &
O'Hare (1990) who showed that the level of LAT promoter
repression was even greater than that observed due to the 
autoregulatory effect of Vmwl75 on it s own expression. LAT 
repression by Vmwl75 is most likely mediated through a
possible Vmwl75 binding homology located around the Pvul 
site at -661. The LAT6 clone is truncated for this
homology, with it s 3' end immediately adjacent to this 
motif, thus explaining why pLAT6CAT, like the identical 
clone of Zwaagstra et al. (1989) is actually induced, 
albeit weakly, by Vmwl75. Batchelor & O'Hare (1990) found 
that their Pvul clone (-1267 to -658) was repressed by
Vmwl75, however, the central AT of the Pvul site in their
clone was retained, and when fused to their vector
sequences, reformed a Vmwl75 binding homology. The final
proof that Vmwl75 does interact with this ATCGTC homology 
in the LAT sequence will come from gel retardation
experiments, however, it is interesting to note that, like 
the IE-gene Vmwl75 binding sites, the putative binding site 
in the LAT gene is located at the mapped cap site of the
primary LAT transcript (Zwaagstra et al., 1990; Devi-Rao et
al., 1991).
Data from the transfection assays demonstrated that 
the LAT8 promoter clone is induced 4.7-fold following 
infection with virus (Table 4). In addition, when 
introduced into the virus vector genome, CAT activity 
exhibited by vLAT8CAT steadily rose during infection of
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both BHK and C1300 neuroblastoma cells. While it has been 
shown that Vmwl75 can repress the IE-1, 3 and 4/5 promoters 
(Gelman & Silverstein, 1987a, b; Paterson & Everett, 1988a, 
b; Resnick et al., 1989), and now the LAT promoter 
(Batchelor & O'Hare, 1990; this study), during transfection 
assays, it has only ever been convincingly shown for the 
IE-3 promoter during virus infection (DeLuca & Schaffer,
1988). Indeed, Everett & Orr, (1991), demonstrated that a 
mutated Vmwl75 binding site in the IE-1 promoter which 
destroyed the ability of Vmwl75 to bind the site, and 
greatly reduced the ability of Vmwl75 to repress the IE-1 
promoter in transfection assays, had no effect on the level 
of VmwllO expression during normal HSV-1 infection. It 
seems that the direct repression of IE and LAT promoters by 
Vmwl75 is not a major feature of viral growth in tissue 
culture, though it may have an important role in some other 
aspect of the virus life cycle. Batchelor & O'Hare (1990), 
proposed that the Vmwl75-mediated repression of the LAT 
gene may be responsible for the apparent decrease in LAT 
expression observed during virus reactivation in 
explantation and cocultivation experiments (Spivack & 
Fraser, 1988b).
3G.3. Virus Vector Experiments
While transfection assays are clearly useful for 
mapping promoters, and providing an insight as to how they 
are regulated, a proper understanding of the LAT promoter 
can only come from it's characterisation in the context of 
the HSV-1 genome during lytic infection of tissue culture 
cells, and in animal latency systems. To this end, LAT 
promoter/reporter gene constructs were introduced into the 
1802 and 1804 HSV-1 vectors. The inherent advantage of this 
system over other virus-based studies (Javier et al., 1988; 
Dobson et al., 1989; Steiner et al. , 1989) is that it
allows the definitive characterisation of promoters by 
defining both the 5' and 3' ends of promoter fragments, and
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thereby the minimal promoter sequences capable of LAT 
promoter function.
The results of sections 3D. 4 and 3F.3 demonstrated 
that the LAT promoter clones behaved in the same manner 
relative to each other in the context of the virus genome 
during infection of tissue culture cells as they did during 
the infected transfection assays. This is an important 
validation of the findings from the transfection 
experiments which are prone to anomalous results due to the 
inconsistent nature of the short term transfection assay.
Perhaps the most significant result to come from 
the vector experiments was the differential activities of 
the LAT6 and LAT60 clones observed during lytic infection 
of BHK and C1300 neuroblastoma cells. While infection of 
BHK cells showed that, as observed from the infected 
transfection assays, CAT activity exhibited by vLAT60CAT is 
marginally less than that exhibited by vLAT6CAT 
vLAT60CAT activity in C1300 neuroblastoma cells is more 
than three times that exhibited by vLAT6CAT, thereby 
suggesting that sequences upstream of the Hinfl site at - 
940 may confer neuronal specificity to the LAT promoter. 
Batchelor & O'Hare (1990) showed that in transfection 
assays, their Pvul clone (-1267 to -658) was eight times 
stronger than a Pstl/Pvul clone (-797 to -658) in IMR-32 
neuroblastoma cells while being only twice as strong in 
Hela cells, thus concluding that the upstream -1267 to -797 
region is selective for promoter activity in neuroblastoma 
cells. Similarly, Zwaagstra et al. (1991), showed that 
sequences upstream of the Hinfl site could increase 
activity up to 3-fold in immortalised neurons and 
neuroblastoma cells. From examination of the LAT sequence, 
it would seem that the most likely location of the motifs 
responsible for selective expression in neuronal-derived 
cell lines is in conserved loci 1 or 2, however, this can 
only be verified by more precise studies.
Now that the LAT promoter has been clearly mapped,
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further characterisation of it is required to identify 
specific motifs and associated binding factors which, 
particularly in neuronal cells, could contribute to 
selective expression of the LAT gene during latency. A step 
in this direction has been taken by Zwaagstra et al. 
(1991), who, using DNA footprinting and gel retardation 
analysis to identify regulatory sequences in the -940 to - 
659 Hinfl/Pvul region, identified a LAT promoter binding 
factor (LPBF) which bound a region that includes the 
sequence CCACGTGG located at -731 to -724. Deletion of this 
sequence causes a significant reduction in promoter 
activity in all neuronal and non-neuronal cell lines, and 
it is therefore probably required for maximum constitutive 
activity of the LAT promoter. Interestingly, this LPBF 
sequence is one of those identified in section 3B.4 as 
having significant homology to a CCAGG motif found in a 
number of neuronal specific genes. The LPBF sequence, 
though is not well conserved in the HSV-2 ; (..CC-CGTG- 
. .) (see Figures 7 and 8). Gel shift assays with a probe 
containing the upstream homology located at -915 to -911 
did not identify any prominent bands, though some subtle 
differences were seen when comparing Hela and C1300 
extracts (Zwaagstra et al., 1991). Further analysis by Leib 
et al., (1991) has demonstrated the presence of a 
functional cAMP-response element at position -704 to -698 
(..TGCGTCA..), the mutation of which results in a complete 
loss of cAMP-mediated inducible stimulation, and a 4-fold 
reduction in basal activity.
The next stage in characterisation of the LAT 
promoter is to apply the 1804 vector system to animal 
latency systems. An ideal strategy for this is to replace 
the CAT reporter gene with the the l a d  gene, thus allowing 
the use of histochemical analysis to allow detection of 
promoter activity in individual cells in latently infected 
tissues. Due to lack of time, however, this aspect of the 
study of the LAT promoter was unable to be carried out,
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though this should ultimately allow a definitive mapping of 
the minimal 5' and 3 1 ends of the LAT promoter necessary 
for LAT gene expression in neuronal cells during latency.
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CHAPTER 4 
CHARACTERISATION OF THE HUMAN NEUROFILAMENT GENE (HNF-L) 
PROMOTER 
4A. Introduction
An intriguing question regarding HSV latency in the
neuron is whether or not the promoter of an endogenous
neuronal gene will function correctly in the context of the 
latent virus genome. To date, only the LAT and MMTV LTR 
(Dobson et al., 1990) promoters have been shown to be 
active in the HSV-1 genome during latency. To this end, a 
clone comprising the coding and 5 1 flanking sequences of 
the human neurofilament-light chain (HNF-L) gene was 
acquired (kindly supplied by K. Yazdanbakhsh).
Neurofilaments (NF's) are major cytoskeletal
elements of nerve cells and are believed to play an 
important role in the control of axon calibre and 
maintenance of cell shape (Morris & Lasek, 1982; Hoffman et 
al., 1984; reviewed by Julien & Grosveld, 1991). NF 
proteins have also been widely used as markers of nerve 
cells, with their neuronal specificity being confirmed by 
the use of cloned DNA probes in in situ analysis (Leisi et 
al., 1986; Zopf et al., 1987). NF's belong to the multigene 
family of intermediate filament (IF) proteins which 
consists of a number of ubiquitous and cell specific 
proteins including vimentin in cells of mesenchymal origin, 
desmin in muscle cells, glial fibrillary acid protein 
(GFAP) in glial cells and keratins in epithelial cells
(reviewed by Lazarides et al., 1982; Osborn & Weber, 1982). 
NF's are made by copolymerisation of three proteins with 
apparent molecular weights on SDS gels of 68,000 (NF-L), 
150,000 (NF-M) and 200,000 (NF-H) (Julien & Grosveld, 
1991) .
The 5' end of the HNF-L gene, like those of the 
other NF genes, contains a GC rich methylation free region
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suggesting that the promoter region may be accessible to 
transcription in all tissues, and that nerve cell specific 
expression of NF genes may be achieved, in part, by 
suppression in non-nerve cells (cited in Julien & Grosveld, 
1991). All three NF genes have a proximal TATA box 
resulting in a single transcription initiation site
approximately 30 bp downstream (Julien et al. , 1987a).
Other upstream elements which were identified by sequence 
analysis included a complementary CAAT box homology 
("GATCGATC") located 35 bp upstream of the TATA box, and a 
complementary Spl binding site consensus ("ACCCCGCCTT") 
located H O b p  upstream from the TATA box (Julien et al., 
1987b). The sequence of the HNF-L gene, published in Julien 
et al, (1987b), extends upstream to only -160bp from the
HNF-L gene cap site.
4B . Strategy
To characterise the promoter of the HNF-L gene, two 
5 ’ flanking sequences extending from an Xmalll site at +84 
to BamHl sites at -296 and -896 were purified and fused to 
the CAT gene in pFJ5. The Xbal fragments from these
plasmids were isolated and purified, and introduced into 
the genome of the virus vector. The plasmids and viruses 
were then used for characterisation of the HNF-L promoter 
in transfection assays, and during lytic infection of
tissue culture cells respectively. A diagrammatic
representation of the fragments used for characterisation 
of the HNF-L promoter can be seen on Figure 33.
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4C. CHARACTERISATION OF THE HNF-L PROMOTER IN TRANSFECTION 
ASSAYS
4C.1. Construction of HNF-L Promoter/CAT Plasmids 
p NFICAT Plasmid pNFlCAT contains a 380 bp fragment of HNF-L 
sequence extending from a Xmalll site at +84 to a BamHl 
site at -296. The Xmalll site in pHNF-L (see Figure 33) was
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converted to a Bglll site by Xmalll digestion, blunt-ending 
with T4 DNA polymerase and ligation of the Bglll linker 
5 1-CAGATCTG-3', thereby generating pHNF-L-Xmalll+Bglll. The 
BamRl/Bglll fragment from pHNF-L-Xmalll+Bglll was isolated 
and purified, then ligated into Bglll digested pFJ5 DNA. 
Clones with the appropriately orientated fragment were 
selected for by restriction enzyme digestion and designated 
pNFlCAT. Diagnostic restriction profiles of these plasmids 
are shown on Figure 34.
PNF2CAT Plasmid pNF2CAT contains a 980bp fragment of HNF-L 
sequence extending from the Xmalll site at +84 to the BamHl 
site at -896. Plasmid pHNF-L-Xmalll+Bglll was partially 
digested with BamRl. The linearised plasmid was further 
digested with Bglll and the appropriate BamHI/BglH 
fragment isolated and purified, then ligated into Bglll 
digested pFJ5. Clones with the appropriately orientated 
fragment were selected for by restriction enzyme digestion 
and designated pNF2CAT. Figure 34 indicates the presence of 
an Xbal site approximately 150 bp downstream from the 5' 
end of the NF2 sequence. This sequence from the 5' end of 
the NF2 clone will therefore be missing when the Xbal 
fragment is purified from pNF2CAT for ligation into the 
virus vector (section 4D.1).
4C.2. Transfection Assays
The promoter activity of the pNFCAT constructs were 
determined by quantitation of CAT activity in transfection 
assays. 3p.g of each plasmid was transfected into BHK 
monolayers, and after 24h, extracts were prepared and 
assayed for CAT activity. The results shown in columns 2 
and 3 of Table 8 compare the activity of the pNFCAT 
constructs to that of the HSV lytic promoters in pFJIO and 
pgDCAT. As in section 3C, the data has been normalised with 
respect to the CAT activity exhibited by pLATlCAT. The data 
for pLATlCAT is not shown, but the transfection assays for
Figure 33. Schematic representation of NF promoter 
fragments. The top line gives the scale of the Figure in 
bp. The second line shows the main features of the pHNF-L 
clone which was obtainied as an EcoRl fragment cloned into 
the EcoRI site of pUC18. The exons of the NF-L gene are 
shown as dark boxes, with the positions of the ATG and TGA 
initiation and termination codons indicated. The two 
fragments used for characterisation of the NF promoter are 
shown below. The NF1 fragment extends from -296 to +84 and 
the NF2 fragment from -896 to +84 relative to the cap site 
of the NF-L gene.
Table 8. Relative CAT activities exhibited by NF promoter 
plasmids. The CAT activities exhibited by the NF promoter 
plasmids together with plasmids pgDCAT and pFJIO were 
determined and calculated relative to the CAT activity 
exhibited by pLATlCAT which was given the nominal value of 
1 (data not shown) . The mean of at least four independent 
determinations is given (column 2) with the standard error 
of the mean (SEM) (column 3). Column 4 records the relative 
CAT activity exhibited upon infection of transfected cells 
with 5pfu/cell HSV-1 17+ for 18h, with the SEM given in 
column 5. The level of induction of CAT activity upon 
infection, relative to uninfected cell CAT activity is 
given in column 6.
EcoRI 
|_
Xmain ATG
TGA EcoRI
Exon I II III IV
NF-1
NF-2
P la s m id
Relative CAT Activity
In d u c tio n
Uninfected Std. Error (+/-) Infected
Std. Error 
(+/-)
pFJIO 55.91 10.9 582.37 89.59 10.4
pgDCAT 3.4 0.59 555.91 90.26 163.5
pNFlCAT 3.6 0.14 484.9 43.2 132.8
pNF2CAT 6.8 0.85 649.6 48.5 95.5
BamHI BamHI
Figure 34. Restriction digest demonstrating integrity of 
the NF promoter plasmids. Plasmids pNFlCAT (lane 1) and 
pNF2CAT (lane 2) were digested with Hin&III and Xbal and 
run on a 1% agarose gel along with 123 bp size markers 
(lane 3). The top two fragments of pNFlCAT and pNF2CAT 
represent vector sequences. The third and fourth fragments 
co-migrating in lanes 1 and 2 respectively Qact, the 797bp 
Hin&III fragment containing the CAT gene. The Hin&III/Xbal 
NF1 promoter fragment migrates the correct distance 
consistent with it s expected size. The NF2 promoter 
fragment, however, runs slightly smaller than expected. The 
presence of an additional band marked (X) in lane 2 
indicates the presence of an Xbal site approximately 150bp 
downstream from the 5' end of the NF2 clone.
2 46  bp
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the NF/CAT and LAT promoter/CAT fusion plasmids described 
in section 3C were all carried out at the same time.
The results demonstrate that both NFCAT clones 
perform well as promoters in this assay, exhibiting as 
least as much activity as pgDCAT. The activity exhibited by 
pNF2CAT is twice as much as pNFlCAT, thereby demonstrating 
that in BHK cells, sequences upstream of the BaniHI site at 
-296 of the NF sequence can contribute to NF promoter 
activity.
4C.3. Infection Studies
The effect on NF promoter activity of infecting 
cells transfected with the pNFCAT constructs was 
investigated. The results are shown in columns 4 and 5 of 
Table 8 together with the level of induction indicated in 
column 6. They show that the CAT activity exhibited by the 
pNFlCAT and pNF2CAT are induced to very high levels (132 
and 95-fold respectively), thereby demonstrating that the 
NF promoter, like the HSV-1 lytic cycle promoters, and 
unlike the HSV-1 LAT promoter, responds strongly in the 
presence of HSV-1 trans-activating factors. As both NF 
clones exhibit this response, the sequences through which 
it is mediated are presumably located within the NF1 
sequence.
4D. ANALYSIS OF THE NF PROMOTER IN THE VIRUS VECTOR 
4D.1. Generation of NFCAT Viruses
The Xbal fragments from both pNFlCAT and pNF2CAT 
were isolated and purified, and introduced into the 1802 
(LAT+) vector as described in section 3D.4. These viruses, 
designated with the prefix "v" were used for further 
characterisation of the NF promoter during lytic infection 
of BHK and C1300 neuroblastoma cell lines.
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4D.2. Analysis of NFCAT Virus Genomes
Total DNA was prepared from BHK monolayers infected 
with vNFlCAT and vNF2CAT, and analysed by restriction 
enzyme digestion with Xbal and tfindlll, running on a 1% 
agarose gel alongside the Xbal/Hin&III digests of the 
corresponding NFCAT plasmids, followed by Southern transfer 
to nitrocellulose filters and probing with the Xbal/Hin&III 
NF promoter fragment derived from pNFlCAT. Figure 35 shows 
that the viral DNAs yield NF promoter fragments of similar 
size to those yielded by the corresponding plasmids, thus 
indicating that the NF promoter fragments located within 
the virus genome are intact, and free from any 
rearracfments.
4D.3. CAT Expression from Recombinant Viruses
3.1. BHK Cells The level of CAT activity exhibited by 
vNFlCAT and vNF2CAT, together with controls vFJ5, vFJ7, and 
vFJIO were determined at 6, 12, 24 and 48h pi at a moi of 5 
at 37°C. A typical set of data presented on a linear plot, 
is shown of Figure 36(a). The data parallels that of the 
transfection studies by demonstrating that the NF promoter 
performs very strongly in BHK cells. The CAT activity 
exhibited by vNF2CAT is twice that of vNFlCAT thereby 
confirming that the upstream 5' flanking regions exert an 
influence on NF promoter activity in BHK cells.
3.2. C1300 Cells As for the BHK cells, the level of CAT 
activity exhibited by vNFlCAT, vNF2CAT and controls vFJ5, 
vFJ7 and vFJIO were determined at 6, 12, 24 and 48h pi with 
a moi of 5 at 37°C. A typical set of data, again presented 
on a linear plot is shown on Figure 36(b). The data 
indicates that in neuroblastoma cells, the activity 
exhibited by vNF2CAT is greater than that exhibited by the 
lytic cycle promoter in vFJ7, and indeed is almost 
identical to that of vFJIO. The activity exhibited by 
vNF2CAT is five times that of vNFlCAT, thereby indicating
Figure 35. Southern blot analysis of NF promoter/reporter 
gene fusion viruses. Viral DNA was prepared from infected 
cells when extensive cpe became apparent. Each viral and 
corresponding plasmid DNA was digested with Xbal and 
Hin&III and subjected to Southern blot analysis using a 
nick translated Xbal/Hindlll NF promoter probe derived from 
pNFlCAT.
Track 1: vNFlCAT infected cell DNA 
Track 2: pNFlCAT
Track 3: vNF2CAT infected cell DNA 
Track 4: pNF2CAT
The positions of the NF promoter fragments from each 
recombinant virus are indicated (PI and P2) .

Figure 36. CAT activities produced by recombinant NF 
promoter viruses at various times after infection of BHK 
and neuroblastoma C1300 cells, a) CAT activities generated 
by vFJ5, vFJ7, vFJIO, vNFlCAT and vNF2CAT in BHK cells, b) 
CAT activities generated by vFJ5, vFJ7, vFJIO, vNFlCAT and 
vNF2CAT in neuroblastoma C1300 cells. CAT activities were 
determined at 6, 12, 24 and 48 h post infection and
expressed as the percentage [14C]chloramphenicol converted 
per h per pg protein. The symbols representing each virus 
are indicate in the legends beside each graph.
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that sequences upstream from -296 of the NF gene have 
greater effect on NF promoter activity in neuroblastoma 
cells than in fibroblastic cells. These differences were 
consistently reproduced in every experiment, and suggests 
that this upstream region of the NF gene may contain 
neuronal specific sequences capable of enhancing NF 
promoter activity in these cells.
4E. DISCUSSION
The main conclusions to be drawn from the 
transfection assays (section 4C) are that the two HNF-L 
promoter/CAT fusions (extending back to -296 and -896 from 
the cap site of the HNF-L gene) perform as functional 
promoters in BHK cells and exhibit at least as much 
activity as pgDCAT. pNF2CAT consistently exhibited twice as 
much activity as pNFlCAT, demonstrating that, at least in 
BHK cells, sequences upstream from -296 of the HNF-L 
sequence contribute to HNF-L promoter activity. Other 
studies, (Julien et al., 1987a; Monteiro & Cleveland,
1989), have demonstrated that the HNF-L gene is transcribed 
from its own promoter and processed correctly in mouse 
L-cell and Hela cell lines, despite the fact that these, 
and presumably BHK cells, do not express their endogenous 
NF genes. In mouse L-cells, it was shown that the majority 
of NF-L proteins co-polymerised with the vimentin IF 
network (Monteiro & Cleveland, 1989).
Interestingly, it was found that upon infection 
with HSV-1, CAT activity exhibited by cells transfected 
with the HNF-L/CAT fusions was induced at least as much as 
lytic cycle promoters in pgDCAT and pFJIO. Since both NF 
clones exhibited this response, the sequences through which 
it is mediated are presumably contained within the NF1 
clone (-296 to +84). While the effects of HSV-1 infection 
on cellular promoters has not been extensively studied, it
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has been noted that although host transcription in general 
is reduced, a small number of cellular proteins are 
observed to increase in abundance, eg, heat-shock genes 
(Notarianni & Preston, 1982; Russell et al., 1987a). 
Everett, (1984a, 1985) has shown that when the rabbit 6-
and e-globin promoters are transfected into BHK cells, they 
were activated upon infection with HSV-1. It was also 
demonstrated that when the rabbit B-globin promoter is 
introduced into cell lines by biochemical transformation, 
it is stimulated by HSV-1 infection, whereas the endogenous 
B-globin promoter in rabbit kidney cells is not (Everett, 
1985) . It seems that the activity exhibited by the HNF-L 
promoter in BHK cells (and the B- and e-globin promoters in 
transfection assays (Everett, 1984a, 1985)) probably
reflects the relative chromatin structure of the endogenous 
and transfected genes. While the inactive endogenous 
B-globin gene in rabbit kidney cells is probably wrapped up 
in a densely packed chromatin structure, and therefore 
unavailable for activation, transfected plasmid DNA is 
assembled into an open nucleosomal structure accessible to 
nuclease digestion (Cereghini & Yaniv, 1984), and therefore 
presumably, the cellular transcription apparatus and HSV-1 
transcription factors. The same is probably true for the 
NF-L promoter described here.
The high level of NF promoter activity exhibited in 
the infected transfection experiments is paralleled in the 
virus vector experiments detailing CAT activity during 
lytic infection of tissue culture cells. Expression from 
the HNF-L promoter in C1300 neuroblastoma cells, which have 
been shown to express their endogenous NF genes (cited in 
Julien & Grosveld, 1991) demonstrated that the CAT activity 
exhibited by the strongest HNF-L promoter clone (vNF2CAT) 
was no greater than that exhibited by the HSV-2 IE4/5 
promoter in vFJIO. This is perhaps a reflection of these 
promoters working at maximum capacity in the context of the 
lytic infection, and it would be interesting to see how
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these promoters would perform relative to each other in 
transfection assays in C1300 cells. In another study, the 
rabbit B-globin promoter, when introduced into the HSV 
genome, has been shown to be regulated as an early viral 
gene during infection of fibroblasts (Smiley et al., 1987). 
It was also noted here that while the activity exhibited by 
vNF2CAT is twice that of vNFlCAT in BHK cells, it is almost 
five times greater in C1300 cells, thereby suggesting that 
sequences upstream of -296 may contribute to neuronal 
specificity of the HNF-L gene.
Studies of HNF-L gene expression in transgenic mice 
(Julien et al., 1987b) have found that a 21kb fragment, 
including 14kb of 5' flanking sequences, specifically 
expressed the HNF-L transgene in neuronal tissues. It was 
subsequently found that a transgenic carrying the HNF-L 
gene and 292bp of 5 1 flanking sequence expresses the 
transgene specifically in the nervous system, while a 
deletion to -55 abolishes transcription (cited in Julien & 
Grosveld, 1991). Another study (Vidal et al., 1990), has 
shown that when the thy-1 promoter is replaced with 2. 5kb 
of flanking sequence of the HNF-L promoter in a thy-1 
transgene (a member of the immunoglobulin supergene family 
expressed specifically in neurons), the thy-1 hybrid is 
still expressed in a neuronal specific manner, but retains 
the thy-1 developmental expression pattern, thus 
demonstrating that the NF promoter alone is not sufficient 
for the early developmental expression normally associated 
with the NF gene. It is therefore quite likely that some 
regulatory signals of the NF gene, like those of the thy-1 
gene (Vidal et al. , 1990) are located downstream of the
promoter region.
The transgenic experiments described above would 
appear to suggest that neuronal specific expression can be 
achieved with both the NF1 and NF2 promoter fragments. It 
would therefore be interesting to examine whether this is 
the case when fused to a reporter gene in the context of
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the latent HSV-1 genome. Unfortunately, the NFCAT viruses 
are unsuitable for this kind of study since the CAT assay 
is probably not sensitive enough to allow detection of the 
limited amount of HSV gene expression in latently infected 
ganglia. The virus vector system has been adapted to use 
the l a d  gene instead (see Chapter 5) thereby allowing the 
use of histochemical assays to examine expression of the 
promoter/ l a d  gene fusions in individual cells. These 
viruses were in the process of being made at the time of 
this study, and it will be of great interest to see what 
they tell us about gene expression from the HSV-1 genome 
during latency.
If the NF-L promoter did prove to be active in the 
context of the latent virus genome, it should be possible 
to clone the whole human NF-L gene (including introns) 
together with the 296bp promoter flanking sequence as a 
4.5kb fragment into the 1802 vector genome. Human NF-L 
protein expression from the latent HSV genome in murine DRG 
neurons could be distinguished from the endogenous NF-L 
proteins by use of a monoclonal antibody which detects the 
human, but not the mouse NF-L proteins (Julien & Grosveld, 
1991) . Expression of NF and other neuronal specific genes 
from latent HSV-1 genomes in the murine nervous system 
should provide an alternative to the use of transgenic mice 
for the study of tissue specific gene expression, and 
interaction of NF proteins with the cytoskeleton. If the NF 
promoter did not prove to be active, then the LAT or MMTV 
LTR promoters which are functional during latency, could be 
used as alternatives to drive heterologous gene expression 
from the latent virus genome.
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CHAPTER 5: ANIMAL LATENCY STUDIES
5A. Introduction
The ultimate aim of this study was to examine gene 
expression from the NF and LAT promoter fragments in the 
context of the HSV-1 genome during latency. The NFCAT and 
LATCAT viruses are, however, unsuitable for this work, 
since the CAT assay is unlikely to be sensistive enough to 
allow detection of HSV gene expression in latently infected 
ganglia. For this reason, it was decided to substitute the 
lacZ gene for the CAT gene, thus allowing use of 
histochemical assays for detection of gene expression in 
individual cells in latently infected ganglia. These 
viruses were in the process of being made at the time of 
this study, however, one virus, vFJ12 (containing the HSV-2 
IE-4/5 promoter fused to the l a d  reporter gene) was 
available, and was initially tested in the animal latency 
system.
The mouse footpad model was used, whereby virus is 
inoculated into the right rear footpad, and following 
establishment of latency, typically after 4 weeks, dorsal 
root ganglia are dissected and either explanted to test for 
virus reactivation, or further processed and analysed for 
characteristics of virus gene expression. The first part of 
this study was to determine that the virus vector can 
establish latency, and that the 1802 vector expresses LATs.
5B. Latency Characteristics of the Virus Vector
Comprehensive explantation reactivation and 
pathogenesis studies of the 1802/1804 vectors were not 
carried out, however, some interesting observations of 
these characteristics were made. It was noted that vNFlCAT, 
vFJ12 (see Section 5D.2) and indeed, the other insertion- 
containing recombinants, were non-pathogenic in the footpad 
model; inoculation of up to 2x108 pfu (the maximum 
available dose) failed to register any ill effect. This
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contrasts with HSV-1 17+ which has a lethal dose of 5xl05 
pfu, and interestingly, 1804 where 2/3 mice died after 
inoculation with a dose of 3xl07 pfu. This suggests that 
insertion of sequences into the vector affects 
pathogenicity of the virus. Rixon & Mclauchlan (1990), 
observed that the amount of a Mr 21,000 (21K) protein
synthesised by vFJ7 and vFJIO is reduced compared with the 
parental 1802 vector. The 21K is encoded by US11, one of 
the genes flanking the unique Xbal site in 1802, and it was 
proposed that this reduction could be a result of read 
through transcription from the inserted sequences in vFJ7 
and vFJIO. Other studies (Meignier et al., 1988; M.Y.M 
Taha, Ph.D. Thesis, University of Glasgow, 1990) have 
implicated a role for US11 in pathogenesis of HSV-1, and it 
is intriguing to consider that the non-pathogenicity of the 
insertion-containing virus vector is due to the reduction 
of 21K expression. Further characterisation of the 
1802/1804 vectors is obviously necessary to determine 
whether this is the case.
In reactivation/explantation experiments,
reactivation of vNFlCAT was consistently observed, 
typically from 2-3 ganglia 8-10 days post explant, thereby 
demonstrating that by this criterion, vNFlCAT is able to 
establish a reactivatable latent infection in the footpad 
model.
5C. HSV 1802 Expresses LAT
In order to confirm that HSV-1 1802 expresses LAT, 
in situ hybridisation analysis was performed on sections of 
latently infected ganglia from mice that had been 
inoculated with 2x108 pfu of vNFlCAT (an 1802-derivative). 
These were probed with 35S-labelled riboprobes derived from 
a 219bp Sail/EcoRI fragment excised from plasmid pllOE35 
(Everett, 1987), and ligated into Sall/EcoR! digested pT7T3 
19U such that riboprobes synthesised from the T7 promoter 
were antisense to the IE-1 mRNA, and those from the T3
Figure 37. In situ hybridisation riboprobes. The top line 
gives a schematic representation of the region of TRl/IRl 
between the 5 1 ends of the 2 kb LAT and the 5' end of the 
IE-1 gene. The third line down gives a partial restriction 
enzyme profile of this region, indicating the positions of 
unique Sal I and EcoRI sites. The latter is derived from an 
EcoRI linker insertion IE-1 mutant (pllOE35; Everett, 
1987). The Sall/EcoRI fragment from pllOE35 was excised 
and ligated into Sail/EcoRI digested pT7T3 (shown below) 
such that riboprobes synthesised from the T7 promoter are 
antisense to the IE-1 mRNA, and those from the T3 promoter 
antisense to LAT.
IE-1 mRNA
LAT
S ail EcoRI (HaeDQ c__
pT7T3 LAT
Figure 38. In situ hybridisation of lytically infected BHK 
cells using 35S-labelled riboprobes. a) Lytically infected 
BHK cells hybridised with an anti-IE-1 riboprobe. Labelling 
is predominantly cytoplasmic, b) Lytically infected BHK 
cells hybridised with an anti-LAT riboprobe. The nuclei of 
two cells (marked with an arrow) demonstrate strong signals 
restricted largely to the nucleus.
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Figure 39. In situ hybridisation of sections of latently 
infected murine spinal ganglia using 35S-labelled 
riboprobes. The spinal ganglion section was probed with an 
antisense probe to LAT, and stained with haemotoxy1 in and 
eosin which stains the nuclei and cytoplasm of neuronal 
cells, but only the nuclei of non-neuronal cells. A single 
neuron (marked with an arrow) demonstrates strong signals 
restricted to the nucleus.
» 1
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promoter antisense to LAT (see Figure 37). These riboprobes 
were also used on coverslips of BHK cells 24h pi with HSV-1 
17+ at a moi of 0.01. This work was carried out in 
conjunction with Dr. Marion Ecob-Prince, Southern General 
Hospital, Glasgow.
Figure 38(a) shows HSV-1 infected BHK cells probed 
with the anti-IE-1 riboprobe, and as expected, dense 
patterns of cytoplasmic and nuclear graining can be 
observed in infected cells. With the anti-LAT probe (Figure 
38(b)), graining is observed almost exclusively in nuclei, 
consistent with the known localisation of the LAT 
transcripts in latently infected ganglia. This pattern is 
also observed when the sections of latently infected 
ganglia are probed with the anti-LAT riboprobe; Figure 39 
shows an extremely dense area of graining which, when 
counterstained with haematoxylin and eosin, is found to be 
localised to the nucleus of a neuron. This is identical to 
the pattern of LAT expression shown by others (Stevens et 
al., 1987), and is therefore a clear demonstration that 
vNFlCAT, and thus presumably the parental 1802 vector, 
expresses LAT.
5D. Activity of the HSV-2 IE-4/5 Promoter during Latency
The strategy for this study entailed replacing the 
SV40 promoter/enhancer driving lacZ gene expression in pFJl 
(Rixon & Mclauchlan, 1990; see Figure 40), with the HSV-2 
IE-4/5 promoter. The IE-4/5 promoter/lacZ fusion could then 
be excised as an Xbal fragment and ligated into the 1802 
vector. The high IE-4/5 promoter activity, as observed from 
the CAT assays in BHK cells (section 4C) would allow 
blue/white selection to be used when plaque purifying the 
recombinant virus.
5D.1. Construction of the IE-4/5 Promoter/lacZ Plasmid
The HSV-2 IE-4/5 promoter sequence in plasmid pFJIO 
was excised and purified as a Xbal/Hindlll fragment. This
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was ligated into Xbal/tfindlll digested pFJl (with the SV40 
promoter/enhancer removed). The BamRI site downstream of 
the lacZ gene was converted to a Xbal site by BamRI 
digestion, blunt-ending with T4 DNA polymerase, and 
ligation of the phosphorylated linker 5 1-CTCTAGAG-31 
thereby generating plasmid pFJIOGal+Xbal (this treatment 
regenerated BaniRI sites on either side of the Xbal linker). 
A diagnostic restriction profile of this plasmid is shown 
on Figure 41.
5D.2. Construction of vFJ12
The Xbal fragment from pFJIOGal+Xbal was isolated 
and purified, and introduced into the 1802 vector as 
described in section 3D.4. This virus, designated vFJ12, 
was used for measuring activity of the HSV-2 IE-4/5 
promoter during HSV-1 latency.
5D.3. Analysis of the vFJ12 Genome
Total cellular DNA was prepared from BHK monolayers 
infected with vFJ12 and analysed by restriction digestion 
with Hindlll and Xbal. This analysis, however, failed to 
release the expected IE-4/5 promoter fragment (data not 
shown). Further analysis of restriction profiles of the 
viral DNA revealed that some form of genomic rearrangment 
had occurred within the region. Figure 42 shows a
restriction map of this region of the HSV-1 genome, and 
Figure 43 depicts a series of restriction profiles of vFJ12 
and HSV-1 17+ DNA. The BaniRI profile of vFJ12 shows that 
both BamRI x and z fragments are missing, and the 
appearance of an additional band marked XI. A desitometric 
scan of the negative for the photograph in Figure 43 also 
indicates that one copy of the BaniRI y band is missing as 
well (see Figure 44) . The absence of the BamRI z track is 
expected as the unique Xbal site utilized by the vector 
system is located there (Rixon & McLauchlan, 1990) , and any 
insertion at this site will therefore cause a shift in the
Figure 40. Construction of pFJIOGal+Xba. The Xbal/Hin&III 
HSV-2 IE-4/5 promoter fragment was excised, purified and 
ligated into Xbal/Hindlll digested and purified pFJl DNA to 
give pFJIOGal . The unique BaniRI site in pFJIOGal was then 
converted to a Xbal site by BaniRI digestion, 'blunt-ending' 
with T4 DNA polymerase, and ligation of a XJbal linker. This 
treatment regenerated BamRI sites on either side of the 
Xbal linker insert. SV40; SV40 early promoter. lad; 
E.coli l a d  gene. CAT; chloramphenicol acetyltransferase 
gene. AMP; ampicillin resistance gene.
Xbal Xbal
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SV40 SV40,
pFJl pFJIO
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Figure 41. Restriction digest demonstrating integrity of 
pFJIOGal+Xba. This Figure shows a Xbal/ HindllI digest of 
pFJIOGal+Xba DNA (lane 2) run alongside a 123bp ladder 
(lane 1) on a 1% agarose gel stained with EtBr. This digest 
releases a Xbal/Hindlll IE-4/5 promoter fragment, which 
from the gel, runs alongside the 492bp ladder fragment. 
This is consistent with the expected size of 470bp.
123bp
Figure 42. Map of the S region of the HSV-1 genome. The top
line shows the scale of the figure in map units. The second 
top and bottom lines show the position and scale of the
figure in kbp. The third and fourth top lines show BaniRI 
and Hindlll restriction maps of the S region respectively. 
The Us region, flanked by the repeat regions, TRs and IRs 
are represented by the open boxes in the centre of the 
diagram. The horizontal arrows above and below the open 
boxes represent RNAs; the arrows give the direction of
these transcripts. The shaded black boxes represent the 
ORF's of IE genes; boxes with horizontal lines represent 
early genes; boxes with diagonal lines represent early late 
(delayed early) genes, and cross-hatched boxes represent 
late genes. Open boxes directly below the S region 
(labelled R) represent tandem repeats. The position of the 
unique Xbal site utilized in the 1802 and 1804 vectors is 
also indicated. This Figure is reproduced and adapted from
one originally published in McGeoch et al. (1990), with
permi ss ion.

Figure 43. Restriction profiles of vFJ12 and HSV-1 17+ DNA.
Lanes 1 and 2 shows BamRI restriction profiles of vFJ12 and 
HSV-1 17+ virion DNA. The HSV-1 17+ bands are labelled from 
o to d '. As observed from lane 2, BamRI x and z are missing 
from the vFJ12 profile which also has an additional band, 
marked XI, present. Lanes 4 to 7 show additional BamRI and 
Ua/nHI/i7indIII profiles of vFJ12 and HSV-1 17 + 
electrophoresed further than those in lanes 1 and 2. Lane 3 
shows a lkb DNA ladder with bands labelled 2 (2kb) to 8
(8kb). The fragments of the BamRI profile of HSV-1 17+ 
(lane 7) are labelled 1 to z. The .BaTnHI/tfindlll profile of 
vFJ12 has an additional band marked X 2 .
VFJ12 HSV-1 wt
1 kb I----
Udder I Bam
M  W H B H H "  * m
Lanes : 1 2 3 4  5 6 7
Figure 44. Densitometric scans of vFJ12 and HSV-1 wt 
restriction profiles. A negative of the photograph showing 
the BamHI restriction profiles of vFJ12 and HSV-1 wt in 
Figure 43 was scanned using a Hoefer Scientific Instruments 
GS300 transmittance/reflectance densitometer. The vFJ12 
profile is shown on the upper scan while HSV-1 wt is on the 
lower. Both scans show the region between BamHI u and v, 
(corresponding to peak 5) and BamHI b ' (corresponding to 
peak 9 on vFJ12 and peak 11 on HSV-1 w t .)
5: BamHI u. V. HSV-1 wt: Peak 5: BamHI u, v .
6: BamHI w. 6: BamHI w.
7: BamHI y- 7: BamHI X.
8: BamHI a \ 8: BamHI y-
9: BamHI b ’. 9: BamHI z.
10: BamHI a '.
11: BamHI b' .
The BamHI y peak on the wt profile is larger than those of 
it's neighbours indicating that it is present at a higher 
molar ratio, ie, present as two copies. In contrast, the 
BamHI y peak on the vFJ12 profile is comparatively smaller, 
especially when compared to the BamHI w peak. This 
indicates that BamHI y is present as a single copy in 
vFJ12.
V F J12
HSV-1 wt
Figure 45. DNA sequence of the region upstream from the 
iacZ gene in pFJIOGal and vFJ12. The first four tracks show 
the sequence of the HSV-2 IE-4/5 promoter upstream from the 
l a d  gene in plasmid pFJIOGal. The sequencing reaction was 
carried out using a primer complementary to the 5 1 end of 
the l a d  gene. The second four tracks show a similar 
sequencing reaction carried out on vFJ12 virion DNA. 
Although the resolution of the vFJ12 sequence is very poor, 
close examination reveals certain similarities between the 
vFJ12 and pFJIOGal tracks, thus confirming that at least a 
major portion of the HSV-2 IE-4/5 promoter remains upstream 
from the l a d  gene in vFJ12.
A C G T  A C  G T
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mobility of this band. The additional band marked XI is, in 
fact, the half of BamRI z between the BamRI site at the 3' 
end of the lacZ gene (regenerated by the insertion of the 
Xbal linker into the BamRI site of pFJIOGal; see section 
5D.1), and BamRI j (see Figure 42). The size of this band 
(1135 bp) between BamRI b' (1313 bp) and c' (428 bp) is 
indeed indicative of the orientation of the l a d  gene, ie, 
pointing away from the adjacent short repeat (Figure 42) . 
The only significant difference between the BamRI/Hindlll 
profiles of vFJ12 and wt DNA (Figure 43) is an additional 
band marked 2X (running between BamRI o (3866bp) and BamRI 
p (3579bp). This is, in fact, a 3731bp band containing the 
lacZ gene between the BamRI site at it's 3' end (re-created 
by ligation of the Xbal linker into the blunt-ended BamRI 
site of pFJIOGal), and the Hindlll site between the IE-4/5 
promoter and the lacZ ORF. In an attempt to determine the 
sequence immediately upstream of the l a d  gene, sequencing 
of purified vFJ12 virion DNA using a primer complementary 
to the 5' end of the l a d  was performed, and run on a gel 
alongside a similar sequencing reaction performed on 
pFJIOGal DNA. Although the resolution of the vFJ12 
sequencing.tracks was poor, (Figure 45), it is quite clear 
that the pattern of bands in the viral DNA tracks are 
similar to those in the plasmid DNA tracks, thereby 
demonstrating that at least a major portion of the IE-4/5 
promoter is still present upstream of the l a d  gene. At 
this point, the work for this thesis came to an end, and 
although the analysis of the genomic structure of this 
virus was being continued, latency studies had already been 
initiated in mice, and gave the interesting results 
desribed below.
5D.4. fl-Galactosidase Expression during Acute and Latent 
Infection of Murine Sensory Ganglia
4.1. Expression during Acute Infection of Sensory Gancrlia
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To examine lacZ gene expression by vFJ12 during the 
lytic phase of viral infection, murine dorsal root ganglia 
were examined at 2, 4, 6, and 8 days following footpad
inoculation with 1.6xl07 pfu of vFJ12. fi-galactosidase 
activity was detected by histochemical staining at all 
timepoints (except day 2) in the lumbar dorsal root ganglia 
of infected mice, and was visible in both whole mount 
preparations and wax-embedded sections. The majority were 
located in the L4 and L5 ganglia (see Table 9). The 
labelling observed in neurons on days 4 and 6 was so 
intense that in whole mounts, it could also be observed in 
axons, an effect probably due to diffusion of 
fi-galactosidase from the neuronal soma (see Figure 46) . 
These cells appeared completely opaque in sections of these 
ganglia (see Figure 47). Such labelling is possibly 
indicative of the very strong promoter activity associated 
with IE promoters during the acute phase of virus infection 
in ganglia which peaks at around 5 days post infection (see 
Section ID.2). The histochemical staining of neurons at day 
8 (Figure 47) was much less intense, and cytological detail 
could be observed in those cells. This lower level of 
fi-galactosidase activity probably corresponds to a 
reduction in IE promoter activity following the peak of 
acute infection.
4.2. Expression during Latent Infection of Sensory Ganglia
To examine l a d  gene expression by vFJ12 during 
latency, whole mounts and sections of murine dorsal root 
ganglia were examined 1 month following footpad inoculation 
with up to 1x10® pfu of vFJ12. As observed from the whole 
mounts (Figure 48) , and sections (Figure 49) , 
histochemically stained neurons were observed in the spinal 
ganglia of these mice, but not those of uninfected 
controls, or indeed, controls infected with the parental 
vector virus. Labelled neurons were observed in both whole 
mounts and sections, and as during acute infection, most
Ganglion Number of blue cells per ganglion observed at:
4 Days 6 Days 8 Days 20 Weeks
LI 0 0 7 0
L2 0 0 5 0
L3 2 3 6 2
L4 5 5 36+ 17
L5 1 8 28+ 23
Table 9: Number of neurons expressing fi-galactosidase in
lumbar sensory ganglia dissected from the right hand side 
of mice examined at intervals following inoculation with 
vFJ12. One mouse was examined per time point except at 20 
weeks when two mice were examined.
Figure 46. fl-galactosidase activity in a whole mount of a 
dorsal root ganglion from a mouse acutely infected with 
vFJ12. At 4 days after inoculation, animals were sacrificed 
and spinal ganglia removed. This whole mount spinal 
ganglion was stained histochemically for 6-galactosidase 
activity. The photograph clearly shows a densely stained 
neuron and associated axon.
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Figure 47. fi-galactosidase expression in sections of dorsal 
root ganglia from mice acutely infected with vFJ12. At 4
and 8 days after inoculation, animals were sacrificed and 
spinal ganglia removed. Whole mounts were stained 
histochemically for 6-galactosidase activity and sectioned 
at 6pm. a) shows a densely stained neuron in a section from 
an acutely infected ganglion at 4 days after inoculation,
b) shows a lightly stained neuron in a section from an 
infected ganglion at 8 days after inoculation.
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Figure 48. B-galactosidase expression in whole mounts from 
dorsal root ganglia from mice latently infected with vFJ12.
At 6 months after inoculation, animals were sacrificed and 
spinal ganglia were removed. Whole mounts of spinal ganglia 
were stained histochemically for B-galactosidase activity, 
a) shows a control ganglion from an uninfected mouse, b) 
shows a ganglion from a mouse latently infected with vFJ12.
c) shows a latently infected ganglion at higher 
magnifiction and demonstrates a speckled pattern of 
labelling within positive cells.
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Figure 49. fi-galactosidase expression in sections of dorsal 
root ganglion neurons from mice latently infected with 
vFJ12. At 6 months after inoculation, animals were 
sacrificed and spinal ganglia were removed. The ganglia 
were histochemically stained for B-galactosidase activity, 
paraffin embedded, and sectioned at 6p.m. a) Shows a whole 
section from a ganglion latently infected with vFJ12. 
Several neurons can be observed with a speckled pattern of 
cytoplasmic labelling, b) shows a higher magnification of 
cytoplasmic staining in neurons.
av
i
*)0 ]yf^ \
168
were located in the L4 and L5 ganglia (Table 9). Labelling 
was occasionally observed in the lower thoracic ganglia. 
The histochemical staining of latently infected neurons was 
predominantly of a speckled cytoplasmic nature, and of 
similar intensity to that observed at day 8. Labelling was 
never observed in axons or non-neuronal cells.
This result shows, perhaps surprisingly, that the 
l a d  gene is expressed in neurons of sensory ganglia 
latently infected with vFJ12. The implications of this 
result are discussed in the following section.
5E. DISCUSSION 
5E.1. Characterisation of Gene Expression from vFJ12
The aim of this study was to test the animal 
latency system and histochemical gene expression assay by 
examining HSV-2 IE-4/5 promoter activity in the context of 
the HSV-1 genome during acute and latent infection of 
murine dorsal root ganglion neurons. As described in 
Section 5D.3, histochemically stained neurons were observed 
at 4, 6 and 8 days post infection with vFJ12. The most
intensely stained neurons were observed at 4 and 6 days 
which is coincidental with the peak of acute infection (see 
Section ID.3.1). This result indicates that the HSV-2 IE- 
4/5 promoter is capable of exhibiting high expression 
during acute infection of dorsal root ganglion neurons, and 
is consistent with the notion of IE promoters working at 
maximum efficiency during lytic infection. Those neurons 
observed at 8 days post infection were very much less 
intensely stained, probably as a result a reduction in IE 
promoter activity near the end of the acute stage of viral 
infection. They also appeared speckled as was observed 
during latency.
The most intriguing result of this study was the 
observation that vFJ12 is capable of exhibiting long term
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expression (up to 6 months) in latently infected sensory 
ganglia. This seems contrary to the accepted opinion that, 
with the exception of the LAT gene, the HSV-1 genome is 
transcriptionally silent (Stevens et al., 1987; Deatly et 
al., 1988; Gordon et al.t 1988). It is possible that the 
B-galactosidase activity observed in latently infected 
ganglia is residual from the initial infection. This seems 
unlikely, however, since on the basis of the difference in 
the labelling of neurons between days 4 and 6, and day 8 of 
acute infection, B-galatosidase does not appear to be a 
particularly stable enzyme. Even if it were stable, it is 
difficult to concieve of it being present in neurons for up 
to 6 months. Another possibility is that the virus was in 
the process of reactivating at the time of dissection, 
although this again is unlikely due to the fact that 
histochemical labelling was observed in sensory ganglia 
from all mice latently infected with vFJ12, and it is
highly improbable that all of these mice were undergoing 
reactivation. B-galactosidase activity has been used as a 
criterion of promoter activity in latently infected ganglia 
in a number of other studies (Dobson et al., 1989, 1990; Ho 
& Mocarski, 1989), and thus supports the view that the
B-galactosidase activity observed in sensory ganglia was 
due to genuine latent expression of lacZ from vFJ12.
Studies of the genome structure have, however, revealed 
certain ambiguities in the region surrounding the insertion 
of IE-4/5 promoter lacZ fusion in Us. As explained in
section 5D.4, while initial sequencing studies appear to 
confirm that the IE-4/5 promoter is still upstream of the 
l a d  gene, restriction profile analysis of the viral DNA 
has revealed deletions in the Us region which take out 
BamUl x, and one copy of BamRI y. It is possible that this 
has occurred by homologous recombination between the 
introduced HSV-2 IE-4/5 promoter and the endogenous HSV-1 
IE-4/5 promoters which flank Us in TRs and IRs 
respectively. Comparison of the HSV-1 and HSV-2 IE-4/5
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promoter sequences does indeed reveal some homology (see 
Figure 50) , thus making this prospect a definite 
possibility. More likely is that the deletion in vFJ12 
could have moved the IE-4/5 promoter/IacZ fusion into the 
LAT transcription unit, thereby effectively placing the 
l a d  gene under control of the LAT promoter, with ensuing 
B-galactosidase activity being observed during latency. As 
both BamHI b and e are unaffected by the deletion in vFJ12, 
it seems most likely that the l a d  gene has moved into 
.Ba/nHI k. This possibility can only be confirmed by further 
characterisation of the vFJ12 genome, most likely by 
sequencing from the HSV-2 IE-4/5 promoter into the flanking 
endogenous HSV-1 sequence. If this were the case though, 
then a precise determination of where l a d  is inserted into 
the LAT gene in vFJ12 could provide valuable information 
concerning the size and nature of the LAT transcript.
Although the majority of other studies have, with 
the exception of LAT, failed to detect gene expression from 
the latent HSV-1 genome, it is interesting to note that 
Deatly et al. (1987), when using JBamHI n and .BamHI x probes 
(specific for the IE-3 and 4, and IE-5 genes respectively) 
could detect a limited number of strongly positive cells in 
latently infected mice. Although they scored these sections 
overall as negative, they stated that transcripts from 
these genes may be present at very low levels and/or 
expressed in a small fraction of latently infected cells. 
This would fit in with the comparatively low (compared with 
that during acute infection) B-galactosidase activity 
observed in sensory ganglia latently infected with vFJ12.
All other studies have, as yet, failed to detect 
expression from any of the other IE genes during latency. 
Deatly et al. (1988) and Gordon et al. (1988) failed to 
detect any IE-1, 2 or 3 transcripts using in situ
hybridisation, and Lynas et al. (1989) failed to detect 
IE-1 gene expression using the polymerase chain reaction. 
In another study, Ho & Mocarski, (1989), when using a
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HSV-1 recombinant containing an IE-3 promoter/lacZ fusion, 
could detect strong fi-galactosidase activity in murine 
sensory ganglia during acute infection, but did not observe 
any long term expression during latency.
5E.2. Applications of HSV-1 Based Vectors
The demonstration that recombinant herpes simplex 
viruses are able to express foreign genes under the control 
of viral and heterologous promoters during latent infection 
of PNS and CNS neurons (Dobson et al, 1990), raises the 
possibility for the use of such vectors in neurobiological 
investigations. For example, as proposed earlier, a vector 
expressing the whole neurofilament gene under control of 
its own or the LAT promoter could be used to study the 
interaction of NF proteins with the neuron cytoskeleton. 
Also, as Geller & Freese (1990), suggested, HSV vectors 
could be used to alter the physiology of neurons by 
transduction of genes encoding second messengers or 
neurotransmitters.
Perhaps the most exciting potential application of 
herpes vectors is in human gene therapy in the brain. 
Several pioneering gene therapy studies have been carried 
out involving retrovirus-mediated gene transfer of genetic 
material into cells derived from a variety of somatic host 
tissues, including cells from the haemopoietic system, 
fibroblasts, hepatocytes, endothelial cells and myoblasts 
(reviewed in Verma, 1990) . Retroviral-mediated gene 
transfer in the nervous system is not feasible, however, 
since retroviruses cannot integrate their DNA into non- 
mitotic cells such as neurons. HSV on the other hand, is 
capable of long term retention of its genome in neurons, 
and of expressing foreign genes while latent. Potential 
problems that may have to be overcome are, for example, 
establishing that any promoters used to drive gene 
expression are active in the CNS, and also how efficiently 
the virus establishes latency when inoculated directly into
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the brain. Additionally, it is possible that 
straightforward neuronal expression per se of any 
transduced gene may not be sufficient, and control of 
expression may have to be considered.
Two neurological disorders which can be considered 
as candidates for herpesvirus based gene transfer therapy 
are Lesh-Nyhan syndrome and Parkinson's disease. The former 
is a devastating disease caused by a deficiency of the 
purine salvage enzyme hypoxanthine guanine
phoshoribosyltransferase (HGPRT) which catalyses the 
conversion of hypoxanthine and guanine to the 
mononucleotides IMP and GMP respectively. This leads to the 
build up of uric acid culminating in severe neurological 
disease. Pallela et al. (1988), have reported HSV-mediated 
HGPRT gene transfer into a HGPRT-deficient neuroma cell 
line. Their virus had the HGPRT gene inserted into the TK 
locus of the HSV-1 genome, and under control of the TK 
promoter. This particular construct would therefore not be 
useful for in vivo studies since the TK promoter is not 
functional during latency. The HGPRT gene would have to be 
expressed from a neuronally active promoter, eg, the LAT or 
perhaps from its own promoter.
Parkinson's disease is caused, at least in part, by 
failure of neurons of the substantia nigra to synthesise 
the neurotransmitter dopamine. Currently, the most 
effective treatment of the symptoms of Parkinsons disease 
is L-dopa, the precursor of dopamine, the systemic 
administration of which results in undesirable side 
effects. A more effective therapy would perhaps be the use 
of a HSV vector to transduce the gene encoding tyrosine 
hydroxylase (the enzyme that converts tyrosine to L-dopa) 
into neurons of the substantia nigra, thereby restoring the 
ability to produce dopamine directly to appropriate target 
areas within the brain. Another therapy being considered 
involves intracerebral grafting of primary fibroblasts 
genetically engineered to produce L-dopa by retrovirus-
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mediated gene transfer. Fisher et al. (1991) demonstrated 
that fibroblasts transduced with the tyrosine hydroxylase 
cDNA or B-galactosidase gene continued to express the 
transgene for at least 10 weeks. Tyrosine hydroxylase was 
also synthesised by fibroblasts implanted into a host (rat) 
brain as assessed by a behavioural measurement of an animal 
model of the disease. Graft efficacy however, diminished 
between 4 and 8 weeks post grafting, a possible reason for 
which was the shut-off of tyrosine hydroxylase gene 
expression through loss of MMTV LTR promoter function. Loss 
of LTR function has been observed in other retroviral 
vectors (Xu et al. , 1989), as well as in a HSV-1 based
vectors in motor neurons (Dobson et al., 1990). Transient 
expression has also been observed with a HSV-1 based vector 
containing a CMV major IE promoter/IacZ fusion in cultured 
neurons (Johnson et al,. 1992). It thus seems that further 
improvements are required in the design of HSV vectors to 
allow long-term gene transfer to neurons, both in vitro and 
in vivo.
The notion of HSV-1 mediated gene transfer in the 
nervous system must, however, be treated with reserve, 
since it is quite clear that a greater understanding of the 
mechanisms underlying the pathogenesis of latent HSV 
infection is required before any potential gene therapy 
vector can be put to serious use. Such a vector will 
probably have to be delivered directly to target neurons in 
the CNS, and will therefore have to be rendered incapable 
of entering the lytic cycle, thus establishing a permanent 
unreactivatable latent infection. Furthermore, the vector 
could not be cytotoxic, as certain viruses with mutations 
preventing entry into the lytic cycle, (eg tsk at npt) are 
still capable of being. Finally there is the possibility 
that HSV can cause transformation and oncogenesis, though 
this has never been shown for cells in the nervous system. 
Nevertheless, despite these important issues, all of which 
could be overcome in due course, it is certain that HSV
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vectors have tremendous potential, and it will be of great 
interest to see what further developments can bring to this 
field.
4F.4. Future Prospects
The demonstration that lacZ can be used as an 
effective reporter gene to evaluate promoter function 
during latency is certain to aid the understanding of the 
control of gene expression from the latent HSV genome, 
especially with respect to analysing the LAT promoter. 
Indeed, plasmids have been constructed which have portions 
of the LAT promoter (the LAT6 and LAT60 fragments) driving 
lacZ activity and these await insertion into the virus and 
subsequent characterisation. This study should allow a 
definitive characterisation of the minimal sequence 
required for LAT promoter function during latency, with 
subsequent mutagenesis being carried out to define and 
determine the importance of critical sequence motifs.
In addition to determining why certain promoters 
are functional during latency, the vectors can also be 
employed to determine why the HSV lytic cycle promoters are 
non-functional. As well as deletion and site-directed 
mutational analysis, it would be interesting to swap 
sequences between the LAT and lytic cycle promoters. An 
additional virus which should aid this analysis, vFJ7Gal 
with the HSV-2 RR2 driving lacZ gene expression has been 
constructed and awaits characterisation.
In addition to experiments characterising promoter 
functionality during latency, recombinants could be 
constructed where the reporter gene is replaced by other 
genes of greater interest. As well as the NF gene suggested 
earlier (section 4F.3), the coding sequences of other HSV 
genes, in particular the IE genes, could be used, and these 
viruses characterised for their ability to establish, 
maintain and reactivate from latency. Continuous expression 
of IE genes from the viral genome in neurons, however,
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carries inherent dangers, in as such that they may prevent 
HSV from entering the latent state and going on to cause 
neuronal destruction with potentially lethal consequences. 
These vectors may also allow us to address questions such 
as whether or not a latently infected neuron can be further 
infected following a secondary application of HSV in mice, 
or if all latent HSV-1 genomes containing intact LAT 
transcription units actually express LAT. To answer the 
former question, one could establish a latent infection 
with a LAT~, B-galactosidase expressing virus, followed by 
superinfection with a LAT+ virus. Alternative sections of 
latently infected ganglia could then be processed for 
histochemical staining for B-galactosidase activity, and in 
situ analysis for LAT respectively. Doubly-infected neurons 
could subsequently be identified by comparison of alternate 
sections. With respect to the latter question, one could 
establish a latent infection with a virus that expresses B- 
galactosidase (though not under control of the LAT 
promoter) and again process alternative sections of 
latently infected ganglia for histochemical and in situ 
analysis. The identification of neurons which express lacZ, 
but not LAT, would be an indication that not all latently 
infected genomes express LAT. It may be, however, that 
genomes not able to express LAT may also not be able to 
express lacZ.
Finally, a comprehensive study of the latency and 
pathogenesis characteristics of 1802/1804 is required. Of 
possible interest here is the apparent correlation between 
non-pathogenicity and reduction in expression of the 21K 
protein encoded by Usll when sequences are inserted into 
the Xbal site. It will be interesting to see if further 
studies can determine a direct role for this gene, of as 
yet unknown function, in virus pathogenesis.
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-14 61 TTTAAATAAACCAATGTCGGAATAAACAAACACAAACACCCGCGACGGGGGGACGGAGGG
-14 01 GACGGAGGGAGGGGGTGACGGGGGACGGGAACAGACACAAAAACAACCACAAAAAACAAC
-13 41 CACCCACCGACACCCCCACCCCAGTCTCCTCGCCTTCTCCCACCCACCCCACGCCCCCAC
-12 81 TGAGCCCGGTCGATCGACGAGCACCCCCGCCCACGCCCCCGCCCCTGCCCCGGCGACCCC
-12 21 CGGCCCGCACGATCCCGACAACAATAACAACCCCAACGGAAAGCGGCGGGGTGTTGGGGG
-1161 AGGCGAGGAACAACCGAGGGGAACGGGGGATGGAAGGACGGGAAGTGGAAGTCCTGATAC
<-------------------------------------
-1101 CCATCCTACACCCCCCTGCCTTCCACCCTCCGGCCCCCCGCGAGTCCACCCGCCGGCCGG 
--------------Conserved locus 1  > <-------------
-10 41 CTACCGAGACCGAACACGGCGGCCGCCGCAGCCGCCGCAGCCGCCGCCGACACCGCAGAG
—  Conserved locus 2 --->
Hinfl
-9 81 CCGGCGCGCGCACTCACAAGCGGCAGAGGCAGAAAGGCCCAGAGTCATTGTTTATGTGGC
<---------------
Spl
-921 CGCGGGCCAGCAGACGGCCCGCGACACCCCCCCCCCGCCCGTGTGGGTATCCGGCCCCCC
- Conserved locus 3 — > <------------
Spl. CAAT
-8 61 GCCCCGCGCCGGTCCATTAAGGGCGCGCGTGCCCGCGAGATATCAATCCGTTAAGTGCTC 
Conserved locus 4 -> <------
PstI
-8 01 TGCAGACAGGGGCACCGCGCCCGGAAATCCATTAGGCCGCAGACGAGGAAAATAAAATTA 
  Conserved locus 5 ------------------------>
LPBF CRE TATA
-7 41 CATCACCTACCCACGTGGTGCTGTGGCCTGTTTTTGCTGCGTCATCTCAGCCTTTATAAA 
<-----------  Conserved locus 6------------------------
Pvul
-6 81 AGCGGGGGCGCGGCCGTGCCGATCGCGGGTGGTGCGAAAGACTTTCCGGGCGCGTCCGGG 
 >
PstI
-6 21 TGCCGCGGCTCTCCGGGCCCCCCTGCAGCCGGGGCGGCCAAGGGGCGTCGGCGACATCCT
Nael
-561 CCCCCTAAGCGCCGGCCGGCCGCTGGTCTGTTTTTTCGTTTTCCCCGTTTCGGGGGTGGT
-501 GGGGGTTGCGGTTTCTGTTTCTTTAACCCGTCTGGGGTGTTTTTCGTTCCGTCGCCGGAA
Smal
-4 41 TGTTTCGTTCGTCTGTCCCCTCACGGGGCGAAGGCCGCGTACGGCCCGGGACGAGGGGCC
<----- Conserved
Nael
-381 CCCGACCGCGGCGGTCCGGGCCCCGTCCGGACCCGCTCGCCGGCACGCGACGCGAAAAAG 
locus 7 ----- > <---------------
-321 GCCCCCCGGAGGCTTTTCCGGGTTCCCGGCCCGGGGCCTGAGATGAACACTCGGGGTTAC 
  Conserved locus 8 ------------->
Nael
-261 CGCCAACGGCCGGCCCCCGTGGCGGCCCGGCCCGGGGCCCCGGCGGACCCAAGGGGCCCC
<---------  Conserved locus 9------------
SphI
-201 GGCCCGGGGCCCCACAACGGCCCGGCGCATGCGCTGTGGTTTTTTTTTCCTCGGTGTTCT 
 >
-141 GCCGGGCTCCATCGCCTTTCCTGTTCTCGCTTCTCCCCCCCCCCTTCTTCACCCCCAGTA
-81 CCCTCCTCCCTCCCTTCCTCCCCCGTTATCCCACTCGTCGAGGGCGCCCCGGTGTCGTTC
I—  5' end of 2 kb L A T  >
-21 AACAAAGACGCCGCGTTTCCAGGTAGGTTAGACACCTGCTTCTCCCCAATAGAGGGGGGG
3 9 GACCCAAACGACAGGGGGCGCCCCAGAGGCTAAGGTCGGCCACGCCACTCGCGGGTGGGC
Hinfl
9 9 TCGTGTTACAGCACACCAGCCCGTTCTTTTCCCCCCCTCCCACCCTTAGTCAGACTCTGT
Nael
159 TACTTACCCGTCCGACCACCAACTGCCCCCTTATCTAAGGGCCGGCTGGAAGACCGCCAG
219 GGGGTCGGCCGGTGTCGCTG
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